text
stringlengths 102
99.6k
| url
stringlengths 31
426
| crawl_date
timestamp[us, tz=UTC]date 2022-04-01 00:29:49
2022-09-19 04:34:15
|
|---|---|---|
Topeka pool to hold 3rd annual Sunflower Aquathon
TOPEKA, Kan. (WIBW) - The 3rd annual Sunflower Aquathon will be returning to the Shawnee North Family Aquatic Center on July 16.
The aqua event is a three hour fitness class designed to raise awareness for fun and effective water fitness. The Sunflower Aquathon gives participants challenges of different formats designed and led by Shockwave Aqua Fitness.
Sharlie Peterson, Shockwave Aqua Fitness Director, said participation in water fitness classes has been growing in Topeka.
“We’ve seen our classes double in participation this year and also in 2021. People are finding out they can receive a challenging, effective workout while enjoying the water,” Peterson said.
The Sunflower Aquathon begins at 9:00 a.m. on July 16. To sign up for the event, click here.
Copyright 2022 WIBW. All rights reserved.
|
https://www.wibw.com/2022/07/07/topeka-pool-hold-3rd-annual-sunflower-aquathon/
| 2022-07-07T22:50:19Z
|
Clea Shearer and Joanna Teplin are best friends from Nashville who turned their friendship into a partnership and started a business and you may have heard of it, “The Home Edit.” This dynamic duo have created an easy to do, fool proof organizational and cleaning method and it has caused quite the sensation.
Once the world discovered the two and their organizational skills there was no going back, since starting their business it has grown into a full empire. They have paired up with the container store and designed their own products, there are two season of “The Home Edit” on Netflix and now they have partnered with CESAR dogfood.
Clea and Joanna are not only friend and family friendly but they are now canine friendly. The pair has helped the brand with not only exceptional organizational ideas for your pet zones but they are also spreading the message of having a pet friendly work place.
You can purchase ‘Cesar’s Canine Cuisine’ in stores and you can catch both seasons of ‘The Home Edit’ on Netflix now.
This segment aired on the KTLA 5 Morning News on July 27, 2022.
|
https://cw33.com/entertainment-news/the-home-edits-clea-shearer-and-joanna-teplin-gives-a-whole-new-experience-on-canine-organization/
| 2022-07-27T21:45:46Z
|
- Real-world data shows that at a 94% sensitivity level for prostate cancer ClarityDX Prostate® is 147% more specific than the PSA test for predicting clinically significant prostate cancer.
- Using ClarityDX Prostate® as a reflex test vs. PSA test alone could have resulted in 37% fewer unnecessary biopsies.
- The clinical study recruited men from two sites in Alberta, Canada, and one site in Baltimore, USA.
EDMONTON, AB, June 30, 2022 /PRNewswire/ - Nanostics Inc., a precision health diagnostics company, today announces positive data from a pre-biopsy clinical validation study of its ClarityDX Prostate® test designed to improve the accuracy of detecting clinically significant prostate cancer in men that are at risk of the disease.
The ClarityDX Prostate® test uses a proprietary machine-learning algorithm that combines data from two biological biomarkers and three clinical biomarkers to generate a risk score for clinically significant prostate cancer. The ClarityDX Prostate® test is intended to be used as a reflex test for men with elevated levels of PSA, the current prostate cancer screening test, and is designed to help physicians and patients make a more informed decision to proceed with biopsy or not.
"We are extremely excited to announce positive results from the clinical validation study of the ClarityDX Prostate test in Alberta", John Lewis, CEO of Nanostics said, "Implementing ClarityDX Prostate as a reflex test for men with elevated PSA levels will improve decision-making for men and their families, while providing substantial savings for healthcare systems and resulting in better health outcomes for men with prostate cancer."
A total of 1,437 men between 40-75 years of age, with elevated PSA levels, no prior prostate cancer diagnosis, and who were referred for prostate biopsy, were recruited for this clinical study. Algorithmic risk models to predict prostate cancer or clinically significant (grade group ≥2) prostate cancer were generated using data from 1036 men recruited at the Kipnes Urology Center in Edmonton, AB, and a site in Baltimore, USA. These models were then tested in a validation cohort of 401 men recruited at the Prostate Cancer Center in Calgary, AB.
The ClarityDX Prostate® test provided 94% sensitivity, 37% specificity, 49% positive predictive value, and 90% negative predictive value for predicting clinically significant (grade group ≥2) prostate cancer. The potential impact of the ClarityDX Prostate® test is considerable; implementation could eliminate up to 37% of unnecessary biopsies and significantly reduce the number of unnecessary treatments for prostate cancer. The results from the study are being submitted for peer-reviewed publication. Beyond the immediate cost savings to the healthcare system, the launch of the ClarityDX Prostate® test will positively impact the overall healthcare experience and quality of life for men with prostate cancer.
The study was conducted in partnership with DynaLIFE Medical Labs and the Alberta Prostate Cancer Research Initiative (APCaRI) at the University of Alberta. Funding for the clinical study comes in part from The Bird Dogs, Motorcycle Ride for Dad, Alberta Cancer Foundation, Alberta Innovates, the University Hospital Foundation Kaye Fund, and the Frank and Carla Sojonky Chair in Prostate Cancer Research funded by the Alberta Cancer Foundation, held by Dr. John Lewis from 2012 to 2022.
Nanostics is a private Alberta-based company focused on the development and commercialization of novel and non-invasive diagnostic tests. Its core technology, ClarityDX®, uses advanced machine learning algorithms to create a disease risk score. ClarityDX® is applicable to a wide range of cancers and other diseases. Nanostics' lead product, ClarityDX Prostate®, is a test that improves the accuracy of detecting clinically significant prostate cancer. Read more at: www.nanosticsdx.com.
For more information:
Corporate Contact:
John Lewis, Ph.D.
CEO, Nanostics, Inc.
info@nanosticsdx.com
Media Contact:
Perrin Beatty
+1-800-672-2027
View original content to download multimedia:
SOURCE Nanostics
|
https://www.mysuncoast.com/prnewswire/2022/06/30/nanostics-announces-study-data-supporting-claritydx-prostate-reflex-test-predict-clinically-significant-prostate-cancer/
| 2022-06-30T13:06:33Z
|
Near doubling of demand by 2035 would create 'unprecedented and untenable' supply deficits
WASHINGTON, July 14, 2022 /PRNewswire/ -- The challenge of meeting Net-Zero Emissions by 2050 "will be short-circuited and remain out of reach" unless significant new copper supply comes online in a timely way, according to a new study by S&P Global that examines the growing mismatch between available copper supply and future demand resulting from the energy transition.
A presentation of the study findings will be made via webinar Thursday, July 14, 2022, at 10:00am EDT. Click here to register for the event.
The study, entitled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition? projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035 in order to deploy the technologies critical to achieving net-zero by 2050 goals. The record-high level of demand would be sustained and continue to grow to 53 million metric tons in 2050—more than all the copper consumed in the world between 1900 and 2021.
The new study is in response to concerns raised by a number of authorities—including the U.S. government, the European Union, the International Monetary Fund, the World Bank and the International Energy Agency—about the availability and reliability of supply of minerals that will be needed to meet climate goals.
The study projections are based on a detailed bottom-up, technology by technology approach that leverages the S&P Global Multitech Mitigation scenario, which achieves net-zero goals by 2050 and is comparable to the International Energy Agency's new Net Zero by 2050 scenario.
"Copper is the metal of electrification and absolutely essential to the energy transition," said Daniel Yergin, vice chairman, S&P Global. "Given the global consensus for Net-Zero Emissions by 2050, it is critical to understand the physical materials required for achieving that ambition. The world has never produced so much copper in such a short timeframe as would be required. On current trends, the doubling of global copper demand by 2035 would result in significant shortfalls."
The demand surge would be driven, in large part, by the rapid, large-scale deployment of technologies such as electric vehicles, charging infrastructure, solar PV, wind and batteries. More copper intensive than their conventional counterparts, demand from these areas would nearly triple by 2035. At the same time, copper demand from traditional sources not directly related to the energy transition would continue to grow.
This "New Era of Copper Demand" would result in unprecedented and untenable shortfalls in supply, the study says.
Notably, growth in new copper supply capacity—from new mines or expansions of existing projects—would unlikely be able to keep pace with the surge in demand, the study says. The International Energy Agency has estimated that it currently takes 16 years, on average, to develop a new mine, meaning that a new mine seeking permission today would not become productive in time to accommodate the demand spike.
That leaves increases in capacity utilization (output as a percentage of an existing mine's total capacity) and recycling as the main sources of additional supply, according to the study.
Under current trends—whereby both capacity utilization and recycling rates remain at their current 10-year global average—the study's Rocky Road Scenario projects annual supply shortfalls that reach nearly 10 million metric tons in 2035. That is equivalent to 20% of the demand projected to be required for a 2050 net-zero world.
Even under the study's optimistic High Ambition Scenario—which assumes aggressive growth in capacity utilization rates and all-time high recycling levels—the copper market will endure persistent supply deficits through most of the 2030s, including a deficit of nearly 1.6 million metric tons in 2035—much higher than any previous shortfall.
Under either scenario, there would not be enough supply to meet the demand of Net-Zero Emissions by 2050. The study also identifies eight key operational challenges that can constrain supply, ranging from infrastructure limitations, to changing tax regimes and permitting.
"This comprehensive analysis demonstrates that, even at the outer edge of what could happen in copper mining and refining operations, there would not be enough supply to meet the demands of a Net-Zero Emissions by 2050 world," said Mohsen Bonakdarpour, executive director, economics and country risk, S&P Global Market Intelligence. "Even strong price signals and incentivizing policy initiatives, aggressive capacity utilization rates and all-time high recycling rates would not be enough to close the gap."
Such a supply gap would have broader consequences across the global economy, disrupting supply chains for both energy transition and non-energy transition industries, the study says. Given copper's use in a wide range of end markets, it would also exert tremendous upward pressure on the cost of goods for global manufacturers as well as energy costs for consumers.
The study also finds that the burgeoning supply gap would exacerbate the growing reliance on copper imports in the United States, in particular. Imports made up nearly 44% of U.S. copper usage in 2021—up from just 10% in 1995. Under the study's scenarios, that share would swell to between 57 and 67% by 2035. An intensifying competition for critical metals is very likely to have geopolitical implications, the study says.
"The challenge for all active participants in the energy transition will be to manage often competing and seemingly contradictory priorities in this New Era of Copper Demand," said John Mothersole, director, non-ferrous metals, S&P Global Market Intelligence. "Technology and innovation will both be critical in meeting this challenge, as will partnership between governments, producers and end-users. 'Dr. Copper', as the metal is called, may well currently be, as it has been in the past, a leading indicator of a slowdown in economic growth or recession, but the overall supply outlook for the years ahead is extremely tight."
About the Study:
The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition? is available at https://ihsmarkit.com/Info/0722/futureofcopper.html.
The study examines whether sufficient copper supplies will be available in the time frame required to build and deploy the technologies for achieving the target of Net-Zero Emissions by 2050. It presents a holistic view, drawing on the expertise and data across S&P Global's Commodity Insights, Market Intelligence and Mobility divisions.
The study utilizes a detailed bottom-up approach, technology by technology to quantify the amount of additional copper that will be required by increased electrification and the energy transition—most specifically, the rapid move to electric vehicles and renewable electricity and the need for increased electricity infrastructure. It then examines the ability of copper supply to meet that demand on the basis of current trends, or with an unprecedented acceleration of supply from mining and recycling. It also identifies the key operational risks that can constrain future supplies.
The study makes no policy recommendations. It is intended to contribute to the continuing dialogue about achieving Net-Zero Emissions by 2050 by quantifying the requirements of that goal and benchmarking them against the supply response.
The analysis and metrics developed during the course of this research represent the independent analysis and views of S&P Global.
This study was supported by the following organizations: Anglo American plc; Antofagasta plc; BHP Ltd; Compania de Minas Buenaventura S.A.A.; Freeport-McMoRan Inc; Glencore plc; Ivanhoe Mines Ltd; Rio Tinto Corporation; Sumitomo Metal Mining Co. Ltd; Taseko Mines Limited; Teck Resources Limited; Lundin Mining Company; Trafigura Group Pte Ltd; and Vale Limited Mining Company.
S&P Global is exclusively responsible for all of the analysis, content and conclusions of the study.
About S&P Global:
S&P Global (NYSE: SPGI) provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through ESG and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world.
We are widely sought after by many of the world's leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world's leading organizations plan for tomorrow, today. For more information, visit www.spglobal.com.
News Media Contacts:
Jeff Marn
S&P Global
+1 202 463 8213
jeff.marn@spglobal.com
View original content:
SOURCE S&P Global
|
https://www.wibw.com/prnewswire/2022/07/14/looming-copper-supply-shortfalls-present-challenge-achieving-net-zero-2050-goals-sampp-global-study-finds/
| 2022-07-14T13:05:51Z
|
Senate to vote on $40 billion Ukraine aid package
By Ali Zaslav, Clare Foran and Ellie Kaufman, CNN
The Senate is expected to vote on Thursday to pass a roughly $40 billion bill to send aid to Ukraine as the country fights back against Russia’s brutal and unprovoked attacks.
The measure passed the House earlier this month and once passed by the Senate will go to President Joe Biden to be signed into law.
The legislation provides money for military and humanitarian aid, including funding to assist Ukrainian military and national security forces, help replenish stores of US equipment sent to Ukraine, and provide public health and medical support for Ukrainian refugees.
Aid to Ukraine has been a rare area of bipartisan consensus on Capitol Hill with many Democrats and Republicans rallying around calls to help the embattled nation.
Not all lawmakers are on board with the push to send an additional $40 billion in aid to Ukraine, however. Some Republican senators have taken issue with the high price tag of the legislation and the fact that the cost is not offset, and have expressed concerns that European countries are not contributing enough funds. Earlier this week, 11 Republican senators voted to oppose advancing the aid package.
Sen. Mike Crapo, the top Republican on the Senate Finance Committee and who is up for reelection in Idaho, said he voted no on a procedural motion to advance the bill because he wanted cost offsets for the expensive bill. He said he is not concerned the vote will send the wrong message to Ukraine, which is battling for its survival against Russia.
“No, I don’t worry about it,” he said. “I understand the question. I’ve made my support for Ukraine very clear. And I’ve made my support for offsetting legislation that was big spending legislation very clear.”
What’s in the bill
The bill includes an increase in presidential drawdown authority funding from the $5 billion the Biden administration originally requested to $11 billion. Presidential drawdown authority funding allows the administration to send military equipment and weapons from US stocks.
The bill also provides $6 billion in Ukraine Security Assistance Initiative funding, another way the Biden administration has been providing Ukraine with military assistance. The funding allows the administration to buy weapons from contractors and then provide those weapons to Ukraine, and as a result does not draw directly from US stocks.
According to a fact sheet from House Democrats, the funding will be used to assist Ukrainian military and national security forces and will go toward weapons, equipment, training, logistics and intelligence support as well as other needs.
There will also be roughly $9 billion to help restock US equipment that has been sent to Ukraine, which comes as many lawmakers have raised concerns about replacing US stocks of weapons the US is giving to Ukraine, especially stingers and javelin missiles.
The bill provides $3.9 billion for European Command operations, which includes “mission support, intelligence support, hardship pay for troops deployed to the region and equipment, including a Patriot battery,” according to a House Democrat fact sheet. The Department of Defense has added additional US troops in Eastern European countries to bolster support for NATO allies near Ukraine since the Russian invasion of Ukraine began.
To address humanitarian needs, the bill will include $900 million to bolster refugee assistance, including housing, trauma support and English language instruction for Ukrainians fleeing the country.
The measure provides an additional $54 million that will be used for public health and medical support for Ukrainian refugees.
Ukraine aid delayed in Senate
Bipartisan Senate leaders had hoped to approve the emergency funding bill last week to swiftly send billions in military aid to Ukraine as the war enters almost its third month.
But Sen. Rand Paul, a Republican from Kentucky, blocked passage of the aid package until Thursday of this week, which is the day the Biden administration said additional funds must be approved to avoid a lapse in support for Ukraine.
Paul has demanded that language be added to the bill that provides a special inspector general new authority to oversee how the Ukraine aid is being spent. And while members from both parties broadly agree with that notion, forcing a change to the bill at such a late stage is time consuming and would slow getting the needed emergency aid to country.
Under Senate rules, any one senator can slow down the process. It took about a week to overcome Paul’s objection through timely procedural steps that the majority leader had to take on the Senate floor.
“I think we should have an inspector general,” Paul told CNN earlier this week. “We have one out there and overseeing Afghan waste. He’s been very good at it. You don’t have to wait for an appointment. He’s got a team up and running. And I think that’s what we should do.”
Schumer slammed Paul for delaying the emergency funding aid, arguing it was for “purely political motives” and only “strengthens Putin’s hand.”
Paul said in a floor speech before objecting to the legislation’s passage last week that his “oath of office is the US constitution not to any foreign nation” and, “we cannot save Ukraine by dooming the US economy.”
Senate Majority Leader Chuck Schumer said he expects that on Thursday the Senate will “finish the critical task of approving another round of military, humanitarian and economic aid for the people of Ukraine.”
He continued to say, “This should already have been done and over with, but it is repugnant that one member from the other side, the junior senator from Kentucky, chose to make a show and obstruct Ukraine funding knowing full well he couldn’t actually stop its passage.”
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
CNN’s Ted Barrett and Manu Raju contributed to this report.
|
https://localnews8.com/politics/cnn-us-politics/2022/05/19/senate-to-vote-on-40-billion-ukraine-aid-package/
| 2022-05-19T11:17:29Z
|
DALLAS (KDAF) — Fair food, get your fair food here!
Well, if there was a better time to tell you this we would, but there’s no better time than the present. Monday, July 11 is National State Fair Food Day! So, if you’re into corn dogs, funnel cakes and all things giant and fried, we’re about to speak your language.
But first, let’s see what NationalToday has to say about this glorious celebration of fried fair food, “But let’s be honest, it’s all about the fried and delicious food, on sticks, and otherwise. The food is memorable and we look forward to enjoying it again all year long. Some of the best state foods include corn dogs, cotton candy, funnel cakes, deep-fried cookies, cheese on a stick, and chicken wings.”
While the State Fair of Texas is a couple of months away, you may need a few options to celebrate today and find fair food around Dallas. We checked some spots that sell corn dogs, funnel cakes and some other norm fair foods around North Texas:
- Maple Leaf Diner
- Pinstack
- Golden Chick
- Norma’s
- Cocina Italiano
- Buc-ee’s
- Oh K-dog & Egg Toast
- Fletcher’s Original Corny Dogs
- TJ’s Dawg House
- Funnel Cake Paradise
- Shaved Ice & Funnel Cake
- Southside Steaks & Cakes
- UNICORNDOG
|
https://cw33.com/news/food-and-drink/where-to-get-the-best-state-fair-food-in-dallas-outside-of-fair-season/
| 2022-07-11T22:09:34Z
|
FORT WORTH, Texas and SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- The Starr Conspiracy, an experience agency for brands that put employees first to build business value, announced today being named to the prestigious Best Workplaces for Innovators list by Fast Company and one of only 11 small businesses to be recognized alongside the likes of Google, Microsoft, SAP, and many other global technology companies.
The Fast Company Innovators list honors organizations that foster a culture of innovation. The Starr Conspiracy dubs its winning approach the reverse mullet — party in the front and business in the back. Or, put another way, putting the employee experience first to impact the customer experience.
The Starr Conspiracy invests first in its employees' needs — in their safety, finances, and emotional and physical well-being through things like unlimited PTO, flexible work schedules, a decentralized system of opting into work, blocked quiet time for focused work, three-day weekends, and a digital-by-default/remote work structure. It also gave profit-sharing bonuses for the first time in 2021.
"Invest in your people first because the employee and customer experience cannot be separated," said Ashley Bernard, vice president of client services at The Starr Conspiracy. "We've designed a work culture that supports our people and focuses on defining moments in the employee and, by extension, the customer experience."
The Starr Conspiracy is focusing on the future of work by helping its HR and work technology clients understand the connection between the user experience, customer experience, and employee experience.
"Experiences are not siloed and they are often specific, defining moments that are critical to brand loyalty, whether you're talking about employees or customers," said Bret Starr, CEO of The Starr Conspiracy. "Our goal is to create a decentralized autonomous organization that supports people so they are better able to focus and create a great experience for our customers."
Developed in collaboration with Accenture, the 2022 Best Workplaces for Innovators ranks 100 winners from a variety of industries, consumer products, and services. Fast Company editors and Accenture researchers worked together to score nearly 1,500 applications, and a panel of eight eminent judges reviewed and endorsed the top 100 companies and 11 small businesses. The 2022 awards feature workplaces from around the world.
"This year's list of the Best Workplaces for Innovators recognizes organizations that have demonstrated a deep commitment to cultivating creativity across the board," said Brendan Vaughan, editor-in-chief of Fast Company. "In the face of powerful headwinds, these leaders and teams continue to spur innovation."
To see the elite list of small businesses acknowledged by the Fast Company award, go to: https://www.fastcompany.com/90769088/best-workplaces-for-innovators-2022-11-small-company-standouts.
The Starr Conspiracy is an experience agency for brands that put employees first to build business value. We have the expertise to create defining moments that will transform your business.
View original content:
SOURCE The Starr Conspiracy
|
https://www.kxii.com/prnewswire/2022/08/25/starr-conspiracy-named-2022-fast-company-best-workplaces-innovators/
| 2022-08-25T11:30:03Z
|
– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication –
– Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 –
NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, today announced that the European Commission (EC) has granted Marketing Authorisation for NEXPOVIO® (selinexor), a first-in-class, oral exportin 1 (XPO1) inhibitor, in combination with once-weekly bortezomib (Velcade®) and low-dose dexamethasone (SVd) for the treatment of adults with multiple myeloma who have received at least one prior therapy. With this approval for the extension of NEXPOVIO®'s indication in the European Union (EU), the conditional marketing authorisation is now converted to a full approval. The marketing authorisation, which marks the second indication for NEXPOVIO®, is valid in all 27 member states of the EU as well as Iceland, Liechtenstein, Norway, and Northern Ireland. Stemline Therapeutics B.V., a wholly owned subsidiary of the Menarini Group, will be responsible for all commercialization activities in Europe.
The approval follows a positive opinion granted in May 2022 by the CHMP based on results from the Phase 3 BOSTON study that demonstrated once-weekly SVd resulted in a statistically significant reduction in the risk of disease progression or death compared to standard twice-weekly bortezomib plus dexamethasone (Vd) regimen. The results from the BOSTON study were published in The Lancet (Grosicki, et al.) in November 2020.
"The European Commission's approval of an expanded use of NEXPOVIO® provides another option for patients with multiple myeloma who have relapsed, or become resistant to current treatment regimens," said Richard Paulson, President and Chief Executive Officer of Karyopharm. "Our decision to pursue approval for this patient population is indicative of our commitment to expand access to selinexor across the globe and we look forward to working closely with Menarini who will commercialize NEXPOVIO® in Europe."
"The approval of NEXPOVIO® marks an important step forward for patients in Europe where nearly 51,000 new cases of multiple myeloma are diagnosed each year and therapeutic options are limited," said Elcin Barker Ergun, Chief Executive Officer of Menarini. "We are committed to offering patients and physicians a valuable new treatment option and are working hard to make NEXPOVIO® available in different European countries as quickly as possible."
About the BOSTON study
The Marketing Authorisation is based upon the Phase 3 BOSTON (Bortezomib, Selinexor and Dexamethasone) study, which was a multi-center, randomized study (NCT03110562) that evaluated 402 adult patients with relapsed or refractory multiple myeloma who had received one to three prior lines of therapy. The study was designed to compare the efficacy, safety and certain health-related quality of life parameters of once-weekly SVd versus twice-weekly Vd. The primary endpoint of the study was progression-free survival and key secondary endpoints included overall response rate, rate of peripheral neuropathy, and others. To learn more about this study, please refer to Karyopharm and Menarini's press release on the positive CHMP opinion issued on May 20, 2022.
About Multiple Myeloma in Europe
Multiple myeloma is an incurable cancer with significant morbidity and the second most common hematologic malignancy. According to the World Health Organization, in 2020, there were approximately 51,000 new cases and 32,000 deaths from multiple myeloma in Europe1. While the treatment of multiple myeloma has improved over the last 20 years, and overall survival has increased considerably, the disease remains incurable, and nearly all patients will eventually relapse and develop disease that is refractory to all approved anti-myeloma therapies. Therefore, there continues to be a high unmet medical need for new therapies, particularly those with novel mechanisms of action.
About NEXPOVIO® (selinexor)
NEXPOVIO®, which is marketed as XPOVIO® in the U.S., has been approved in the following oncology indications by the European Commission: (i) in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-CD38 monoclonal antibody, and who have demonstrated disease progression on the last therapy; and (ii) in combination with bortezomib and dexamethasone for the treatment of adults with multiple myeloma who have received at least one prior therapy.
The expanded NEXPOVIO® indication now allows adult patients with multiple myeloma to be treated in earlier lines of therapy. The indication for NEXPOVIO® is valid in the EU Member States as well as Iceland, Liechtenstein, Norway, and Northern Ireland. NEXPOVIO® is also approved in the UK under a Conditional Marketing Authorisation. The extension of indication in combination with bortezomib and dexamethasone for the treatment of adults with multiple myeloma who have received at least one prior therapy is currently under review by Medicines and Healthcare Products Regulatory Agency.
NEXPOVIO® is a first-in-class, oral exportin 1 (XPO1) inhibitor. NEXPOVIO® functions by selectively binding to and inhibiting the nuclear export protein exportin 1 (XPO1, also called CRM1). NEXPOVIO® blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The forced nuclear retention of these proteins can counteract a multitude of the oncogenic pathways that, unchecked, allow cancer cells with severe DNA damage to continue to grow and divide in an unrestrained fashion.
Please see NEXPOVIO® Summary of Product Characteristics and European Public Assessment Report at https://ec.europa.eu/health/documents/community-register/html/h1537.htm
UNITED STATES IMPORTANT SAFETY INFORMATION
Contraindications: Hypersensitivity to selinexor.
Special warnings and precautions for use:
Recommended concomitant treatments
Patients should be advised to maintain adequate fluid and caloric intake throughout treatment. Intravenous hydration should be considered for patients at risk of dehydration.
Prophylactic concomitant treatment with a 5-HT3 antagonist and/or other anti-nausea agents should be provided prior to and during treatment with NEXPOVIO®.
Haematology:
Patients should have their complete blood counts (CBC) assessed at baseline, during treatment, and as clinically indicated. Monitor more frequently during the first two months of treatment.
Thrombocytopenia:
Thrombocytopenic events (thrombocytopenia and platelet count decreased) were frequently reported in adult patients receiving selinexor, which can be severe (Grade 3/4). Patients should be monitored for signs and symptoms of bleeding and evaluated promptly.
Neutropenia:
Severe neutropenia (Grade 3/4) has been reported with selinexor.
Patients with neutropenia should be monitored for signs of infection and evaluated promptly.
Gastrointestinal toxicity:
Nausea, vomiting, diarrhoea, which sometimes can be severe and may require the use of anti-emetic and anti-diarrhoeal medicinal products.
Weight loss and anorexia:
Patients should have their body weight, nutritional status and volume checked at baseline, during treatment, and as clinically indicated. Monitoring should be more frequent during the first two months of treatment.
Confusional state and dizziness:
Patients should be instructed to avoid situations where dizziness or confusional state may be a problem and to not take other medicinal products that may cause dizziness or confusional state without adequate medical advice. Patients should be advised not to drive or operate heavy machinery until symptoms resolve.
Hyponatraemia:
Patients should have their sodium levels checked at baseline, during treatment, and as clinically indicated. Monitoring should be more frequent during the first two months of treatment.
Cataract:
Selinexor can cause new onset or exacerbation of cataract. Ophthalmologic evaluation may be performed as clinically indicated. Cataract should be treated as per medical guidelines, including surgery if warranted.
Tumour lysis syndrome (TLS):
TLS has been reported in patients receiving therapy with selinexor. Patients at a high risk for TLS should be monitored closely. Treat TLS promptly in accordance with institutional guidelines.
Fertility, pregnancy and lactation
Women of childbearing potential/contraception in males and females:
Women of childbearing potential and male adult patients of reproductive potential should be advised to use effective contraceptive measures or abstain from sexual intercourse while being treated with selinexor and for at least 1 week following the last dose of selinexor.
Pregnancy:
There are no data from the use of selinexor in pregnant women. Selinexor is not recommended during pregnancy and in women of childbearing potential not using contraception.
Breast-feeding:
It is unknown whether selinexor or its metabolites are excreted in human milk. A risk to breast-fed children cannot be excluded. Breast-feeding should be discontinued during treatment with selinexor and for 1 week after the last dose.
Undesirable effects
Summary of the safety profile
The most frequent adverse reactions (≥30%) of selinexor in combination with dexamethasone were nausea, thrombocytopenia, fatigue, anaemia, decreased appetite, decreased weight, diarrhea, vomiting, hyponatraemia, neutropenia and leukopenia.
The most commonly reported serious adverse reactions (≥3%) were pneumonia, sepsis, thrombocytopenia, acute kidney injury, and anaemia.
Description of selected adverse reactions
Infections: Infection was the most common non-haematological toxicity. Upper respiratory tract infection and pneumonia were the most commonly reported infections with 25% of reported infections being serious and fatal infections occurring in 3% of treated adult patients.
Elderly population
Patients 75 years and older had a higher incidence of discontinuation due to an adverse reaction, higher incidence of serious adverse reactions, and higher incidence of fatal adverse reactions.
Reporting of suspected adverse reactions
Reporting of suspected adverse reactions after Authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies. Since its founding, Karyopharm has been the industry leader in oral Selective Inhibitor of Nuclear Export (SINE) compound technology, which was developed to address a fundamental mechanism of oncogenesis: nuclear export dysregulation. Karyopharm's lead SINE compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications and has received regulatory approvals in various indications in a growing number of ex-U.S. territories and countries, including Europe and the United Kingdom (as NEXPOVIO®), China, Singapore, Canada, Israel, South Korea, and Australia. Karyopharm has a focused pipeline targeting multiple high unmet need cancer indications, including in multiple myeloma, endometrial cancer, myelodysplastic syndromes and myelofibrosis. For more information about our people, science and pipeline, please visit www.karyopharm.com, and follow us on Twitter at @Karyopharm and LinkedIn.
About Menarini Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for oncology, cardiology, pneumology, gastroenterology, infectious diseases, diabetology, inflammation, and analgesia. With 18 production sites and 9 Research and Development centers, Menarini's products are available in 140 countries worldwide. For further information, please visit www.menarini.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those regarding the ability of selinexor to treat adult patients with multiple myeloma, the commercial launch of NEXPOVIO® in Europe, and expectations related to future clinical development and potential regulatory submissions of selinexor. Such statements are subject to numerous important factors, risks and uncertainties, many of which are beyond Karyopharm's control, that may cause actual events or results to differ materially from Karyopharm's current expectations. For example, there can be no guarantee that Karyopharm will successfully commercialize XPOVIO or that any of Karyopharm's drug candidates, including selinexor and eltanexor, will successfully complete necessary clinical development phases or that development of any of Karyopharm's drug candidates will continue. Further, there can be no guarantee that any positive developments in the development or commercialization of Karyopharm's drug candidate portfolio will result in stock price appreciation. Management's expectations and, therefore, any forward-looking statements in this press release could also be affected by risks and uncertainties relating to a number of other factors, including the following: the risk that the COVID-19 pandemic could disrupt Karyopharm's business more severely than it currently anticipates, including by negatively impacting sales of XPOVIO, interrupting or delaying research and development efforts, impacting the ability to procure sufficient supply for the development and commercialization of selinexor or other product candidates, delaying ongoing or planned clinical trials, impeding the execution of business plans, planned regulatory milestones and timelines, or inconveniencing patients; the adoption of XPOVIO in the commercial marketplace, the timing and costs involved in commercializing XPOVIO or any of Karyopharm's drug candidates that receive regulatory approval; the ability to obtain and retain regulatory approval of XPOVIO or any of Karyopharm's drug candidates that receive regulatory approval; Karyopharm's results of clinical trials and preclinical studies, including subsequent analysis of existing data and new data received from ongoing and future studies; the content and timing of decisions made by the U.S. Food and Drug Administration and other regulatory authorities, investigational review boards at clinical trial sites and publication review bodies, including with respect to the need for additional clinical studies; the ability of Karyopharm or its third party collaborators or successors in interest to fully perform their respective obligations under the applicable agreement and the potential future financial implications of such agreement; Karyopharm's ability to enroll patients in its clinical trials; unplanned cash requirements and expenditures; development or regulatory approval of drug candidates by Karyopharm's competitors for products or product candidates in which Karyopharm is currently commercializing or developing; and Karyopharm's ability to obtain, maintain and enforce patent and other intellectual property protection for any of its products or product candidates. These and other risks are described under the caption "Risk Factors" in Karyopharm's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, which was filed with the Securities and Exchange Commission (SEC) on May 5, 2022, and in other filings that Karyopharm may make with the SEC in the future. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by law, Karyopharm expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
References
1 World Health Organization. 2020. https://gco.iarc.fr/today/data/factsheets/cancers/35-Multiple-myeloma-fact-sheet.pdf
View original content:
SOURCE Karyopharm Therapeutics Inc.
|
https://www.kxii.com/prnewswire/2022/07/21/karyopharm-menarini-group-receive-full-marketing-authorisation-european-commission-nexpovio-selinexor-treatment-patients-with-multiple-myeloma-after-least-one-prior-therapy/
| 2022-07-21T11:23:46Z
|
Kansas Cold Cases: Anna Marie Baldwin
TOPEKA, Kan. (WIBW) - Family told authorities it wasn’t unusual for Anna Marie Baldwin to go weeks or even months without checking in.
So when a park ranger with the U.S. Army Corps of Engineers at Melvern Lake found skeletal remains near the Turkey Point Area, no one immediately reached out thinking it could be her.
It was the evening of Aug. 25, 2017. The Kansas Bureau of Investigation had little to go on. They said the remains were badly decomposed, but they could tell the person had been shot. They asked the Washburn University Anthropology Dept. to help find any clues as to who this was. They determined the victim was a woman, between the ages of 35 and 50, likely killed between April and July 2017 - but possibly as long ago as late fall 2016.
Weeks passed, with no leads. In late September 2017, the KBI released new details about the victim’s clothing, along with photos of items found with the body: two rings, a bracelet and eyeglasses. They hoped someone might recognize the items, and, more importantly, would know who wore them.
Finally, July 27, 2018 - nearly a year after she was found - the KBI had their answer. The woman was Anna. She was never reported missing, and the black and white pit bull she always had at her side also disappeared. No one seemed to know where she’d been since late 2016.
Anna’s death is part of a new effort to get new leads on cold cases. She is the six of hearts in the Kansas Cold Case Deck. The special playing cards featuring information on unsolved murders and missing persons cases will be distributed in the state’s prisons and jails.
The KBI wants to hear from anyone who had contact with Anna Marie Baldwin in late 2016 or anytime in 2017. They hope they can retrace her contacts and movements, and find her killer.
Anyone with information can call the KBI at 1-800-KS-CRIME.
Prior KS Cold Case Profiles:
Mercedes Holford and Crystal Andrews
Carla Avery, Eric Avery, Tamesha Lee, and Marvin Woods
Copyright 2022 WIBW. All rights reserved.
|
https://www.wibw.com/2022/08/15/kansas-cold-cases-anna-marie-baldwin/
| 2022-08-15T03:34:06Z
|
CHEONGJU, South Korea, June 10, 2022 /PRNewswire/ -- The Cheongju Craft Biennale (referred to as the Biennale) published the competition guidelines for the '2023 Cheongju International Craft Competition (referred to as the Competition)' on Monday, June 10.
The competition is conducted in two areas: "Craft Competition" and "Craft City Lab Competition", where proposals are open for public offering. The application period is from March 31 to May 7, 2023. The first application for both fields is conducted only online on the Biennale's official website (www.okcj.org).
In the "Craft Competition" field, one person or one team can submit one piece at a time, regardless of genre or material. Only works produced between 2021 and 2023 can be submitted.
Only those selected in the first online screening will be submitted actual craft works, and the final results will be announced in August of next year.
In particular, four categories were newly established this time: Young Artist Award, Partner Award, Popularity Award, and Residency Award. This was prepared to provide motivation for creation to excellent domestic and foreign artists and to support more active activities.
In the "Craft City Lab Competition" field, ideas for a city where crafts and humans coexist under the theme of 'Craft and City' are contested.
One person or one team can apply for one project, and only applicants selected in the first screening will undergo the 2nd PT screening. The final winner will complete their research and manuscript writing by August 2023, and the writing period will be a total of two months.
In both fields, applicants from 18 years of age or older can apply regardless of nationality.
Detailed information such as the application guidelines can be found on the official website (www.okcj.org) and related inquiries can only be made via email cbcompetition2019@gmail.com.
The Competition began in 1999 along with the Cheongju Craft Biennale, and has produced over 1,800 award-winning works by artists from 50 countries to date, leading the world craft trend.
The 2023 Biennale will be held for 45 days from September 1 to October 15 in 2023, Cheongju, South Korea.
View original content to download multimedia:
SOURCE The Organizing Committee of the Cheongju Craft Biennale(South Korea)
|
https://www.mysuncoast.com/prnewswire/2022/06/10/2023-cheongju-international-craft-competition-outline-published/
| 2022-06-10T14:36:07Z
|
SAN JOSE, Calif., Aug. 3, 2022 /PRNewswire/ -- Lumentum Holdings Inc. (NASDAQ: LITE) ("Lumentum"), today announced that it has completed its previously announced acquisition of NeoPhotonics Corporation ("NeoPhotonics").
"I am excited to unite NeoPhotonics' differentiated products and technology and talented team with those of Lumentum," said Alan Lowe, Lumentum President and CEO. "This acquisition better positions us for attractive growth opportunities created by the digital transformation of work and life, which is driving relentless growth in the needed volumes and performance of cloud and network infrastructure. I welcome our new colleagues to the Lumentum team and want to thank NeoPhotonics' CEO Tim Jenks and the rest of NeoPhotonics' leadership team for their contributions in getting us to this important milestone."
Under the terms of the merger agreement, NeoPhotonics stockholders will receive $16.00 in cash for each share of NeoPhotonics common stock in accordance with the terms of the merger agreement.
As previously announced, Lumentum anticipates achieving more than an estimated $50 million in annual run-rate synergies within 24 months of the closing of the transaction. Lumentum financed the transaction consideration with cash from the combined companies' balance sheets.
Due to the timing of the closing of the NeoPhotonics acquisition, there is no impact to Lumentum's fiscal fourth quarter 2022. During its fiscal fourth quarter and fiscal year 2022 earnings conference call, which is scheduled for Tuesday, August 16, 2022 at 5:30 a.m. PT / 8:30 a.m. ET, Lumentum will provide an update on the NeoPhotonics transaction. More information on this call can be found in the Investors section on Lumentum's website at http://investor.lumentum.com.
Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in San Jose, California with R&D, manufacturing, and sales offices worldwide. For more information, visit www.lumentum.com and follow Lumentum on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
NeoPhotonics is a leading developer and manufacturer of lasers and optoelectronic solutions that transmit, receive, and switch high-speed digital optical signals for Cloud and hyper-scale data center internet content providers and telecom networks. NeoPhotonics' products enable cost-effective, high-speed over distance data transmission and efficient allocation of bandwidth in optical networks. NeoPhotonics maintains headquarters in San Jose, California and ISO 9001:2015 certified engineering and manufacturing facilities in Silicon Valley (USA), Japan and China. For additional information visit www.neophotonics.com.
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, including the timing of the transaction and other information related to the transaction. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern the transaction and our expectations, strategy, plans or intentions regarding it. Forward-looking statements in this communication include, but are not limited to, (i) expectations regarding the timing, completion and expected benefits of the transaction, (ii) plans, objectives and intentions with respect to future operations, customers and the market, and (iii) the expected impact of the transaction on the business of the parties. Expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include the effect of the announcement or pendency of the transaction on our business relationships, results of operations and business generally; risks that the transaction disrupts current plans and operations; the risk of litigation and/or regulatory actions related to the transaction; potential impacts of the Covid-19 pandemic; changing supply and demand conditions in the industry; and general market, political, economic and business conditions. The forward-looking statements contained in this communication are also subject to other risks and uncertainties, including those more fully described in filings with the Securities and Exchange Commission, including reports filed on Form 10-K, 10-Q and 8-K and in other filings made by NeoPhotonics and Lumentum with the SEC from time to time and available at www.sec.gov. These forward-looking statements are based on current expectations, and with regard to the transaction, are based on Lumentum's and NeoPhotonics' current expectations, estimates and projections about the potential benefits thereof, its business and industry, management's beliefs and certain assumptions made by Lumentum and NeoPhotonics, all of which are subject to change. The parties undertake no obligation to update the information contained in this communication or any other forward-looking statement.
Category: Financial
Contact Information:
Investors: Kathy Ta, (408) 750-3853; investor.relations@lumentum.com
Media: Sean Ogarrio, (408) 546-5405; media@lumentum.com
View original content:
SOURCE Lumentum
|
https://www.wibw.com/prnewswire/2022/08/03/lumentum-announces-completion-neophotonics-acquisition/
| 2022-08-03T12:53:39Z
|
LONDON, July 15, 2022 /PRNewswire/ -- The agenda of Sustainable Development Goal 16, which talks of resolving the challenge around 'Conflict, insecurity, weak institutions and limited access to justice,' seeks to promote a peaceful society and provide equal access to justice to all.
RELX, a global provider of information and analytics for professional and business customers across industries, hosted their 'Free Virtual SDG Inspiration Day' on May 9, 2022. The topics discussed during the session was the role of businesses in furthering the agenda of SDG 16.
Organizations that partnered the event included the Ban Ki-moon Centre for Global Citizens; UN Global Compact Network UK; Global Citizen, the World Humanitarian Forum; the Responsible Media Forum; Schneider Electric; The Elsevier Foundation, and the LexisNexis Rule of Law Foundation.
The keynote speakers included Ban Ki-moon, Former Secretary General of the United Nations and Sir Bob Geldof, legendary musician and political activist. Other speakers included Dr. Heinz Fischer, former President of Austria; Irina Bokova, former Director-General of UNESCO; and Michael Sheldrick, Co-Founder of Global Citizen. The event was moderated by lawyer and activist Dr. Shola Mos-Shogbamimu.
"All around the world, armed conflicts are causing humanitarian emergencies in countries such as Yemen, Syria, Afghanistan, Ethiopia, and Ukraine. We are at a turning point, and we must choose peace," encapsulated Secretary Ban Ki-Moon in his keynote address.
Several speakers touched upon the Russia-Ukraine conflict. Dr. Heinz Fischer commented, "The significance and relevance of the SDGs will survive the ongoing war between Russia and Ukraine and will thrive after the war – particularly SDG 16." Former Director-General of UNESCO Irina Bokova, during her keynote speech, said that the COVID-19 pandemic, the war in Ukraine, and impact of food production due to climate change have impacted the 2030 SDGs, and SDG 16 in particular.
Sir Bob Geldof said that the biggest challenges facing the SDGs were human cynicism and extreme nationalism. "However, it is in our self-interest to make the SDGs work. It is in the self-interest of the world; the self-interest of business and politics, and the self-interest of the global economy – all of them will begin by embracing and working to achieve the 2030 SDG goals," he said.
Several panel discussions were held as part of the event. The first, 'SDG 16 and Defence,' was moderated by BBC journalist Justin Webb, and had Monika Froehler, CEO, Ban Ki-moon Centre for Global Citizens; Dr. Imogen Parsons, Senior Research Fellow, Terrorism and Conflict, The Royal United Services Institute; and Sir Mark Moody-Stuart, Chairman, Global Compact Foundation, as the panellists.
The second discussion, 'Operating in a Conflict Zone,' was moderated by Teresa Jennings, Head of Rule of Law Development, LexisNexis Rule of Law Foundation. The panellists included Mark Waddington, CEO, Hope and Homes for Children; Kimberly Parker, Hinari Programme Manager, World Health Organization; Alison Tweed, CEO, Book Aid International; and Geraldine Anup-Willcocks, Emergency Specialist, UNICEF UK.
The final discussion was 'Women and SDG 16', which was moderated by Amanda Ellis, Former UN Ambassador, Executive Director Asia-Pacific, Global Institute of Sustainability and Innovation. Zoya Lytvyn, Ukrainian entrepreneur, expert in impact investment and education, founder of NGO Osvitoria, Global Teacher Prize Ukraine Award; Martin Chungong, eighth Secretary-General of the Inter-Parliamentary Union (IPU); and Tea Trumbic, WE Empower Lead Partner and Program Manager for the Women, Business and the Law Project, World Bank, were the speakers.
To learn more and watch the entire event, click here.
Media Details:
Laure Lagrange
Corporate Responsibility
pressoffice@relx.com
Telephone:- +44 20 7166 5500
Photo: https://mma.prnewswire.com/media/1860110/SDG_Inspiration_Day_speakers.jpg
View original content to download multimedia:
SOURCE RELX Group
|
https://www.wibw.com/prnewswire/2022/07/15/2022-relx-sdg-inspiration-day-aspiring-make-sdg-16-reality/
| 2022-07-15T11:57:01Z
|
Announced globally at FESPA 2022, Canon Premieres FLXfinish+ Solution and New Arizona 6100 Mark II
MELVILLE, N.Y., June 6, 2022 /PRNewswire/ -- Canon U.S.A. Inc., a leader in digital imaging solutions, today unveiled the next step for the Colorado series: FLXfinish+, the unique ability to print a mixed matte and gloss finish in one print, at the click of a button. Being able to have both finishes in one print enables print service providers (PSPs) to take a whole list of applications to the next level – from making brands stand out on point-of-sale (POS) and retail advertising, to bringing labels and decals to life with glossy highlights, to creating amazing effects for interior décor applications.
The patented UVgel technology enables this unique effect without having to use an extra varnish channel or consumables and does it in a one-step, fully automated process, so you can run it unattended and without additional running costs.
FLXfinish+ will be standard on all Colorado 1650s and optional on Colorado 1630s. It will also available as an upgrade to all 1630s and 1650s already installed with customers, which emphasizes Canon's commitment to offering customers a smart investment solution.
"Large format graphics PSPs and print factories need to be able to respond to the latest consumer trends, such as meeting increased demand for personalization and made-to-order applications, while ensuring customization is economically viable, even for samples and print-of-one orders," said Shinichi "Sam" Yoshida, executive vice president and general manager of Canon U.S.A., Inc. "Our customers are constantly looking to deliver value to their customers and offering that 'extra special thing' that makes them stand out. At the same time, pressures on delivery times require higher levels of continuous 24/7 production with fewer operators, so customers need to integrate workflow automation into their activities, by means of smart technology solutions."
New Arizona 6100 Mark II, the fastest flatbed in the Arizona range
Designed for high-volume, large format graphics producers and the latest model in the next generation of the Arizona family, the Arizona 6100 Mark II is a reliable, easy-to-integrate, high-volume, true flatbed flagship printer. The Arizona 6100 Mark II series is the fastest flatbed printer in the world-leading Arizona family, with a print speed of up to 220m²/hr (2,368ft²/hr), servicing print environments with volumes of 20,000m² (200,000ft²) up to 300,000m² (3,000,000ft²) per year.
The Arizona 6100 Mark II series consists of two models. The first is the Arizona 6100 XTS Mark II, which has been designed for PSPs who use a more varied range of substrates as it can print on almost any rigid media. With the XTS version, the independent control of vacuum zones means customers can simultaneously handle multiple boards, unusually shaped substrates and staged/staggered jobs for continuous printing.
The second model is the Arizona 6100 XTHF Mark II, which is supported by Arizona High-FLOW technology. This version has been created for large format graphics PSPs and print factories who specialize in packaging or print on more challenging substrates — such as porous corrugated cardboard or severely warped substrates like plywood — that may not adequately seal the vacuum area. On this model, the Arizona High-FLOW technology achieves pull-down and hold-down by effectively overwhelming the substrate with a suction power 15 times stronger than the pressure exerted by the vacuum of the Arizona XTS.
The Arizona 6100 Mark II series has the latest technical innovations to support customers who are looking to improve production efficiencies with automation. Thanks to the future-ready Application Programming Interfaces (APIs) for accounting and automation, users can achieve easy integration with third-party systems like management reporting systems and create an end-to-end workflow for increased productivity through robotization.
"With FLXfinish+ on the Colorado series, our latest next-generation technology in the Arizona 6100 Mark II series, and the PRISMA XL Suite, we want to help our customers spot new business opportunities, produce commercially viable applications with ease, and help them to transform those opportunities into ongoing business success," said Yoshida.
For more information, please visit www.usa.canon.com.
About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately $30.6 billion in global revenue, its parent company, Canon Inc. (NYSE: CAJ), as of 2021 has ranked in the top-five overall in U.S. patents granted for 36 consecutive years† and was one of Fortune Magazine's World's Most Admired Companies in 2022. Canon U.S.A. was featured in Newsweek's Most Loved Workplaces list for 2021, ranking among the top 100 companies for employee happiness and satisfaction at work. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss and follow us on Twitter @CanonUSA.
† Number of patents for 2021 are based on figures released by IFI CLAIMS Patent Services. Figures for 2005 to 2020 are based on information issued by the United States Patent and Trademark Office.
Contact:
Nicole Esan
631-327-1108
niesan@cusa.canon.com
View original content to download multimedia:
SOURCE Canon U.S.A., Inc.
|
https://www.mysuncoast.com/prnewswire/2022/06/06/canon-reveals-new-finishing-solution-colorado-devices-new-flatbed-printer/
| 2022-06-06T15:43:58Z
|
Holistic Platform Now Includes New Unified Communications and SaaS Monitoring Capabilities Giving IT Teams Greater Visibility to Support Employees, Increase Productivity, and Reduce the Cost of IT Operations for Today's Work-From-Anywhere (WFA) World
SAN JOSE, Calif., June 9, 2022 /PRNewswire/ -- ControlUp, the industry leader in Digital Employee Experience (DEX) management, today one of the first platforms to provide a holistic approach to unified communications insights, user sentiment analysis, and advanced SaaS monitoring to help IT teams make smarter decisions when supporting work-from-anywhere (WFA) employees. These expanded capabilities reduce the cost of IT operations by examining the performance, availability, and productivity of multiple, disconnected solutions in support of industries–such as healthcare, insurance, retail, finance, and technology companies–around the globe.
"A top issue IT admins are struggling with today is unified communications. With 80 percent of our enterprise customers using Microsoft Teams and other unified communications tools to perform their jobs daily, it was imperative to have a more holistic solution that gives IT greater control from one platform to resolve issues with greater speed and accuracy," said Yoni Avital, COO, and Co-founder, ControlUp. "The ability to access granular details about where and why problems exist and address them proactively is a gamechanger."
With 65 percent of IT service desks already experiencing heightened levels of stress and burnout, growing service desk tickets and the lack of visibility into unified communication tools and SaaS applications are only making the problem worse. By investing in DEX management tools, companies can reduce IT spend while improving the experience for both IT teams and employees. A recent Forrester Total Economic Impact Study found a 238 percent ROI and a payback within the first six months for customers who use ControlUp's platform. ControlUp's expanded solution now includes monitoring and optimization for:
- Unified Communications: Provides usage insights and the ability to pinpoint the root cause of problems employees experience when they use tools like Microsoft Teams.
- SaaS and Web Applications: Gives full visibility into the performance and availability of SaaS applications with proactive alerting so IT teams can get in front of issues before the service desk phone starts ringing.
- User Sentiment: Collects data about employee experiences to help IT teams maximize productivity and satisfaction while removing the need for additional survey tools.
- Microsoft Azure Virtual Desktop (AVD): Delivers real-time visibility into key metrics for one of the fastest growing Desktop as a Service (DaaS) platforms.
Today's WFA experience is made more difficult by the use of a variety of technologies employees leverage every day as they work remotely. The tools enterprises traditionally used were not designed to support the WFA experience. With ControlUp, companies are meeting the needs of this changing world as demonstrated by over 35 Gartner Peer Insights™ reviews with an average of 4.8 stars.
"Before now, monitoring outside services like Microsoft Teams, Azure Virtual Desktop, and SaaS applications required IT professionals to log into multiple dashboards to gain visibility and pull specific reports, which still did not provide a complete picture," continued Avital. "According to Harvard Business Review, 50 percent of employees say they will look for a new job if they are forced to return to the office full-time. It is clear that a comprehensive platform for monitoring the digital employee experience is a requirement to meet the demands of today's WFA workforce."
ControlUp powers the work-from-anywhere world by delivering a Digital Employee Experience (DEX) Management Platform built for IT teams to make remote work more flexible and reliable. Whether your desktops are physical or virtual, your applications are local or SaaS, IT can optimize remote work environments from the datacenter or from the cloud with rich, real-time visibility across the entire digital employee experience. Headquartered in Silicon Valley with R&D in Israel, ControlUp supports over 2,000 customers and counting. Learn more at www.controlup.com. Follow us on Twitter, Facebook, LinkedIn, and YouTube.
Media Contact(s):
Joy Capps, Intersect Communications
joy@intersectcom.com
843-730-3857
Michelle Van Jura, Intersect Communications
michelle@intersectcom.com
310-420-4062
View original content:
SOURCE ControlUp
|
https://www.mysuncoast.com/prnewswire/2022/06/09/controlup-delivers-industry-leading-digital-employee-experience-dex-management-platform/
| 2022-06-09T14:13:58Z
|
TAMPA, Fla. (WFLA) – A 13-year-old Florida boy who has been fighting a brain-eating amoeba for more than two months was flown to Chicago for continued treatment.
Caleb Ziegelbauer and his family left Tampa International Airport on for Chicago on Wednesday afternoon. His mom, Jesse Ziegelbauer, is hopeful that her son will pull through.
“Caleb is brave. Caleb is strong. Caleb is a fighter. Caleb is young. Caleb is healthy. Caleb has a brain capable of healing,” Jesse Ziegelbauer said. “He is made of pure grit and determination and it is exactly that which we are banking on to wake him up.”
Caleb got sick after his family took a trip to Port Charlotte Beach on July 1, NBC affiliate WBBH reported at the end of July. It took a week before the boy started showing symptoms, including headaches and hallucinations. He later ended up in the emergency room.
Doctors told Caleb’s parents they believed an amoeba, known as Naegleria fowleri, had entered the 13-year-old’s body through his nose and reached his brain.
Naegleria fowleri is typically found in warm freshwater, as well as soil, according to the Centers for Disease Control and Prevention. Experts said the amoeba enters through a person’s nose when tainted water enters the nasal cavities. It typically happens while a person is swimming.
Brain-eating amoeba are not spread through person-to-person contact, but can be highly fatal to those who contract it. Victims develop a condition called “primary amebic meningoencephalitis.” The CDC said the fatality rate is over 97%, and only four people with confirmed cases are known to have survived.
“We won’t dwell on the last two months. We move forward, we continue to heal,” Jesse Ziegelbauer said. “And we couldn’t do without the help of our community, our family — all of you.”
Jet ICU, the air ambulance service that transported Caleb from Tampa to Chicago, flies seven aircraft, operating the largest long-range air ambulance fleet in North America. The accredited Tampa-based company also flies globally.
“He’s already fought one of the hardest, rarest diseases there are,” Jared Wayt of Jet ICU said of Caleb. “Jet ICU’s not gonna let a couple-hour flight up to Chicago stop his recovery.”
|
https://cw33.com/news/nexstar-media-wire/florida-boy-in-months-long-battle-against-rare-brain-eating-amoeba/
| 2022-09-01T16:12:05Z
|
LOS ALAMITOS, Calif., June 8, 2022 /PRNewswire/ -- The Computer Vision and Pattern Recognition (CVPR) conference—the largest worldwide event exploring artificial intelligence, machine learning, and computer vision research and applications—will take place from 19-24 June 2022 in New Orleans, Louisiana, and virtually. Featuring keynote speakers, presentations, tutorials, a panel session, and workshops all delivered by leading authors, academics, and experts, the event is expected to attract more than 7,500 attendees.
Registration is open now: https://na.eventscloud.com/ereg/index.php?eventid=672829&?source=pr
The 2022 CVPR keynote speakers are:
- Josh Tennebaum - Professor, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology (MIT)
- Xuedong Huang - Technical Fellow, Chief Technology Officer Azure AI
- Kavita Bala - Dean, Ann S. Bowers College of Computing and Information Science, Cornell University
A panel titled "Embodied Computer Vision" will take place on June 24 and feature Martial Hebert, Carnegie Mellon University, as the moderator, with panelists including Kristen Grauman, University of Texas, Austin, and Meta AI; Nicholas Roy, Zoox, and MIT; and Michael Ryoo, Stonybrook University and Google.
Details on the full CVPR 2022 schedule can be found on the conference website under the CVPR program menu.
CVPR 2022 conference program summary:
- June 19, 20, 2022 – Workshops
- June 21 - 24 – Main Conference
- June 21 - 23 – Expo
Hosted by the IEEE Computer Society (IEEE CS) and the Computer Vision Foundation (CVF), CVPR is the premier annual computer vision event comprising the main conference and several co-located workshops and short courses. Held as a hybrid event, CVPR 2022 will hold an in-person program at the New Orleans Ernest N. Morial Convention Center and will provide virtual attendance options. The conference content hosted on the virtual platform will be available exclusively to CVPR 2022 registered attendees. The conference proceedings will be publicly available via the CVF website, with the final version posted to IEEE Xplore after the conference.
Interested individuals can still register for CVPR at CVPR Registration.
Accredited members of the media can register for the CVPR virtual conference at CVPR Media Center.
The Computer Vision and Pattern Recognition Conference (CVPR) is the premier annual computer vision and pattern recognition conference. With first-in-class technical content, the main program, tutorials, workshops, a leading-edge expo, and attended by more than 7,500 people annually, CVPR creates a one-of-a-kind opportunity for networking, recruiting, inspiration, and motivation.
The IEEE Computer Society is the world's home for computer science, engineering, and technology. A global leader in providing access to computer science research, analysis, and information, the IEEE Computer Society offers a comprehensive array of unmatched products, services, and opportunities for individuals at all stages of their professional careers. Known as the premier organization that empowers the people who drive technology, the IEEE Computer Society offers international conferences, peer-reviewed publications, a unique digital library, and training programs.
The Computer Vision Foundation is a non-profit organization whose purpose is to foster and support research on all aspects of computer vision. Together with the IEEE Computer Society, it co-sponsors the two largest computer vision conferences: CVPR and the International Conference on Computer Vision (ICCV).
View original content to download multimedia:
SOURCE IEEE Computer Society
|
https://www.kxii.com/prnewswire/2022/06/08/cvpr-2022-program-reveal-new-research-computer-vision-ai-machine-learning-19-24-june-2022-global-conference/
| 2022-06-08T19:41:27Z
|
In a fractured world, leadership is coming from the people brave enough to shape the future. TBD Media Group introduces these ambitious leaders to the global community
LONDON, Sept. 15, 2022 /PRNewswire/ -- The world is changing and businesses are behind the change.
Businesses can be a force for social and environmental good. Through TBD Media Group, Global Thought Leaders are sharing great ideas with the wider world. Businesses will be more successful if they connect with people in a more meaningful, more human way and build relationships based on trust and relevance. To do this, businesses must be transparent about who they are and what they stand for.
Global Thought Leaders, a campaign by acclaimed production company TBD Media Group is showcasing the ideas of the world's most innovative business minds, examines their motivation and looks at the future they are creating.
TBD Media Group, which has a reputation for finding and telling the stories of the world's most influential businesses, is highlighting the ways in which Global Thought Leaders are driving change through technology and innovation.
Paolo Zanini, Founder and CEO at TBD Media Group says:
"The real power in the world is not in the hands of politicians: it belongs to those who actually get things done and use the levers at their disposal to make a difference. In Global Thought Leaders we have built a campaign around highlighting these individuals. We find out what their vision is, how they will achieve it and what benefits we will see as a result."
The Global Thought Leaders documentary series will provide valuable insights into how today's businesses are taking action to shape the future of the planet.
Companies featured in this launch:
More information on the Global Thought Leaders Campaign may be found here: https://www.globalthoughtleaders.org/
About TBD Media Group:
TBD Media Group is an international, purpose-driven, media developer that helps companies, organizations and governments tell their brand stories in a human and direct way. Learn more at https://www.tbdmediagroup.com/
Media Contact:
Anna Berkman
Chief Marketing Officer
a.berkman@tbdmediagroup.com
Video - https://mma.prnewswire.com/media/1897912/TBD_Media_Group.mp4
View original content to download multimedia:
SOURCE TBD Media Group
|
https://www.kxii.com/prnewswire/2022/09/15/global-thought-leaders-are-heading-charge-into-transformed-world/
| 2022-09-15T08:47:59Z
|
LOS ANGELES, Sept. 7, 2022 /PRNewswire/ -- Consumer Watchdog and a coalition of nonprofits opposed preemption of California's landmark privacy law in a letter sent to House Speaker Nancy Pelosi today urging her to protect the rights of 40 million Californians.
The California Consumer Privacy Act (CCPA), strengthened by voters in 2020 with the California Privacy Rights Act to give people unprecedented control over their personal data collected by businesses, would be preempted by the federal American Data Privacy and Protection Act (ADPPA).
Californians would lose a slew of rights because of federal preemption, primarily the right to make their laws stronger. The CCPA can only be amended by the legislature in a way that benefits consumer privacy, or with voter support.
"The bill will exempt companies that provide data to government agencies, leave the law vulnerable to weakening by industry lobbyists, and swiftly cancel years of progress in California," stated the letter, signed by Consumer Action, Children's Advocacy Institute, Consumer Protection Policy Center, Consumer Watchdog, and Privacy Rights Clearinghouse.
Pelosi recently raised questions about the federal law overriding privacy protections.
"With so much innovation happening in our state, it is imperative that California continues offering and enforcing the nation's strongest privacy rights," Pelosi said in a statement.
"All Americans deserve privacy protections, but preemption is a false choice pitting California's law against protections for all Americans. We can have both. Strong federal privacy laws already co-exist with stronger state privacy laws," states the letter.
Preemption will impact everything from immigration rights to freedom of assembly. It will also handicap the fight for reproductive rights, enabled by a loophole that allows companies who contract with government entities for data collection to avoid its protections.
"In contrast, under California law companies who contract with the government are covered businesses that must comply with the law," states the letter.
This loophole provides a shortcut for governments to purchase personal information without needing to obtain a warrant or subpoena. For example, a location data company called SafeGraph collected location information of those who visited abortion clinics and made it publicly available for sale.
"Under California's law, any resident who exercised their opt-out choice is protected from a government's extra-judicial purchase of their private information. ADPPA would overturn that protection," states the letter.
The California doctor who provided an abortion to a woman in an anti-choice state could also be exposed to prosecution if the doctor travels to her home state, because a Californian's ability to prevent their information from being sold to any government – including that anti-choice sheriff – is stripped by the ADPPA.
The loophole will disparately impact communities of color, low-income workers, immigrants, the LGBTQ community, and marginalized people everywhere.
Other rights that will be precluded by ADPPA include:
- The right to opt-out of profiling and automated decision-making. That's where the worst discrimination is built into the system, with biased algorithms making decisions on creditworthiness, employability, insurance eligibility and home purchases.
- Protection against coercive pricing when consumers exercise their privacy rights. The state's law prohibits such charges from being "unjust, unreasonable, coercive or usurious" and requires companies to prove a different price for those who choose privacy is "reasonably related to the value provided to the business by the consumer's data."
- California's ability to enforce the law. The California Privacy Protection Agency, charged with enforcing our state law, cites "significant uncertainties" in its ability to do so.
Federal laws such as the Gramm-Leach-Bliley Act, the Health Insurance Portability and Accountability Act, and the Electronic Communications Privacy Act all established national policy "floors" and let states enact more privacy-protective legislation. The ADPPA could do the same.
Californians are enjoying the protections of the law now. The enhancements enacted by voters take effect this January. But it will take years for the FTC to write rules implementing much of the federal law, stripping our protections in the meantime.
"Delay is denial," states the letter.
The California Privacy Protection Agency, Governor Gavin Newsom, Assembly Speaker Anthony Rendon, Attorney General Rob Bonta, and numerous other state and federal lawmakers have expressed similar objections to preemption.
Consumer Watchdog is a non-profit public interest organization. Visit us on the web at www.ConsumerWatchdog.org
View original content:
SOURCE Consumer Watchdog
|
https://www.mysuncoast.com/prnewswire/2022/09/07/privacy-groups-urge-pelosi-halt-preemption-california-privacy-law/
| 2022-09-07T22:29:29Z
|
The Academy of Emergency Nursing honors emergency nursing professionals who advance the specialty and the association
SCHAUMBURG, Ill., June 8, 2022 /PRNewswire/ -- On Wednesday, the Emergency Nurses Association announced that the Academy of Emergency Nursing will induct three ENA members in its Class of 2022.
Founded in 2004, the Academy of Emergency Nursing was created to recognize emergency nurses who have made significant and enduring contributions to the emergency nursing specialty. Since then, AEN has inducted more than 200 emergency nurses whose body of work goes beyond being an outstanding nurse and devoted ENA member.
The 2022 Class of Academy of Emergency Nursing Fellows are:
- Angela Alexander, MSN, RN, CEN, AFN-BC, SANE-A, SANE-P – North Carolina
- Kevin McFarlane, MSN, RN, CEN, NE-BC, TCRN – Texas
- Michael Carmine Buffalo (Posthumous), DNP, RN, ACNP, ARNP, CCRN – Texas
"Being inducted into the Academy of Emergency Nursing is a career highlight for an emergency nurse," said ENA President Jenn Schmitz, MSN, EMT-P, CEN, CPEN, CNML, FNP-C, NE-BC. "This shines a spotlight on the work these emergency nurses have done for our specialty, their patients and for ENA. I'm proud to see them become the newest Fellows of the Academy."
The 2022 Class of Fellows will be formally inducted into the Academy of Emergency Nursing during Emergency Nursing 2022 – ENA's annual conference. The inductees will be recognized during the event's Hall of Honor which is dedicated to highlighting ENA members receiving a special award or accolade. They will also be honored during a special AEN reception during the conference.
The AEN Induction ceremony provides an in-depth look at career accomplishments for inductees and officially welcomes them to the prestigious ranks of their peers in the Academy of Emergency Nursing. This year's induction ceremony will be hosted by Academy of Emergency Nursing Chairperson Nick Chmielewski, DNP, RN, CEN, CENP, NEA-BC, FAEN.
"I'm thrilled to welcome these great emergency nurses into the Academy," said Chmielewski. "The work that these nurses have accomplished thus far in their careers is deserving of such a prestigious recognition and I look forward to celebrating them come September."
About the Emergency Nurses Association
The Emergency Nurses Association is the premier professional nursing association dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, and leadership. Founded in 1970, ENA has proven to be an indispensable resource to the global emergency nursing community. With more than 50,000 members worldwide, ENA advocates for patient safety, develops industry-leading practice standards and guidelines, and guides emergency healthcare public policy. ENA members have expertise in triage, patient care, disaster preparedness, and all aspects of emergency care. Additional information is available at www.ena.org.
ENA Media Contact:
Dan Campana
Director of Communications
847-460-4017
dan.campana@ena.org
View original content to download multimedia:
SOURCE Emergency Nurses Association
|
https://www.kxii.com/prnewswire/2022/06/08/academy-emergency-nursing-welcome-three-fellows-class-2022/
| 2022-06-08T16:37:47Z
|
Memphis police are searching for a school teacher they say was abducted while she was out on a jog Friday morning.
Eliza "Liza" Fletcher, 34, was jogging around 4:30 a.m. when an unidentified person approached her, police said. She was forced into a mid-sized dark SUV and taken from the scene, police said, adding that they do not have any idea the direction the vehicle was traveling.
"When we arrived on the scene we were handling possibly a missing person," Memphis Police Major Karen Rudolph told a news conference. "After further investigating we found video that did show a black SUV pull into the area across the street here where the victim was taken."
Photos released by police show Fletcher running in the neighborhood near the University of Memphis. She was last seen wearing a pink jogging top and purple running shorts, the police said in an alert.
Fletcher is White, 5'6," with brown hair and green eyes, police said. She weighs 137 pounds.
The teacher's damaged phone was found near the scene where she is believed to have been abducted, CrimeStoppers Executive Director Buddy Chapman said, according to a news release obtained by CNN affiliate WHBQ.
Now, the family of the mother of two is offering a $50,000 reward through CrimeStoppers for information that would lead to an arrest in the case, WHBQ reported.
"We look forward to Eliza's safe return and hope that this award will help police capture those who committed this crime," her family said in a statement shared by Chapman.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/news/memphis-police-are-looking-for-a-school-teacher-who-was-abducted-while-out-for-an/article_b5b9e1e9-e544-5b14-8d17-4170594862d5.html
| 2022-09-03T10:58:59Z
|
Increase in Retail Footprint Furthers Brand's Mission to Enhance Every Person's Daily Routine, Globally
NEW YORK, June 22, 2022 /PRNewswire/ -- Athena Club, a subscription-based company offering award-winning personal care products, announced its launch in Canada. This is the first international market for the US-based company, and Athena Club will be the first direct-to-consumer women's shave and personal care brand available in Canada.
Athena Club has built a successful and rapidly scaling business in the US, increasing its subscriber base by 1000% and surpassing 1 million products shipped to customers in the past 24 months. Award-winning products like the best-selling Razor Kit have gone viral and earned thousands of five-star reviews from consumers, as well as accolades from media, including Good Housekeeping, Refinery29, and Vogue. The growing shave and body care markets in Canada present the perfect opportunity for Athena Club to expand its retail footprint and bring clean, sustainable, and beautifully designed personal care products to Canadian consumers.
"Expanding into Canada, our first international market, puts us one step closer to our mission to enhance every person's daily routine, globally," said Maria and Charles Desmarais, Co-Founders and Co-CEOs, Athena Club. "This is not only a major milestone for our business, but it also marks Athena Club as the first DTC player in our category to launch in Canada. We're excited to bring the best shave, body, wellness, and period products to Canadian customers who want more from their routines in terms of quality, efficacy, and accessibility. We can't wait to see the response!"
Best-sellers from the brand's portfolio will be available on athenaclub.com, including the award-winning Razor Kit, Cloud Shave Foam, Creamy Body Wash, Dewy Body Lotion, and All Day Deo. The entire line is attainable at under $50 CAD, with prices ranging from $8 CAD to $45 CAD.
About Athena Club
Athena Club is a direct-to-consumer one-stop shop that is transforming the personal care industry by improving the ways people practice self-care. By offering high-quality yet affordable products across Body, Wellness, and Period Care through a convenient subscription service, we make sure that you never have to run out of the essentials you need. Our award-winning products—such as our best-selling Razor Kit—are made alongside experts using the highest quality materials and ingredients that are best for you and your body. You won't find any harsh chemicals, dyes, or additives—only the most natural and sustainable ingredients. In May 2021, the company raised $15M for its Series A funding round, positioning itself for continued growth into further markets and product categories. For more information, visit www.athenaclub.com.
Related Links
www.athenaclub.com
View original content to download multimedia:
SOURCE Athena Club
|
https://www.mysuncoast.com/prnewswire/2022/06/22/athena-club-launches-canada-dtc-brands-first-international-market/
| 2022-06-22T13:54:33Z
|
Study Designed to Evaluate the Safety, Tolerability, and Efficacy with PL8177 Oral Colon Delivery in Adult Subjects with Active Ulcerative Colitis
Oral PL8177 May Provide a Safe and Tolerable Treatment Option for Ulcerative Colitis Patients
CRANBURY, N.J., Sept. 8, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the initiation of a Phase 2 clinical study of PL8177, a potent melanocortin-1 receptor agonist, in ulcerative colitis (UC). The study will evaluate the safety, tolerability, efficacy, pharmacokinetics, and biomarkers of orally administered PL8177 in adult patients with active UC. Clinical sites participating in the study have been activated, with screening and recruitment of potential patients underway.
"We are excited to advance oral PL8177, a potent, selective melanocortin-1 receptor agonist, into a Phase 2 clinical trial in patients with UC, an inflammatory bowel disease that affects an estimated one million people in the United States," stated Carl Spana, Ph.D., President and CEO of Palatin. "The melanocortin system plays an important role in the resolution of inflammation. The oral formulation of PL8177 is targeting melanocortin-1 receptors on the luminal surface of colon epithelial cells. In a prior phase 1 clinical study, the oral formulation successfully demonstrated sustained delivery of PL8177 to the lumen of the colon with no systemic exposure. Our goal is to establish PL8177 as a safe and tolerable treatment for patients eliminating or delaying immunosuppressive treatments that have safety and tolerability concerns."
The Phase 2 study is a multi-center, randomized, double-blind, placebo-controlled, adaptive design, parallel group of PL8177, with once daily (QD) oral dosing in adult UC subjects. The study is designed to enroll up to 28 adult subjects with active UC from approximately 22 sites. All subjects who meet the eligibility criteria will be randomized to receive either placebo or oral PL8177.
"The initiation of Palatin's second clinical program evaluating a melanocortin based therapeutic in an inflammatory indication is an exciting milestone. We continue to compile compelling data that strengthens our belief in the potential for melanocortin therapeutics as safe and effective treatments for inflammatory and autoimmune diseases," concluded Spana.
The study uses an adaptive design with an interim assessment by an independent data monitoring committee after the initial 16 subjects have completed the 8-week evaluation visit. The efficacy evaluations and endpoints are in line with the latest FDA Draft Guidance for Industry: Ulcerative Colitis: Developing Drugs for Treatment (April 2022), including the primary efficacy endpoint the Mayo Endoscopic Subscore, which evaluates the level of disease in the colon mucosa.
The PL8177-205 interim assessment is expected to occur in the first quarter of calendar year 2023, with final topline data anticipated in the second quarter of calendar year 2023. Additional trial information, including inclusion and exclusion criteria, can be found at https://clinicaltrials.gov/ via the identifier NCT05466890.
PL8177 is a synthetic cyclic heptapeptide with demonstrated efficacy in multiple animal inflammatory bowel disease models. PL8177 is a potent, selective agonist at the human melanocortin receptor-1 (MC1r), with sub-nanomolar affinity binding and EC50 functional values. Palatin data demonstrates that the oral formulation of PL8177 was protected from degradation in the stomach and small intestine and delivered to the large intestine and colon over an extended period. In addition, orally administered PL8177 had a significant effect on resolving inflammation in a rat bowel inflammation model.
PL8177 in oral formulations has demonstrated repeated, robust efficacy in ulcerative colitis disease models. MC1r is found on epithelial cells and resident macrophages of the colon which are accessible from the lumen of the colon. Orally administered PL8177 is not systemically absorbed. PL8177 has the potential for excellent efficacy without safety concerns.
Ulcerative colitis is a chronic disease of the large intestine (colon), with inflammation and ulcerations that can cause significant abdominal pain, persistent diarrhea, loss of appetite and other symptoms. An estimated 1 million individuals in the United States are affected by ulcerative colitis, with over 350,000 diagnosed with moderate-to-severe disease. Existing treatments are not effective in a substantial portion of patients with moderate-to-severe ulcerative colitis, with certain severe cases resulting in surgical removal of the colon.
The melanocortin receptor ("MCr") system has effects on inflammation, immune system responses, metabolism, food intake, and sexual function. There are five melanocortin receptors, MC1r through MC5r. Modulation of these receptors, through use of receptor-specific agonists, which activate receptor function, or receptor-specific antagonists, which block receptor function, can have medically significant pharmacological effects.
Many tissues and immune cells located in the eye (and other places, for example the gut and kidney) express melanocortin receptors, empowering our opportunity to directly activate natural pathways to resolve disease inflammation.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.Palatin.com and follow Palatin on Twitter at @PalatinTech.
Statements in this press release that are not historical facts, including statements about future expectations of Palatin, such as statements about clinical trial plans and potential results for PL8177, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends that such forward-looking statements be subject to the safe harbors created thereby. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause Palatin's actual results to be materially different from its historical results or from any results expressed or implied by such forward-looking statements. Palatin's actual results may differ materially from those discussed in the forward-looking statements for reasons including, but not limited to, results of clinical trials, regulatory actions by the FDA and other regulatory and the need for regulatory approvals, Palatin's ability to fund development of its technology and establish and successfully complete clinical trials, the length of time and cost required to complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not responsible for updating for events that occur after the date of this press release.
Palatin Technologies® and Vyleesi® are registered trademarks of Palatin Technologies, Inc.
View original content to download multimedia:
SOURCE Palatin Technologies, Inc.
|
https://www.wibw.com/prnewswire/2022/09/08/palatin-announces-initiation-patient-recruitment-phase-2-clinical-study-evaluating-oral-pl8177-treatment-ulcerative-colitis/
| 2022-09-08T12:39:35Z
|
Which kinesiology tape is best?
Kinesiology tape is used for a variety of reasons. You may have injuries or arthritis you want to treat, or you may want to add support to your body while you’re working out. Kinesiology tape can even help bruises fade faster. And it comes in dozens of colors, so you can showcase your personality while you heal and work out.
The best kinesiology tape is Bear Komplex Athletic Sports Tape. It’s built tough to resist water and sweat, and it’s easy to tear off the piece you need from the roll.
What to know before you buy kinesiology tape
Kinesiology tape possible benefits
Kinesiology tape is said to have multiple benefits. Among those claimed for it:
- Pain relief: Kinesiology tape can help to relieve pressure on your joints and muscles, which in turn lowers the pain you feel.
- Inflammation and swelling: By stretching out the area it’s applied to, kinesiology tape can help the fluid in these areas drain faster, so your tissues heal quicker.
- Bruising: As it does for swelling and inflammation, kinesiology tape can help the pooled blood that causes bruising to dissipate more quickly.
- Muscle recovery: Your muscles become sore due to a buildup of lactic acid. Kinesiology tape can help decrease this acid buildup.
- Cramps: A common cause of cramps is insufficient blood circulation, which kinesiology tape can help to improve.
Solid vs. precut
Kinesiology tape comes in rolls that are either one long piece or precut into strips. Precut strips make it much easier for beginners to get a handle on proper application, but can be restrictive for experienced users.
Some solid tapes have cutting guidelines on them to make trimming easier. Others are designed to be easy to tear so you don’t need to cut at all.
What to look for in quality kinesiology tape
Elasticity
Kinesiology tape is designed to stretch the skin, muscle and joints, and it accomplishes this with increasingly higher percentages of elasticity. Tapes typically come with 120%-180% elasticity, meaning the tape can stretch up to 120%-180% of its original size.
The higher the elasticity the better, as the tape becomes easier to apply, is less limiting and is more effective. That said, higher elasticities are also more expensive.
Material
Kinesiology tape is made of layers, with the outermost layer the most important — and the most varied. Typically, this layer is cotton or a synthetic material.
- Cotton is popular for its breathability and lightweight, but it can struggle to stay on when exposed to too much moisture.
- Synthetics, such as nylon or polyester, aren’t as breathable as cotton but tend be more water-resistant, so they stay on longer.
How much you can expect to spend on kinesiology tape
Kinesiology tape typically costs $10-$75, depending on factors such as the elasticity and size. Basic, small rolls sell for $20 or less, with midrange rolls costing roughly $20-$40. The largest, most elastic rolls cost around $40-$75.
Kinesiology tape FAQ
Has kinesiology tape been scientifically studied?
A. Yes. Most studies, such as those discussed by the National Institutes of Health, come to the same conclusion: that kinesiology tape has minor to little positive effects on the issues it’s designed to treat or manage. However, studies have also suggested that there’s no harm in using kinesiology tape and that its placebo-like effects are potentially helpful.
How long does the adhesive last on kinesiology tape?
A. The adhesive used by most kinesiology tapes is strong — strong enough to stay put for nearly a week, in some cases. In fact, kinesiology tape is frequently worn for several days at a time before being removed. If you plan on wearing it this long, however, make sure it’s water-resistant so it won’t come off from sweat.
Does kinesiology tape cause irritation?
A. It’s possible. Most tapes are made of hypoallergenic materials and adhesives to prevent it, but everyone’s body is different, so you may have a reaction. If you feel any irritation, immediately remove the tape. You should also avoid applying it to damaged skin, including rashes, cuts and scrapes, as it can worsen these areas.
What’s the best kinesiology tape to buy?
Top kinesiology tape
Bear Komplex Athletic Sports Tape
What you need to know: It’s effective and comes at a great price.
What you’ll love: It comes with four or 12 rolls that are 2 inches wide and 14.75 feet long. It absorbs sweat to reduce irritation, even in the midst of the most extreme workouts. Its surface is smooth and nonslip.
What you should consider: A few consumers had problems getting the tape to stay in place. Others had issues with bunching if the tape wasn’t applied tautly.
Where to buy: Sold by Amazon
Top kinesiology tape for the money
What you need to know: It’s cheap and comes precut for simplicity.
What you’ll love: Each roll includes 20 strips that are 2 inches wide and 10 inches long, plus it’s available in two colors. It’s made of cotton with a touch of spandex to be waterproof, comfortable and effective. It uses a visual application aid to help you apply it perfectly.
What you should consider: A handful of customers reported the tape to leave marks on the skin after it was removed. Others found the adhesive to cause itchiness.
Where to buy: Sold by Amazon
Worth checking out
Physix Gear Sport Kinesiology Tape Pro
What you need to know: This tape comes with a guide, making it perfect for those new to kinesiology tape.
What you’ll love: It’s available in 10 colors and comes with one or two rolls that are 2 inches wide and 16 feet long. It’s hypoallergenic and latex-free, plus it’s water- and sweat-resistant. The underside of the tape has grid lines as a cutting guide.
What you should consider: If not applied correctly, it can cause irritation or even blisters. It can be difficult to remove and to cut to the desired length.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Jordan C. Woika writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved.
|
https://cw33.com/reviews/br/sports-fitness-br/fitness-gear-br/best-kinesiology-tape/
| 2022-05-17T14:33:20Z
|
BETHESDA, Md., June 5, 2022 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported that yesterday on June 4, 2022, in the Industry Expert Theater during the ASCO 2022 conference, Dr. Marnix Bosch made a presentation discussing the Company's DCVax-L technology for personalized dendritic cell vaccines, the Sawston, UK facility, the manufacturing technology, the development of automation, and preparations for manufacturing scale-up. In addition, a video presentation about the DCVax®-L clinical program was screened in the Company's exhibit booth in the ASCO Exhibit Hall.
These presentations are now available online at https://virtualtrials.org/dcvax
The Industry Expert Theater is not an official event of the ASCO Annual Meeting. It is not sponsored, endorsed or accredited by ASCO®, CancerLinq®, or Conquer Cancer® the ASCO Foundation. It is not CME-accredited.
About Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company's lead program is a 331-patient Phase III trial of DCVax®-L for newly diagnosed and recurrent Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease." This Phase III trial reached data lock and top line data was recently presented. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial and, as resources permit, plans to pursue Phase II trials. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania.
Disclaimer
Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "design," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we actually will achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as risks related to the Company's ability to achieve timely performance of third parties, risks related to whether the Company's products will demonstrate safety and efficacy, risks related to the Company's ongoing ability to raise additional capital, and other risks included in the Company's Securities and Exchange Commission ("SEC") filings. Additional information on the foregoing risk factors and other factors, including Risk Factors, which could affect the Company's results, is included in its SEC filings. Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.
CONTACTS
Dave Innes
804-513-4758
dinnes@nwbio.com
Les Goldman
240-234-0059
lgoldman@nwbio.com
View original content to download multimedia:
SOURCE Northwest Biotherapeutics
|
https://www.mysuncoast.com/prnewswire/2022/06/06/northwest-biotherapeutics-announces-presentations-dcvax-l-personalized-vaccines-manufacturing-scale-up-dcvax-l-clinical-program/
| 2022-06-06T01:56:20Z
|
Gestalt-Hamamatsu unified solution will provide end-to-end support to the entire workflow
SPOKANE, Wash., June 7, 2022 /PRNewswire/ -- Today, Gestalt Diagnostics, Inc., a leading provider of digital pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, announced the implementation of a unified solution at Intermountain Healthcare. This combined solution will facilitate Intermountain Healthcare's adoption of digital pathology* and accelerate implementation across the entire Intermountain Healthcare system.
As laboratories adopt digital pathology, they must leverage complex hardware and software solutions ecosystems to augment their existing workflows. Intermountain Healthcare recognized the complexity of implementation and adoption of digital pathology. To facilitate adoption and help users recognize the value of digital pathology, Intermountain Healthcare opted for an open ecosystem that was genuinely interoperable. As a result, Intermountain Healthcare selected Gestalt and Hamamatsu to drive efficiencies while reducing turnaround times for their clinicians.
Dylan Miller, MD, who co-led the digital pathology implementation strategy at Intermountain Healthcare, noted, "Combining the flexibility, reliability, and durability of Hamamatsu's latest generation scanning technology with Gestalt's highly adaptable and interoperable image management and reporting solution has been an ideal pairing. We are able to meet diverse and dynamic needs across multiple lab sites and pathology groups in our system as we are rolling out digital pathology because of this tremendous partnership."
Don Ariyakumar, Product Manager at Hamamatsu stated, "Enabling customers to select the best-in-class solutions for their organization along with interoperability is critical for the adoption of digital pathology. We are thrilled to work with Gestalt and help Intermountain Healthcare reach its potential with Hamamatsu NanoZoomer digital pathology systems."
"A truly interoperable platform which incorporates every component necessary to streamline the workflow for pathologists is essential for leveraging the full benefits of digital pathology," said Lisa-Jean Clifford, COO & Chief Strategy Officer at Gestalt. "The deep integration of our Image Management System with Hamamatsu is a cornerstone of the digital process. PathFlow, our digital pathology solution, streamlines the workflow and case management for Intermountain Healthcare's pathologists through interoperability, increasing efficiency. Our ability to integrate bi-directionally with the LIS and EMRs to provide the right case to the right pathologist both internal to Intermountain Healthcare and to their external clients, regardless of their location, has a positive impact on their operations."
Hamamatsu Photonics K.K. is a leading manufacturer of photonics devices. We design, manufacture, and sell optical sensors, light sources, optical components, cameras, photometry systems, and measurement/analysis systems.
Gestalt Diagnostics is committed to bringing anatomic pathology into the digital age. The US company was formed in 2017 and provides enterprise solutions and services to transform anatomic pathology laboratories from glass slides, microscopes, and couriers to an automated, electronic digital workflow. Gestalt has developed its flagship product, PathFlow®, built upon its experience and expertise in a radiology PACS - Image Management System. This experience in radiology forged its success in developing and deploying a fully digital pathology solution specifically for pathology labs. The advisory board contains industry-leading pathologists who continually weigh in on Gestalt's development plans and the usability of solutions in clinical practice, education, and research.
*Whole Slide imaging system is sold for research use only
View original content:
SOURCE Gestalt Diagnostics
|
https://www.wibw.com/prnewswire/2022/06/07/intermountain-healthcare-selects-gestalt-hamamatsu-accelerate-digital-pathology-adoption/
| 2022-06-07T17:13:54Z
|
SUNNYVALE, Calif., Aug. 25, 2022 /PRNewswire/ -- Sonatus, a global leader in software-defined vehicle technology, today announced it has joined the Renesas R-Car Consortium. The R-Car Consortium, enables customers to quickly identify and engage with the partners whose solutions will help them to accelerate innovation and receive end-to-end development support to build advanced Connected Car & ADAS solutions.
"As software becomes a critical driver in automobiles, application software becomes larger and more complex, the R-Car Consortium is a certified and trusted ecosystem that enables customers to cut through information overload to select the partners and solutions that will set them up for success," said Jeffrey Chou, Co-founder and CEO of Sonatus. "Working with the R-Consortium we hope to simplify the journey for system developers to further reduce the number of development steps and costs required to bring the power of software-defined vehicle automation to market faster, while reducing complexity and cost, in the face of rapid change."
The R-Car Consortium creates a flexible and diverse collaborative environment for system developers. By bringing together system integrators, middleware/application developers, and operating system and tools vendors who are developing solutions for the Connected Car, ADAS and Gateway market, with highly reliable and technically advanced SoCs, evaluation boards and software from Renesas. A global automotive semiconductor leader, Renesas has a long history delivering reliable and innovative automotive solutions for a wide range of systems.
To learn more about Sonatus and its award-winning Digital Dynamics™ software-defined vehicle platform, please visit www.sonatus.com.
Sonatus helps automakers build software-defined vehicles that can evolve and adapt over their entire lifetimes through code-less updates that don't require new software. Leveraging extensive software-defined and automotive expertise, the company compresses decades of digital innovation into scalable vehicle and cloud software solutions, empowering OEMs to innovate faster, reduce complexity and costs, and become more agile. Sonatus' award-winning Digital Dynamics™ platform is currently in-market in Hyundai, Kia, and Genesis, and will be on the road in millions more vehicles by 2023. The company has raised more than $35 million USD with world-class automotive, technology, and venture investors including Hyundai Motor Group's Kia Corporation, LG Electronics, Marvell, SAIC Capital, Translink Capital, UMC Capital, and Wanxiang Group Company. The company is headquartered in Sunnyvale, CA, with offices in Detroit, MI, and Seoul, Korea.
Media Contact
Ryan Bender
Clarity PR for Sonatus
sonatus@clarity.pr
View original content to download multimedia:
SOURCE Sonatus
|
https://www.wibw.com/prnewswire/2022/08/25/sonatus-joins-renesas-r-car-consortium-accelerate-software-defined-vehicle-innovation/
| 2022-08-25T10:08:44Z
|
Debut of New Collection, Landau Forward, is First from Chief Product Officer Sallian Song
Elevated Look and Comprehensive Marketing Campaign for Landau Unveiled
SCOTTSDALE, Ariz., Sept. 8, 2022 /PRNewswire/ -- Kindthread, the leading healthcare apparel company, today debuted the relaunch of the iconic Landau brand, modernizing the 70-year-old brand with a trailblazing visual identity and a new high-performance product line, Landau Forward. The debut of Landau Forward marks the first phase of a full rebrand for Landau, including an all new go-to-market approach, a full digital refresh, and an enhanced marketing campaign shot earlier this summer by celebrated fashion photographer Sebastian Kim. The collection marks the first from Kindthread's Chief Product Officer Sallian Song, the industry-renowned designer behind some of today's most popular scrubs.
Landau Forward is a full range of modern, performance-driven scrubs, and features advanced, sustainably-sourced fabrics alongside high-performing design. "Landau has represented quality and reliability for generations and with Landau Forward, we are elevating that celebrated legacy and introducing the brand to a new generation of healthcare professionals," said David Murphy, Chief Executive Officer of Kindthread. "Our team is dedicated to delivering best-in-class products, service, and experiences, and the new Landau represents a significant next chapter for the brand. While the look and feel reflect a more modern aesthetic, the traditions of durability and value are stronger than ever."
The new offering from Landau is available for retail partners to pre-book now, and to healthcare professionals on December 1, 2022. It features a full range collection of five core styles in seven colors inspired by global fashion trends, including tops, joggers and jacket options. The line incorporates CiCLO sustainable fabric which delivers advanced comfort, fit, and durability while also being kinder to the planet. CiCLO technology allows synthetic plastic-based fibers to behave more like natural fibers, such as wool, but improves on natural fibers by biodegrading faster and helping reduce the accumulation of plastic waste in landfills and plastic pollution in our oceans.
"We put healthcare professionals at the center of everything we do. When we began designing Landau Forward, we set out to create a collection that was both comfortable and sustainable, in an elevated professional style," said Sallian Song. "Landau Forward is a prime example of the innovation, comfort, fit, and attention to detail that will be infused into all of our future products."
The Landau Forward collection is moisture-wicking and provides a four-way stretch. Each piece is breathable, wrinkle-resistant, and fade-resistant with flexible panels and ribbed trims. The range is expected to expand in the summer of 2023 with an extended men's collection and additional colors.
Kindthread was founded earlier this year when the company acquired legacy healthcare apparel brands Landau, White Cross, Scrubs & Beyond, as well as leading uniform provider, Chefwear. Kindthread aims to disrupt the sector by offering consumers and industry partners the highest quality apparel through a data-driven omni-channel distribution network.
About Landau
Landau is one of the most trusted makers of healthcare apparel in the U.S. Since our foundation in 1938, we have become known for meticulous craftsmanship, innovative design, and enduring value. Today we continue this legacy by offering a wide range of practical, durable, and stylish products designed to support medical professionals not just on every shift, but at every stage of their careers. We believe that we're on a journey with our customers , and that's why everything we make comes with a clear promise of Landau quality. For more information, please visit www.landau.com.
About Kindthread
Kindthread is a modern, digitally-forward, customer-obsessed organization, dedicated to serving healthcare professionals while driving positive community impact. Our global ecosystem of trusted brands and highly coveted products creates an unprecedented retail experience for healthcare professionals worldwide. The Kindthread portfolio of brands includes Landau, Chefwear, White Cross, and industry leader Scrubs & Beyond.
View original content to download multimedia:
SOURCE Kindthread
|
https://www.mysuncoast.com/prnewswire/2022/09/08/kindthread-debuts-new-landau-complete-modernization-relaunch-iconic-healthcare-apparel-brand/
| 2022-09-08T13:49:27Z
|
The Cole Haan x Keith Haring Capsule Collection Pays Homage to Pop Artist's Life and Lasting Legacy
NEW YORK, June 21, 2022 /PRNewswire/ -- Cole Haan, the iconic American performance lifestyle brand and retailer, is proud to introduce a collection of shoes featuring some of Keith Haring's most iconic works of art. The Cole Haan x Keith Haring Collection features a selection of four shoes, all of which fuse the Cole Haan legacy of craftsmanship with Keith Haring's visionary spirit and lasting activism.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9021352-cole-haan-unveils-new-shoe-collaboration-featuring-art-keith-haring
"Keith Haring was an incredible trailblazer who used his work and creativity as a platform for social activism through his powerful, convention-breaking art," said David Maddocks, Cole Haan Brand President. "Keith Haring's legacy of working for what he believed in is not only intrinsic to our mission here at Cole Haan, but has also empowered generations of his fans to follow suit in their own endeavors. We are honored to help further his mission of using art to enact positive change through this collaboration."
Known as one of the most renowned young artists of the 1980's, Keith Haring began to draw in white chalk over the black paper used to cover vacant advertising panels in NYC subways after becoming inspired by the graffiti artists whose marks covered the city's subway cars. Not only was Haring able to reach a large and diverse audience with his subway drawings but it eventually became, in his words, a "laboratory" for working out his ideas. Haring produced an array of murals, sculptures, and paintings to benefit various children's and AIDS organizations, creating a lasting legacy of giving. The Cole Haan x Keith Haring special-edition collection featuring best-selling ØriginalGrand and GrandPrø Rally styles, is inspired by a similar notion: that exceptional craft, elevated design, and effortless style are meant for everyone everywhere. Some might call this collaboration a perfect fit.
"We really love the designs that Cole Haan developed for this footwear collection," says Gil Vazquez, Executive Director of the Keith Haring Studio. "The artworks really pop on the iconic shoe styles in a way that makes them instant classics, and a great vehicle to help spread Keith's empowering, positive message."
Cole Haan x Keith Haring takes the renowned pop-artist's eclectic, iconic, busy and bold work from the street to your feet and features some of Haring's most memorable icons, including the snake and the radiant baby. The collection features the second drop in the brand's "Ten Years of Defying Convention" series celebrating the ØriginalGrand wingtip, and it ranges from $100-$180. The collection was designed for both men and women and is available now at ColeHaan.com, as well as in US retail locations and select International Cole Haan stores starting today, June 21, 2022.
Partnership done in collaboration with Artestar, a global licensing agency and creative consultancy representing high-profile artists, photographers, designers and creatives.
About Cole Haan
Cole Haan is a global performance lifestyle brand serving always-connected, active professionals with innovative footwear and lifestyle accessories. With a 90-year heritage, Cole Haan infuses its products with time-honored craftsmanship and modern innovation, making footwear and lifestyle accessories that customers wear from work, to workout, to weekend. Cole Haan's mission is to inspire customers to live extraordinary lives.
For more information, contact:
Autumn Communications
colehaan@autumncommunications.com
View original content:
SOURCE Cole Haan
|
https://www.mysuncoast.com/prnewswire/2022/06/21/cole-haan-unveils-new-shoe-collaboration-featuring-art-keith-haring/
| 2022-06-21T13:20:40Z
|
Board puts abortion rights question on Michigan fall ballot
LANSING, Mich. (AP) — A Michigan election board placed an abortion-rights proposal on the fall ballot Friday, obeying an order from the state’s highest court and closing a record-breaking petition drive to try to amend the state constitution.
The amendment would affirm the right to make pregnancy-related decisions without interference in Michigan, including abortion and other reproductive services such as birth control.
The Michigan Supreme Court a day earlier ordered the Board of State Canvassers to put it on the Nov. 8 ballot. The board, comprised of two Democrats and two Republicans, had killed the proposal in a tie vote last week, with GOP members siding with abortion opponents who said the petition had improper or no spacing between certain words.
Chief Justice Bridget McCormack derisively called it a “game of gotcha gone very bad.” She said the words were legible and in correct order.
People cheered and applauded when the board voted 4-0 Friday to add it to the ballot.
“We’ve gotten that clarity,” said Republican board member Tony Daunt, who didn’t address McCormack’s criticism. “There was never any doubt in my mind that once the court spoke what we were going to do.”
The other GOP member, Richard Houskamp, denied any partisanship in rejecting the proposal on Aug. 31.
There are political implications beyond the ballot question.
Democrats say the U.S. Supreme Court’s decision to overturn Roe v. Wade is mobilizing voters and will help Democratic candidates this fall, when top races including governor, secretary of state and attorney general are on the Michigan ballot. They point to conservative Kansas, where voters overwhelmingly defeated a measure that would have allowed the Republican-controlled Legislature to tighten restrictions or ban the procedure outright.
In Michigan, abortion-rights supporters had submitted more than 750,000 signatures, easily clearing the minimum threshold and setting a record for a ballot initiative.
Addressing the board before the vote, volunteers Elizabeth Buckner and Beata Lamparski said they collected more than 5,400 signatures in 38 counties, including signatures from people who oppose abortion but believe voters have a right to decide the issue.
“We collected when it was so cold that our fingers barely worked and when it was so hot that we could barely stand. ... We did our job. Now I’m asking you to do your job,” Lamparski said.
Abortion has remained legal in Michigan even after the fall of Roe. A 1931 law that makes it a crime to perform most abortions was suspended by a judge last spring and declared unconstitutional this week.
But that decision can be appealed. If voters approve the constitutional amendment guaranteeing abortion rights, any legal fight would be moot.
A poll published this week by The Detroit News and WDIV-TV showed abortion and women’s rights as the top issue motivating Michigan residents to vote in November, ahead of inflation, education and the economy. The poll showed a majority of likely voters supporting the amendment to protect abortion rights.
___
White reported from Detroit.
___
Joey Cappelletti is a corps member for the Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.mysuncoast.com/2022/09/09/board-puts-abortion-rights-question-michigan-fall-ballot/
| 2022-09-09T15:30:09Z
|
WELLINGTON, New Zealand (AP) — The foreign ministers of Australia and China were both making their final stops Friday on what has become an island-hopping diplomatic duel in the South Pacific.
Australia’s Foreign Minister Penny Wong arrived in Tonga where she met with Prime Minister Hu’akavameiliku and other officials including King Tupou VI. Her visit came just three days after China’s Foreign Minister Wang Yi held similar meetings in Tonga.
Wong and the officials talked about climate change and rebuilding efforts after the devastating earthquake and tsunami that hit in January. Also on the agenda was the contentious issue of regional security.
“We are not a government or a country that wants to come in and tell you what you should do,” Wong said at a news conference in the capital, Nuku’alofa.
She said Australia considered itself part of the Pacific family.
“We want regional security to be dealt with, to be the responsibility of the Pacific family,” Wong said. “And we will continue to engage with our friends, our partners in the region.”
Hu’akavameiliku said Tonga was honored that Wong had decided to visit just two weeks after taking office, following an election in Australia.
“This is a clear sign of the Australian government’s strong commitment to strengthening our bilateral relations and engagement with our region,” the prime minister said.
Meanwhile, Wang met in Papua New Guinea with Prime Minister James Marape and other officials ahead of a scheduled flight Friday afternoon to East Timor, the final stop on his eight-nation tour of the region and the first outside of the South Pacific. Wang is due to leave from East Timor on Saturday.
Wang had hoped to ink an ambitious multilateral deal with 10 South Pacific nations this week covering everything from security to fisheries. He couldn’t find consensus on that deal but has been notching up smaller wins by signing bilateral agreements with many of the countries he’s been visiting.
The diplomatic push by China, especially around Pacific security, has caused deep concern among some of the island nations as well as farther afield in Canberra and Washington. Since news of the proposed deal emerged, Wong has made two trips to the Pacific to shore up support for Australia.
|
https://cw33.com/news/international/ap-international/china-and-australias-dueling-pacific-tours-make-final-stops/
| 2022-06-03T13:31:27Z
|
49ers WR hopes Kaepernick workout prepares him for Lance
By JOSH DUBOW
AP Pro Football Writer
SANTA CLARA, Calif. (AP) — San Francisco rookie receiver Danny Gray found the ideal workout partner before the draft to prepare him to play with the 49ers’ strong-armed quarterback, Trey Lance. It just happened to be a former 49ers quarterback known for his ability to throw with velocity. Gray was part of a group of receivers who worked out with Colin Kaepernick in Dallas. Kaepernick hasn’t played in the NFL since his final year with the 49ers in 2016 when he made headlines after he began kneeling during the national anthem to protest police brutality and racial inequality.
|
https://localnews8.com/sports/ap-national-sports/2022/05/12/49ers-wr-hopes-kaepernick-workout-prepares-him-for-lance/
| 2022-05-13T00:44:33Z
|
New Patent Pending USB Powered MTS101 Monitor Meets Increasing Demand for Location Flexibility in the OR
PLYMOUTH MEETING, Pa., Aug. 3, 2022 /PRNewswire/ -- MediCapture Inc., a leading manufacturer of medical imaging systems and hospital connectivity software, announces the availability of its new MVR TouchPro™, the combination of a premium-quality MVR medical video recording system with a new medical-grade, 10-inch, multi-touch monitor, the MTS101.
One of the most scalable and highest performance systems in the industry, the MVR TouchPro offers direct network and WiFi connections to PACS with the ability to control surgical sessions from anywhere in the OR, thanks to the bundled MTS101 multi-touch monitor.
The Pat. Pend. USB powered MTS101 multi-touch monitor features "plug and play" setup and easy VESA Mount capability, making it easy to position it in any location in the operating room. Using the large 10-inch user interface, teams can enter patient data, zoom in, edit videos, and develop reports.
In addition to the MTS101, the MVR TouchPro comes with a host of advanced and unique features, including full-patient workflow, with a DICOM Made Easy™ upgrade option, for easy and fast retrieval of patient information and transfer of studies to PACS, and a 4K Ultra HD upgrade option to record delicate surgeries in stunning detail. Both upgrades can be instantly accessed with an activation code when ready to add on.
"The MVR TouchPro with the MTS101 is a complete package for hospitals that require advanced medical video recording systems that are easy to set up and simple to use," said Bernd Jotzat, Product Manager. "Surgical teams can position the monitor anywhere in the OR and handle powerful workflow capability with a swipe of the finger, just like a smartphone."
The MTS101 multi-touch monitor that comes with the MVR TouchPro can also be purchased alone to use with any other MediCapture MVR medical imaging system, and it is available to original equipment manufacturers (OEMs) of endoscopy and other surgical video equipment.
"A versatile plug and play touch screen monitor was a highly expected add-on from our hospital and OEM customers," said Mike Bishop, President and CEO. "With the increasing need to manage and share video content in the surgical market, MediCapture is also working on several storage and peripheral products that will enhance its MVR systems portfolio".
The new MVR TouchPro™ and MTS101 is in stock and available for immediate delivery. For more information on the availability of the MVR TouchPro and the MTS101 Monitor with Touch Screen, contact MediCapture at sales@medicapture.com or call 888-922-7887 (US); +1 503-445-6935 (outside the US).
MediCapture Inc. is a leading manufacturer of medical imaging systems and DICOM compliant software connectivity suites. The company's imaging systems supports a guided workflow from video capture through PACS archiving. Designed for compatibility with any medical video camera, MediCapture's imaging systems are marketed by the world's largest manufacturers of endoscopes, surgical microscopes, and robotic surgery systems. For more information on MediCapture and its products, visit medicapture.com.
CONTACT:
Sherrie Walters
Ensemble Communications
sherriewalters@ensemblecomms.com
610-551-4716
View original content to download multimedia:
SOURCE MediCapture, Inc.
|
https://www.mysuncoast.com/prnewswire/2022/08/03/medicapture-launches-mvr-touchpro-includes-new-medical-grade-10-inch-multi-touch-mts101-monitor-with-mvr-documentation-recording-system/
| 2022-08-03T13:14:00Z
|
MIAMI (AP) — In Miami Heat coach Erik Spoelstra’s mind, the injury situation with Joel Embiid doesn’t doom the Philadelphia 76ers.
He figures it’ll only steel their resolve.
Clearly, the 76ers are not going to be a better team without Embiid, the scoring champion and MVP finalist currently sidelined by a right orbital fracture and mild concussion, injuries that have him officially ruled out for Game 1 and likely Game 2 as well. That said, the 76ers played the Heat once this season without Embiid — and won. They’ll try to do it again Monday night when Philadelphia visits Miami in Game 1 of an Eastern Conference semifinal series.
“Whenever you’re dealing with a team that has to change a little bit, that immediately gets them a built-in sense of urgency,” Spoelstra said. “But again, what we’re trying to accomplish, it is so difficult. When you approach it that way, that just puts you there to compete at a high level, the necessary level that is going to be required.”
The Heat aren’t exactly in perfect health, either. Jimmy Butler has been slowed by a sore knee, Tyler Herro caught a cold that turned into an upper-respiratory-type mess — but not COVID-19 — and PJ Tucker has been dealing with a calf issue. (All three expect to play Monday.) And Philadelphia native Kyle Lowry missed the last two games of the first-round series against Atlanta with a hamstring strain, so the Heat can’t be certain when their point guard will be 100% again. He’s been ruled out for Game 1.
“I think both rosters are going into this battle knowing that both sides got enough to get the job done,” Butler said. “We’ve got a job to do. They’ve got a job to do. But I’m banking on the Miami Heat.”
The 76ers don’t need any hyperbole along the way to realizing that they can have success against Miami. They need only to pop in the tape from March 21.
Embiid didn’t play that night. The 76ers didn’t have James Harden, either. Didn’t matter. Philadelphia outrebounded Miami 45-34, outscored the Heat 45-30 from 3-point range and pulled off a 113-106 win.
“Well, the biggest adjustment is we don’t have Joel,” 76ers coach Doc Rivers said, overstating the obvious for emphasis. “There’s no good thing to it. But we did have one game without Joel against them and honestly, we won the game but I thought it was more than they looked at we didn’t have Joel, I think James was out, so I think mentally that probably played a purpose in that game. That’s not going to happen now. They don’t care who we have on the floor.”
The 76ers went 6-8 without Embiid this season. Plus, with Harden, the 76ers still have a player who is four years removed from being an MVP and two years removed from being a back-to-back-to-back scoring champion.
“Truth be told, it’s just us figuring out what we can go to through the course of a game in the playoffs,” Philadelphia forward Tobias Harris said. “It’s always adapting and figure out how the other teams is playing, what they’re taking away, what they’re allowing, and for us to capitalize in that regard.”
INSIDE THE NUMBERS
Only six players (Tyrese Maxey, Isaiah Joe and Harris for the 76ers; Tucker, Duncan Robinson and Max Strus for the Heat) played in all four Philadelphia-Miami games this season. The 76ers’ defense was stellar, with Gabe Vincent (21.0 ppg in two games) the only Heat player to average more than 20. Team stats were incredibly close: Miami had slight edges in points (404-400) and assists (92-89), Philadelphia had the edge in rebounds (164-159). The 76ers shot 44.8%, Miami 44.6%.
TOP TWO
It’s a matchup of two of the all-time winningest playoff coaches. Rivers (102 wins) is fourth on the NBA postseason list behind Phil Jackson (229), Pat Riley (171) and Gregg Popovich (170). Spoelstra (89) is eighth behind the top four, then Larry Brown (100), Red Auerbach (99) and Jerry Sloan (98). Fun fact: if Miami wins Games 1 and 2 of this series then Spoelstra would pass Riley — the Heat president and his boss — in playoff winning percentage.
HEAD-TO-HEAD
This is the third Miami-Philadelphia playoff series. The other two were first-round matchups: Miami won in five games in 2011, Philadelphia won in five games in 2018. Each team has two players remaining on the roster from that series — Embiid and Furkan Korkmaz for the 76ers, Olympic gold medalist Bam Adebayo and Udonis Haslem for the Heat.
CONSISTENT HARDEN
Home, road, it doesn’t matter to Harden. His career splits are uncanny. For his career, he averages 24.9 points at home, 24.5 on the road. In home games, he’s shot 44% from the field, 36% from 3-point range and 86% from the foul line. And on the road, he has the same percentages. But he’s shot only 39% at Miami as a pro, his fourth-lowest road percentage behind Charlotte (37%), Boston (38%) and Indiana (38%).
FANDUEL SAYS
Embiid’s injury has sent Philadelphia down to the longest shot left in the playoffs, according to FanDuel Sportsbook. The 76ers are the biggest underdog in any of the four conference semifinal series. As the East and West Final Fours were beginning Sunday, Miami was the second favorite (narrowly behind Boston) in the East and had the fourth-best odds for the NBA title behind Phoenix, Golden State and the Celtics.
___
More AP NBA: https://apnews.com/hub/NBA and https://twitter.com/AP_Sports
|
https://cw33.com/sports/ap-sports/heat-know-that-even-without-embiid-76ers-will-be-challenge/
| 2022-05-01T20:35:30Z
|
Temple High School held its annual “signing day” celebration for its fine arts students Monday evening — an event held since 2019 that recognizes students who intend to pursue a degree in fine arts.
Six seniors were honored: Terry Austin, Michelle Boyles, Hanna Prince, Kelsi Seiter, Jesus Garcia and Conner James. Austin will be majoring in music education at Texas A&M University-Commerce. Boyles will be majoring in music education at Sam Houston State University. Prince will major in theater education at Texas State University. Seiter will major in theater design and production at Oklahoma City University.
Jesus Garcia and Conner James also intend to major in music education and music, respectively, but plan to attend Temple College first.
“It has been a special event for us ever since as these are students who are very active in our programs and we have been able to watch them grow and flourish as artists, musicians, actors, and/or dancers,” Catrina Lotspeich, Temple ISD’s director of fine arts, said in a news release. “I am very pleased to honor the six fine arts students … who are going on to pursue careers in theater and music. We look forward to seeing them back in our fine arts programs in the future as teachers, guest speakers, or clinicians.”
These students — who reflected on their career in fine arts as they were recognized — combined for more than $116,000 in scholarships.
“To me this means everything, because it means that I’ve accomplished something in my life and I’ve made it,” Seiter said. “I’ve been stage manager at Temple High School for the past two years and done about eight shows, so I really feel like this has prepared me. I am so grateful for my four years in the program.”
Austin, who earned All-State honors as a Tenor I singer last January, was thankful to everyone who has helped along the way.
“I feel that today marks a great accomplishment and I am really excited about how this can help me in the future,” Austin said. “All of my directors played such a big part in helping me get to where I am. I’m not sure I can really express how grateful I am for all they’ve done, especially this year, with me making it to All-State.”
|
https://www.tdtnews.com/news/central_texas_news/article_a808e4ca-d658-11ec-94b5-63e3773b3e7f.html
| 2022-05-18T03:54:05Z
|
NEW YORK, Aug. 10, 2022 /PRNewswire/ -- The latest Cold-Storage Cryptocurrency competitive assessment by global technology intelligence firm ABI Research provides an in-depth and unbiased examination and ranking of seven prominent solution providers of Cold-Storage Cryptocurrency Hardware Wallets.
The rankings are based on various chosen criteria, split into two overarching categories, covering implementation and innovation, including supported currencies, ease of access/use, security, functionality, connectivity support, global reach, product/service range, partnerships/customers, and financial strength. These criteria were identified as the most vital for the continual growth of market development and the relevance of cold-storage wallets. The companies evaluated and ranked are:
- Market Leaders: Ledger, SatoshiLabs, CompoSecure, NGRAVE
- Mainstream: ShapeShift, CoinKite
- Followers: CoolBitX
"As it relates to cryptocurrencies, there is no way to recover access to lost coin portfolios, whether they were stolen or sent to incorrect addresses. Crypto users become their own bank, meaning they must take security seriously, especially when considering where they store their assets. The growing trends in the crypto space are increasingly necessitating the development of higher-security storage solutions to manage wider ranges of currencies and provide more and more functionality. The market for cold storage wallets is being driven by several factors, including the increase in the use of Central Bank Digital Currencies with pilots deploying in all major regions, crypto exchange expansion driven by neo and challenger bank offerings, and improvements in the level of accessibility for prospective users to crypto exchanges," says Sam Gazeley, Digital Payment Technologies Analyst at ABI Research.
ABI Research assessed Ledger as the highest scorer in the assessment, primarily due to its mature and advanced offerings and the partnerships it has forged in the cold wallet space.
SatoshiLabs ranked second on the overall scores, cementing its place as both an innovation and implementation leader due mainly to its strong financial strength and strong device popularity, driven by a strategy focused on user-friendliness.
Despite being a newer market entrant, CompoSecure secured third place, awarded the leading innovation score, owing largely to their shift away from the traditional dongle form-factor toward a more sleek and portable solution, coupled with their embedded security technology leveraging a CC EAL6+ Secure Element and supported by strong partnerships in the ecosystem, with a compelling and easy-to-use solution.
"With the NFT market taking off quickly, and neo and challenger banks pushing crypto-oriented value-added services, it is very likely that the cold-storage wallet market will become increasingly competitive with more innovative solutions being made available for the end-user. New entrants can ensure market relevance by offering portable and sleek solutions as it relates to the physical form and prioritize secure hardware solutions with high CC EAL specifications to avoid lost assets in a market which is seeing an increase in fraudulent activity," concludes Gazeley.
These findings are from ABI Research's Cold-Storage Wallets and the Security of Cryptocurrency Portfolios competitive ranking report. This report is part of the company's Digital Payment Technologies research service, which includes research, data, and ABI Insights. Competitive Ranking reports offer a comprehensive analysis of implementation strategies and innovation, coupled with market share analysis, to offer unparalleled insight into a company's performance and standing in comparison to its competitors.
About ABI Research
ABI Research is a global technology intelligence firm delivering actionable research and strategic guidance to technology leaders, innovators, and decision makers around the world. Our research focuses on the transformative technologies that are dramatically reshaping industries, economies, and workforces today.
ABI Research是一家国际科技情报公司，为全球科技领袖、创新人士和决策者提供实用的市场研究和战略性指导。我们密切关注一切为各行各业、全球经济和劳动市场带来颠覆性变革的创新与技术。
For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.
Contact Info:
Global
Deborah Petrara
Tel: +1.516.624.2558
pr@abiresearch.com
View original content to download multimedia:
SOURCE ABI Research
|
https://www.wibw.com/prnewswire/2022/08/10/ledger-satoshilabs-composecure-ngrave-ranked-market-leaders-abi-researchs-cold-storage-hardware-wallet-vendor-competitive-ranking/
| 2022-08-10T10:12:48Z
|
MEXICO CITY, June 27, 2022 /PRNewswire/ -- Corporación Inmobiliaria Vesta, S.A.B. de C.V. (BMV: VESTA) ("Vesta") is pleased to invite you to its conference call to discuss the second quarter results of 2022.
The call will take place:
Friday, July 22, 2022
12:00 p.m. Eastern Time
(11:00 a.m. Mexico City time)
The conference call can be accessed by dialing:
US, toll-free: +1-877-423-9813
International, toll: +1-201-689-8573
Mexico, toll-free: 01 800 522 0034
If you would like to receive a call instead of dialing in, please use this link at least 10 minutes before the call.
Call replay will be available starting July 22 until August 5, 2022 and can be accessed by dialing:
US, toll-free: +1-844-512-2921
International, toll: +1-412-317-6671
Conference ID: 13731036
Vesta's Second Quarter 2022 Earnings Results press release will be released after the market close on Thursday, July 21, 2022.
For any queries, please refer to the contact information below.
Investor Relations Contact in Mexico:
Juan Sottil, CFO
jsottil@vesta.com.mx
Tel: +52 55 5950-0070 ext. 133
Fernanda Bettinger, IRO
mfbettinger@vesta.com.mx
investor.relations@vesta.com.mx
Tel: +52 55 5950-0070 ext. 163
In New York:
Barbara Cano
barbara@inspirgroup.com
Tel: +1 646-452-2334
About Vesta
Vesta is a best-in-class, fully integrated real estate company that owns, manages, acquires, sells, develops and re-develops industrial properties in Mexico. As of March 31, 2022, Vesta owned 190 properties located in modern industrial parks in 15 states of Mexico totaling a GLA of 31.4 million ft2 (2.91 million m2). The Company has multinational clients, which are focused in industries such as e-commerce/retail, aerospace, automotive, food and beverage, logistics, medical devices, and plastics, among others. For additional information visit: www.vesta.com.mx.
View original content:
SOURCE Corporación Inmobiliaria Vesta, S.A.B. de C.V.
|
https://www.mysuncoast.com/prnewswire/2022/06/27/vesta-announces-second-quarter-2022-earnings-conference-call/
| 2022-06-27T17:41:04Z
|
Mowilex earns recognition for its commitment to sustainability, innovation and leadership
JAKARTA, Indonesia, Aug. 2, 2022 /PRNewswire/ -- PT Mowilex Indonesia (Mowilex) has earned a 2022 Best Managed Companies in Indonesia award from Deloitte, becoming the only paint company to receive the prestigious honour. The Indonesia's Best Managed Companies program recognises top privately-owned Indonesian companies for their organisational success, industry contributions and economic impact.
An independent panel evaluated applicants against a framework applied to 1,200 other companies in 48 countries worldwide. Judges reviewed strategy, management quality, capabilities and innovation, culture and commitment, and governance and financials.
Mowilex stood out among a large and competitive field thanks, in part, to its commitment to quality and environmental responsibility.
"An award is a snapshot in time, not a destination. Mowilex faces complex challenges and formidable competition, but we succeed when we embrace leadership opportunities and strive for continuous improvement," says Niko Safavi, CEO of PT Mowilex Indonesia. "Our vision is to be the most trusted paint brand in our market. This Deloitte recognition proves that we can be just that."
Safavi received the Best Managed Companies award during a July ceremony at the Hotel Pullman Jakarta. Several Deloitte representatives gathered to recognise Mowilex and other 2022 winners.
"The inclusion of these six companies in this year's winners' list, as well as their contributions to the business community and the Indonesian economy, should make them extremely proud. These companies are at the forefront of their industries, having demonstrated such creativity and innovation, especially over the past couple of years. We applaud the 2022 winners of Indonesia's Best Managed Companies," says Claudia Lauw, Country Managing Partner, Deloitte Indonesia.
By participating in the evaluation process, business leaders gain insights that help them refine operations and optimize growth.
"It can be difficult for people outside our industry to get excited about paint, and we appreciate that Deloitte chose Mowilex from a field of large, well-managed companies and high-profile unicorns here in Indonesia," says Safavi. "Each Mowilex team member does their part to work efficiently and effectively. This Best Managed Companies award recognises that company-wide commitment to success."
The Indonesia's Best Managed Companies award is based on the 29-year-old global Best Managed Companies program, an initiative of Deloitte Private. For information on Mowilex products and sustainability initiatives, please visit mowilex.com/en.
View original content to download multimedia:
SOURCE PT Mowilex Indonesia
|
https://www.wibw.com/prnewswire/2022/08/02/deloitte-names-mowilex-one-indonesias-best-managed-companies-2022/
| 2022-08-02T18:28:44Z
|
MIAMI, June 16, 2022 /PRNewswire/ -- DeFi protocol Paribus announces launch of their testnet MVP, the beginning of a new approach to DeFi. Secure, trustless, and truly decentralized, Paribus users will be able to borrow against previously illiquid digital assets like NFTs.
Paribus, a DeFi borrowing and lending protocol focused on evolving with new digital asset classes, is launching the testnet MVP of their platform. Their testnet MVP will feature traditional borrowing and lending with standard crypto assets for members of their silver and gold staking pools, as well as any individual wallet address that has participated in any of Paribus' staking programs. Paribus Ambassadors will also be able to participate.
Paribus currently offers staking in their silver and gold staking pools. The silver pool, Argenti, allows users to stake between 500,000 and 3,000,000 PBX, locked for 180 days in return for a reward level of a minimum of 25% APY. The gold pool, Aurum, allows users to stake from 1,000,000 to 6,000,000 PBX for 365 days for a minimum of 30% APY reward level. Since these are dynamic APYs, rewards can increase, as current APY for Argenti is 73% and 54% for Aurum.
There is a growing need for both interoperability and the ability to borrow against exotic assets like NFTs in DeFi. The NFT space is growing, institutional investors are becoming more interested in the potential of cryptocurrency, and the industry grows leaps and bounds every day. Paribus plans to be the platform for DeFi lending, leveraging their tech and security to bring users a well-rounded experience. Their full MVP launch will include APY boosts, and attractive rates and returns for users.
This is just the beginning of the Paribus roadmap. With a team that believes in steady growth, strong fundamentals, and providing a new level of security for users, Paribus will bring much-needed legitimacy to DeFi borrowing and lending.
CONTACT:
Panda PR and Marketing, LLC
Amanda Whitcroft
amanda@pandapr.co
www.pandapr.co
View original content to download multimedia:
SOURCE Paribus
|
https://www.wibw.com/prnewswire/2022/06/16/paribus-launches-interoperable-defi-protocol-exotic-digital-assets/
| 2022-06-16T19:00:24Z
|
DALLAS (STACKER) — They say the college years are the best of your life. They shape the way you see the world, the passions you wish to pursue, and the person you hope to be. But much more than an emotional, personal, and professional starting point, college is a significant financial investment.
In the last 10 years, the cost of college has gone up by more than 25%, according to CNBC. For the 2019 academic year, private colleges cost an average of $48,510 per year, and public ones cost $21,370. After four years, and in many cases five to six years, that cost can stack up significantly, so you’re going to want to ensure that you’re putting your dollars into an institution that is going to make it worth your while. Those who have a bachelor’s degree earn about $32,000 more annually than those without, reports the Association of Public & Land-Grant Universities. But some colleges have a higher return on investment than others.
Universities that specialize in STEM studies (science, technology, engineering, and math) tend to have a higher return on investment for their graduates. STEM has gained ground over the past 10 years as more and more careers have a need for science and tech knowledge. According to the U.S. Bureau of Labor Statistics, there were 10.2 million STEM jobs in 2020, and that number is growing. The median annual wage of workers in STEM fields is more than twice the national average, as well.
Stacker compiled a list of the colleges with the best return on investment in Texas, using a 2019 study by Anthony P. Carnevale, Ban Cheah, and Martin Van Der Werf at Georgetown University. Colleges that primarily issue bachelor’s degrees were considered. Colleges are ranked by the highest 40-year ROI, with ties broken by 10-year ROI. The study considered net present value, balancing today’s costs against future earnings.
#10. University of Texas at Arlington
– 40-year NPV: $1,043,000
– 10-year NPV: $131,000
– Median debt: $11,686
#9. Texas Tech University
– 40-year NPV: $1,086,000
– 10-year NPV: $123,000
– Median debt: $15,500
#8. Southwestern University
– 40-year NPV: $1,096,000
– 10-year NPV: $84,000
– Median debt: $23,500
#7. University of Houston
– 40-year NPV: $1,096,000
– 10-year NPV: $129,000
– Median debt: $13,250
#6. University of Texas at Dallas
– 40-year NPV: $1,134,000
– 10-year NPV: $139,000
– Median debt: $13,000
#5. Trinity University
– 40-year NPV: $1,140,000
– 10-year NPV: $111,000
– Median debt: $21,500
#4. Texas A & M University-College Station
– 40-year NPV: $1,222,000
– 10-year NPV: $135,000
– Median debt: $15,500
#3. Southern Methodist University
– 40-year NPV: $1,229,000
– 10-year NPV: $91,000
– Median debt: $18,250
#2. University of Texas at Austin
– 40-year NPV: $1,233,000
– 10-year NPV: $142,000
– Median debt: $20,366
#1. Rice University
– 40-year NPV: $1,393,000
– 10-year NPV: $167,000
– Median debt: $10,000
You may also like: Where people in Texas are moving to most
|
https://cw33.com/news/texas/colleges-with-the-best-roi-in-texas/
| 2022-04-15T21:51:46Z
|
Adjusted EBITDA - $82 million
Earnings Per Share - $1.06/share (Adjusted EPS $0.79/share)
Other Quarter Highlights
- Net sales were $573 million, a $134 million (30.6%) YoY increase, the highest quarterly sales since Q2 2013
- Gross margin was 19%
- Free cash flow was $56 million during the second quarter
CHICAGO, Aug. 1, 2022 /PRNewswire/ -- Titan International, Inc. (NYSE: TWI), a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products, today reported results for the second quarter ended June 30, 2022.
"The positive momentum we have seen in our business kept on rolling this quarter and when combined with the continuing strong execution of our team, it resulted in excellent financial performance. As indicated by the updated full year 2022 guidance we released in June, we feel good about our business and our end-markets," stated Paul Reitz, President and Chief Executive Officer. "We experienced sales growth of 31% from the second quarter last year and sales grew sequentially 3% from the first quarter to the second quarter. More importantly, our margins were good, and we delivered adjusted EBITDA of $82 million in the second quarter. This performance was buoyed by strong financial performance across all parts of the business as our Titan team keeps running hard like a good, long-distance marathoner.
"Perhaps the most important aspect of our performance is that we are generating significant cash flow and we have strengthened our financial position considerably. We generated $56 million in free cash flow in Q2, and our debt leverage fell below 2 times adjusted EBITDA, with expected further improvements in the second half of the year. The strong financial performance over the past couple years, combined with significant improvements in our balance sheet and solid free cash flow now coming through means we are driving increased shareholder value.
"Nearly everywhere you turn these days you will get hit with noise and our end-markets of Agriculture, Construction and Mining are no exception. However, like everything, you need to spend some time sifting through the noise to get a clear picture as a quick look at the headlines likely does not tell the complete, accurate story. We believe that the complete picture is farmers are going to still make a high level of income in 2022 and they are sitting on strong balance sheets as well. The large Ag equipment fleet is aged with low levels of available used equipment. Demand and order books are in a solid position in Ag and should continue on that path well into the future as supply chain and labor disruptions at OEM's have extended the duration of retail demand, not destroyed it. The overall, bigger picture view is that Ag fundamentals remain in a strong position and we expect the future to remain bright in the sector. This view is also true for our global construction and mining markets, where we continue to see demand holding at a good level through 2022 that should carry to 2023 as public infrastructure spending picks up.
Outlook
"Our expectations for financial performance remain strong and during the second half of the year we anticipate continued top-line and bottom-line expansion relative to prior year performance. Given our performance in Q2 and our current visibility in the second half of the year, we now expect full year sales in 2022 to be $2.2 billion, with an increased adjusted EBITDA target between $240 million and $250 million. Based on this latest outlook, current cash flow expectations have improved accordingly, and we now believe we can deliver an increased level of free cash flow between $90 million and $100 million for the full year. By almost all standards, we expect this year to be the strongest in Titan's history, and we continue to see positive signs for demand to remain robust into 2023."
Results of Operations
Net sales for the second quarter ended June 30, 2022, were $572.9 million, compared to $438.6 million in the comparable quarter of 2021, an increase of 30.6 percent. The net sales increase was across all segments and driven by a variety of factors, most notably healthier market conditions, while there was an unfavorable impact from foreign currency translation of 2.7 percent or $11.9 million, primarily due to the weakening euro currency.
Gross profit for the second quarter ended June 30, 2022 was $109.7 million, compared to $61.5 million in the comparable prior year period. Gross margin was 19.1 percent of net sales for the quarter, compared to 14.0 percent of net sales in the comparable prior year period. The solid growth in gross profit and margin during the second quarter as compared to the prior year period was across all segments and was driven by the impact of increases in net sales, as described previously, and better overhead absorption in our production facilities. In addition, cost reduction and productivity initiatives continue to be executed across global production facilities.
Selling, general, administrative, research and development (SGARD) expenses for the second quarter of 2022 were $36.9 million, compared to $35.1 million for the comparable prior year period. As a percentage of net sales, SGARD was 6.4 percent, compared to 8.0 percent for the comparable prior year period. The increase in SG&A was driven primarily by an increase in variable costs associated with improved operating performance and growth in sales.
Income from operations for the second quarter of 2022 was $69.7 million, or 12.2 percent of net sales, compared to income of $23.7 million, or 5.4 percent of net sales, for the second quarter of 2021. The increase in income from operations was primarily due to the higher sales and improvements in gross profit margins.
Brazilian Tax Credits
In June 2021, the Company's Brazilian subsidiaries received a notice that they had prevailed on an existing legal claim in regard to certain non-income (indirect) taxes that had been previously charged and paid. The matter specifically relates to companies' rights to exclude the state tax on goods circulation (a value-added-tax or VAT equivalent, known in Brazil as "ICMS") from the calculation of certain additional indirect taxes (specifically the program of social integration ("PIS") and contribution for financing of social security ("COFINS")) levied by the Brazilian States on the sale of goods.
During the second quarter of 2022, the Company submitted the related supporting documentation and received the approval from the Brazilian tax authorities for one of its Brazilian subsidiaries. For the three months ended June 30, 2022, the Company recorded $22.5 million within other income in the condensed consolidated statements of operations. The Company also recorded $7.8 million of income tax expense associated with the recognition of these indirect tax credits. The Company excluded the impacts from these tax credits within both adjusted net income applicable to common shareholders and adjusted EBITDA. A reconciliation of each of these measures can be found at the end of this release. The Company expects to be able to apply the tax credits received to settle the income tax liability that was incurred as a result of the credit. The Company also expects to utilize the majority of the credit against future PIS/COFINS and income tax obligations over the next twelve months.
During the third quarter of 2022, the Company plans to submit the related supporting documentation to the Brazilian tax authorities for its other Brazilian subsidiary. After review by the Brazilian tax authorities, the Company could receive approximately $10 million of additional indirect tax credits to be applied as credits against future PIS/COFINS and income tax obligations. The Company plans to recognize the full benefit of the indirect tax credits, contingent upon successful approval and verification from the Brazilian tax authorities.
Segment Information
During the quarter ended June 30, 2022, net sales increased 38 percent driven by increased market activity through all of our global operations. Volume increased from healthy demand in the global agricultural market, reflective of high farm commodity prices and increased farmer income, the need for replacement of an aging large equipment fleet and the need to replenish equipment inventory levels within the equipment dealer channels.
The increase in gross profit and margin is primarily attributable to the impact of increases in net sales as described previously and cost reduction and productivity initiatives executed across global production facilities. The Company balanced the increases of related raw materials and other inflationary cost impacts with corresponding price increases to protect profitability.
During the quarter ended June 30, 2022, the 19 percent increase in earthmoving/construction net sales was driven by increased demand across all aspects of the construction and mining markets.
The increase in gross profit and margin was primarily driven by better price and mix of products produced and continued improved production efficiencies stemming from the strong management actions taken to improve profitability for the long-term. The Company balanced the increases related to raw materials and other inflationary cost impacts with corresponding price increases to maintain profitability.
During the quarter ended June 30, 2022, the 44 percent increase in net sales was driven by increased market activity, similar to agriculture and construction markets, with growth coming from product growth initiatives. A portion of the increase in demand related to specialty products in the United States, primarily custom mixing of rubber stock to third parties.
The increase in gross profit and margin was due primarily to sales growth, increased price/product mix and the positive impact of sales volume increase on overhead absorption. Margins related to the growth initiatives in specialty products in the United States are stronger than the average margins for other products in the segment.
Non-GAAP Financial Measures
Adjusted EBITDA was $82.2 million for the second quarter of 2022, compared to $37.4 million in the comparable prior year period. The Company utilizes EBITDA and adjusted EBITDA, which are non-GAAP financial measures, as a means to measure its operating performance. A reconciliation of net income (loss) to EBITDA and adjusted EBITDA can be found at the end of this release.
Adjusted net income applicable to common shareholders for the second quarter of 2022 was income of $50.2 million, equal to income of $0.80 per basic share and $0.79 per diluted share, compared to income of $14.0 million, equal to income of $0.23 per basic and diluted share, in the second quarter of 2021. The Company utilizes adjusted net income applicable to common shareholders, which is a non-GAAP financial measure, as a means to measure its operating performance. A reconciliation of net income (loss) applicable to common shareholders and adjusted net income applicable to common shareholders can be found at the end of this release.
Financial Condition
The Company ended the second quarter of 2022 with total cash and cash equivalents of $116.7 million, compared to $98.1 million at December 31, 2021. Long-term debt at June 30, 2022, was $441.1 million, compared to $452.5 million at December 31, 2021. Short-term debt was $44.1 million at June 30, 2022, compared to $32.5 million at December 31, 2021. Net debt (total debt less cash and cash equivalents) was $368.5 million at June 30, 2022, compared to $386.8 million at December 31, 2021.
Net cash provided by operating activities for the first six months of 2022 was $48.9 million, compared to net cash used by operations of $17.5 million for the comparable prior year period. Capital expenditures were $19.5 million for the first six months of 2022, compared to $14.6 million for the comparable prior year period. Capital expenditures during the first six months of 2022 and 2021 represent equipment replacement and improvements, along with new tools, dies and molds related to new product development, as the Company seeks to enhance the Company's manufacturing capabilities and drive productivity gains.
Teleconference and Webcast
Titan will be hosting a teleconference and webcast to discuss the second quarter financial results on Tuesday, August 2, 2022, at 9:30 a.m. Eastern Time.
The real-time, listen-only webcast can be accessed using the following link https://events.q4inc.com/attendee/382414202 or on our website at www.titan-intl.com within the "Investor Relations" page under the "News & Events" menu (https://ir.titan-intl.com/news-and-events/events/default.aspx). Listeners should access the website at least 15 minutes prior to the live event to download and install any necessary audio software.
A webcast replay of the teleconference will be available on our website (https://ir.titan-intl.com/news-and-events/events/default.aspx) soon after the live event.
In order to participate in the real-time teleconference, with live audio Q&A, participants should use one of the following dial in numbers:
United States Toll Free: 1 844 200 6205
United States: 1 646 904 5544
All other locations: +1 929 526 1599
Participants Access Code: 962862
About Titan
Titan International, Inc. (NYSE: TWI) is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in West Chicago, Illinois, the Company globally produces a broad range of products to meet the specifications of original equipment manufacturers (OEMs) and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. For more information, visit www.titan-intl.com.
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements are covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "plan," "would," "could," "potential," "may," "will," and other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Although we believe the assumptions upon which these forward-looking statements are based are reasonable, these assumptions are subject to significant risks and uncertainties, and are subject to change based on various factors, some of which are beyond Titan International, Inc.'s control. As a result, any of these assumptions could prove to be inaccurate and the forward-looking statements based on these assumptions could be incorrect. The matters discussed in these forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results and trends to differ materially from those made, projected, or implied in or by the forward-looking statements depending on a variety of uncertainties or other factors including, but not limited to, the effect of the COVID-19 pandemic on our operations and financial performance; the effect of a recession on the Company and its customers and suppliers; changes in the Company's end-user markets into which the Company sells its products as a result of domestic and world economic or regulatory influences or otherwise; changes in the marketplace, including new products and pricing changes by the Company's competitors; the Company's ability to maintain satisfactory labor relations; unfavorable outcomes of legal proceedings; the Company's ability to comply with current or future regulations applicable to the Company's business and the industry in which it competes or any actions taken or orders issued by regulatory authorities; availability and price of raw materials; levels of operating efficiencies; the effects of the Company's indebtedness and its compliance with the terms thereof; changes in the interest rate environment and their effects on the Company's outstanding indebtedness; unfavorable product liability and warranty claims; actions of domestic and foreign governments, including the imposition of additional tariffs; geopolitical and economic uncertainties relating to the countries in which the Company operates or does business; risks associated with acquisitions, including difficulty in integrating operations and personnel, disruption of ongoing business, and increased expenses; results of investments; the effects of potential processes to explore various strategic transactions, including potential dispositions; fluctuations in currency translations; risks associated with environmental laws and regulations; risks relating to our manufacturing facilities, including that any of our material facilities may become inoperable; risks relating to financial reporting, internal controls, tax accounting, and information systems; and the other risks and factors detailed in the Company's periodic reports filed with the Securities and Exchange Commission, including the disclosures under "Risk Factors" in those reports. These forward-looking statements are made only as of the date hereof. The Company cautions that any forward-looking statements included in this press release are subject to a number of risks and uncertainties, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events, or for any other reason, except as required by law.
Titan International, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures (Unaudited)
Amounts in thousands, except earnings per share data
The Company reports its financial results in accordance with generally accepted accounting principles in the United States (GAAP). These supplemental schedules provide a quantitative reconciliation between each of adjusted net income (loss) attributable to Titan, EBITDA, adjusted EBITDA, net sales on a constant currency basis, and net debt, each of which is a non-GAAP financial measure and the most directly comparable financial measures calculated and reported in accordance with GAAP.
We present adjusted net income attributable to Titan, adjusted earnings per common share, EBITDA, adjusted EBITDA, net sales on a constant currency basis, and net debt, as we believe that they assist investors with analyzing our business results. In addition, management reviews each of these non-GAAP financial measures in order to evaluate the financial performance of each of our segments, as well as the Company's performance as a whole. We believe that the presentation of these non‑GAAP financial measures will permit investors to assess the performance of the Company on the same basis as management.
Adjusted net income attributable to Titan, adjusted earnings per common share, EBITDA, adjusted EBITDA, net sales on a constant currency basis, and net debt should be considered supplemental to, not a substitute for, the financial measures calculated in accordance with GAAP. One should not consider these measures in isolation or as a substitute for our results reported under GAAP. These measures have limitations in that they do not reflect all of the costs associated with the operations of our businesses as determined in accordance with GAAP. In addition, these measures may be calculated differently than non-GAAP financial measures reported by other companies, limiting their usefulness as comparative measures. We attempt to compensate for these limitations by analyzing results on a GAAP basis as well as a non-GAAP basis, prominently disclosing GAAP results and providing reconciliations from GAAP results to non-GAAP results.
The table below provides a reconciliation of adjusted net income attributable to Titan to net income (loss) applicable to common shareholders, the most directly comparable GAAP financial measure, for the three and six-month periods ended June 30, 2022 and 2021.
The table below provides a reconciliation of net income (loss) to EBITDA and adjusted EBITDA, which are non-GAAP financial measures, for the three and six-month periods ended June 30, 2022 and 2021.
The table below sets forth, for the three and six-month period ended June 30, 2022, the impact to net sales of currency translation (constant currency) by geography (in thousands, except percentages):
The table below provides a reconciliation of net debt, which is a non-GAAP financial measure:
View original content to download multimedia:
SOURCE Titan International, Inc.
|
https://www.mysuncoast.com/prnewswire/2022/08/01/titan-international-inc-reports-strong-quarterly-financial-performance/
| 2022-08-01T21:42:41Z
|
TSX: EQX
NYSE-A: EQX
VANCOUVER, BC, Sept. 12, 2022 /PRNewswire/ - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") reports that, following an initial meeting with Mezcala community leaders, the blockade at the Company's Los Filos Mine in Mexico was removed and the mine resumed operations on September 10th.
The Company will continue to engage with Mezcala and other community leaders to strengthen relationships and foster long-term, stable operations at the Los Filos Mine.
Greg Smith, President & Chief Executive Officer
Rhylin Bailie, Vice President, Investor Relations
Tel: +1 604-558-0560
Email: ir@equinoxgold.com
Equinox Gold is a Canadian mining company operating entirely in the Americas, with six operating gold mines, a mine in commissioning, and a clear path to achieve more than one million ounces of annual gold production from a pipeline of development and expansion projects. Equinox Gold's common shares are listed on the TSX and the NYSE American under the trading symbol EQX. Further information about Equinox Gold's portfolio of assets and long-term growth strategy is available at www.equinoxgold.com or by email at ir@equinoxgold.com.
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation and may include future-oriented financial information. Forward-looking statements and forward-looking information in this news release relate to, among other things: Equinox Gold's relationship with the communities at Los Filos, Equinox Gold's ability to achieve long-term stable operations at Los Filos, and the strategic vision for Equinox Gold and expectations regarding the Company's growth strategy and future production capabilities. Forward-looking statements or information generally identified by the use of the words "will", "continue", "achieve", "long-term", "strengthen" and similar expressions and phrases or statements that certain actions, events or results "may", "could", or "should", or the negative connotation of such terms, are intended to identify forward-looking statements and information. Although Equinox Gold believes that the expectations reflected in such forward-looking statements and information are reasonable, undue reliance should not be placed on forward-looking statements since Equinox Gold can give no assurance that such expectations will prove to be correct. The Company has based these forward-looking statements and information on Equinox Gold's current expectations and projections about future events and these assumptions include: the Company's previous working history with the communities around Los Filos; discussions with the Mezcala community; discussions with other communities around Los Filos; and the Company's working history with the workers and unions at Los Filos.
While Equinox Gold considers these assumptions to be reasonable based on information currently available, they may prove to be incorrect. Accordingly, readers are cautioned not to put undue reliance on the forward-looking statements or information contained in this news release. The Company cautions that forward-looking statements and information involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements and information contained in this presentation and Equinox Gold has made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: employee relations; relationships with, and claims by, local communities and indigenous populations; no other labour-related disruptions and no unplanned delays or interruptions in scheduled construction, development and production, including by blockade or industrial action; operational risks and hazards inherent with the business of mining (including environmental accidents and hazards, industrial accidents, equipment breakdown, unusual or unexpected geological or structural formations, cave-ins, flooding and severe weather); fluctuations in gold prices; fluctuations in prices for energy inputs, labour, materials, supplies and services; fluctuations in currency markets; inadequate insurance, or inability to obtain insurance to cover these risks and hazards; the Company's ability to obtain all necessary permits, licenses and regulatory approvals in a timely manner or at all; changes in laws, regulations and government practices, including environmental and export and import laws and regulations; the Company's ability to comply with all environmental, health and safety laws and other regulatory requirements legal restrictions relating to mining including those imposed in connection with COVID-19; and those factors identified in the section titled "Risks and Uncertainties" in Equinox Gold's MD&A dated March 23, 2022 for the year ended December 31, 2021, and in the section titled "Risks Related to the Business" in Equinox Gold's Annual Information Form dated March 24, 2022 for the year ended December 31, 2021, both of which are available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov/edgar. Forward-looking statements and information are designed to help readers understand management's views as of that time with respect to future events and speak only as of the date they are made. Except as required by applicable law, Equinox Gold assumes no obligation to update or to publicly announce the results of any change to any forward-looking statement or information contained or incorporated by reference to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements and information. If Equinox Gold updates any one or more forward-looking statements, no inference should be drawn that Equinox Gold will make additional updates with respect to those or other forward-looking statements. All forward-looking statements and information contained in this news release are expressly qualified in their entirety by this cautionary statement.
View original content:
SOURCE Equinox Gold Corp.
|
https://www.kxii.com/prnewswire/2022/09/12/equinox-gold-resumes-operations-its-los-filos-mine/
| 2022-09-12T12:14:19Z
|
ORLANDO, Fla., Aug. 1, 2022 /PRNewswire/ -- Marriott Vacations Worldwide Corporation (NYSE: VAC) ("the Company") today announced that its board of directors increased its prior authorization to repurchase common stock of the Company by $500 million.
During the second quarter of 2022, the Company repurchased more than 1.4 million shares of its common stock for $193 million at an average price per share of $135.77. Subsequent to the end of the second quarter, the Company repurchased approximately 1.1 million additional shares of its common stock for $131 million at an average price per share of $124 through the end of July.
As of July 29, 2022, the Company had approximately $28 million of capacity remaining under its prior authorization, and the increase in authorization provides a total remaining capacity of approximately $528 million.
About Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corporation is a leading global vacation company that offers vacation ownership, exchange, rental and resort and property management, along with related businesses, products and services. The Company has over 120 vacation ownership resorts and approximately 700,000 owner families in a diverse portfolio that includes some of the most iconic vacation ownership brands. The Company also operates exchange networks and membership programs comprised of nearly 3,200 affiliated resorts in over 90 countries and territories, as well as provides management services to other resorts and lodging properties. As a leader and innovator in the vacation industry, the Company upholds the highest standards of excellence in serving its customers, investors and associates while maintaining exclusive, long-term relationships with Marriott International, Inc. and Hyatt Hotels Corporation for the development, sales and marketing of vacation ownership products and services. For more information, please visit www.marriottvacationsworldwide.com.
View original content to download multimedia:
SOURCE Marriott Vacations Worldwide Corporation
|
https://www.mysuncoast.com/prnewswire/2022/08/01/marriott-vacations-worldwide-corporation-announces-increased-share-repurchase-authorization/
| 2022-08-01T14:04:39Z
|
COOPERSTOWN, N.Y. (AP) — Writer Tim Kurkjian and the late Jack Graney, the first former major league player to transfer to the broadcast booth, were honored Saturday by the Baseball Hall of Fame for their contributions to the game.
Kurkjian was presented with the Baseball Writers’ Association of America’s Career Excellence Award. He began his career in 1979 at the Washington Star and two years later was the Texas Rangers beat writer for The Dallas Morning News. Four years later, he returned to his native Maryland and joined The Baltimore Sun, covering the Orioles for four years. He then spent seven years as a senior baseball writer at Sports Illustrated.
“It’s such an honor to be here,” said Kurkjian, who moved to broadcasting at ESPN in 1998. “This has been the most overwhelming, most overpowering experience of my life. That love for the game, not in any sort of grace or talent, has carried my career. It was a privilege to cover the game 40 years ago, and now 40 years later, it is still a privilege. Baseball is the greatest game.”
Graney was honored posthumously with the Ford C. Frick Award for broadcasting, but he started his career on the field for Cleveland and was the first major league player to bat against Babe Ruth (1914). He finished a 14-year playing career in 1922 and after a stint in automotive sales was hired in 1932 by Cleveland radio staion WHK to call games. He spent 22 years calling them for several stations and is now widely considered to be the first former big league player to broadcast a major league game.
Graney, who also called the 1935 World Series for a national audience in 1935 and that year’s All-Star Game in Cleveland, died in 1978.
Granddaughter Perry Smith spoke in his behalf.
“If Jack were here today, he would never tell you about his accomplishments,”she said. “He was such a humble man. And he probably was embarrassed by praise. Here’s how Jack described his career. He said, ‘I always tried to give the fans an honest account. It was a tremendous responsibility. And at all times I kept in mind that I was the eyes of the radio audience. I just tried to do my best and I hope my best was good enough.'”
Also Saturday, more than 50 Hall of Famers took part in the annual Parade of Legends. Chairs were lined up four deep on Main Street more than four hours before the parade began. Inside the Hall of Fame’s Plaque Gallery, several fans dressed in Red Sox gear stopped to take photos at the spot where the plaque of former Red Sox slugger David Ortiz, afffectionately called Big Papi, will hang after his induction.
Thousands of Red Sox fans lined the route through the village center, many wearing Big Papi’s No. 34 on the back, and about 20 were carrying a Domincian Republic flag and chanting “Papi! Papi!” Several souvenir tables were set up with Ortiz induction jerseys in red and blue.
Ortiz is just the 58th player selected by the Baseball Writers’ Association of America in his first year on the Hall of Fame ballot. He’s part of the seven-member Class of 2022 that will be inducted on Sunday.
Joining Ortiz on stage will be three-time batting champion Tony Oliva and 283-game winner Jim Kaat.
Also getting their due on induction day are: Dodgers great Gil Hodges, who managed the New York Mets to their first World Series title in 1969; Minnie Miñoso, a star with the Chicago White Sox in the 1950s; Buck O’Neil, who played for the Kansas City Monarchs in the Negro Leagues and was a tireless advocate for the game; and Bud Fowler, a pioneering Black player who grew up in Cooperstown in the 1860s and played in more than a dozen leagues.
___
Freelance writer Ken Powtak contributed.
___
More AP MLB coverage: https://apnews.com/hub/MLB and https://twitter.com/AP_Sports
|
https://cw33.com/sports/ap-sports/tim-kurkjian-jack-graney-honored-by-baseball-hall-of-fame/
| 2022-07-24T12:32:07Z
|
WINOOSKI, Vt., June 8, 2022 /PRNewswire/ -- Today, SOOS announced a new partnership with RKVST to simplify the creation and distribution of software bills of materials (SBOMs). Now developers using SOOS to generate their SBOMs can publish them directly to the RKVST platform, making it easier than ever to share the provenance of their software with business and compliance teams.
An SBOM is a powerful cybersecurity tool that provides an inventory of software components, creating essential visibility into the software supply chain. By using SOOS's SCA tool, developers can easily create and export an SPDX standard SBOM.
But it's not enough to simply create an SBOM, that information needs to be easily accessible to all security and compliance stakeholders. That's where RKVST comes in. RKVST serves as a repository for SBOMs, allowing tailored visibility, privacy control, and bringing the transparency needed for zero trust.
This announcement comes on the heels of two other partnerships for SOOS in recent weeks, including DigitalOcean and CircleCI.
"We see partnership as a critical path to expanding our reach and fulfilling our mission to make software safer for everyone," said Becca Newton, SOOS's V.P. of Business Development. "By integrating with RKVST, we are simplifying the security process for developers and improving transparency for security and compliance teams. Every step of the way, we are focused on breaking down more barriers."
"SOOS makes it easy for developers to set and forget SBOM creation and distribution," said Rob Brown, VP Business Development at RKVST. "The success of SBOMs rests on enabling software suppliers and consumers to each use their preferred tools and distribute SBOMs through APIs. RKVST delivers that capability."
To learn more about RKVST, visit: www.rkvst.com
To see SOOS's full suite of capabilities and learn more about our mission to make software safer for everyone, visit www.SOOS.io
SOOS is on a mission to democratize software security. Founded in 2020, SOOS makes it easy to identify and remediate open source vulnerabilities, with a straightforward pricing model and easy workflow integration. Peace of mind, without the hassle, means safer software for everyone.
View original content to download multimedia:
SOURCE SOOS
|
https://www.kxii.com/prnewswire/2022/06/08/new-soos-partnership-with-rkvst-makes-it-easier-create-share-sboms/
| 2022-06-08T19:42:47Z
|
Kremer is COO of UC San Diego Health and a Healthcare Industry Veteran
SAN DIEGO, June 1, 2022 /PRNewswire/ -- Shadowbox, a leading innovator in healthcare automation solutions, is excited to announce the addition of Brendan Kremer, Chief Operating Officer of UC San Diego Health, to its board of directors. Brendan brings over 25 years of health system administration leadership experience to the Shadowbox board. As COO at UCSD Health, he is responsible for hospital and physician group operations for a $3 billion academic medical center, accountable for the clinical, financial, and operational performance of all clinical service lines as well as physician group and support service operations.
"We are overjoyed to welcome Brendan to our board of directors. His in-depth knowledge of healthcare system interoperability needs and pain points is sure to prove invaluable to Shadowbox, as we work to improve patient care across the healthcare ecosystem." said Gregory A. Stein, Shadowbox CEO.
"Shadowbox offers a unique approach to solving one of healthcare's biggest challenges," said Brendan Kremer. "As a career healthcare administrator and leader, I am honored to join the board of directors."
Prior to the COO role, Kremer worked in a variety of positions at UCSD Health as well as other institutions including Tenet HealthCare, Huntington Memorial Hospital and Children's Hospital Los Angeles. He received both his Bachelors of Science (BSPA) in Public Administration and his Masters of Health Service Administration (MHA) at the University of Southern California.
For more information, please see Shadowbox Team Bios
Shadowbox is a ground-breaking, patented integration and automation platform built for healthcare. By powering a browser with security, AI, and user-driven cross-application connections, Shadowbox offers instant integration and automation across the healthcare ecosystem. For more information see www.shadowbox.com.
UC San Diego Health is the academic health system of the University of California, San Diego. In operation since 1966, it encompasses multiple institutions, including the UC San Diego Medical Center in Hillcrest, the Jacobs Medical Center, Moores Cancer Center, Shiley Eye Institute, Sulpizio Cardiovascular Center, and Koman Family Outpatient Pavilion, all in La Jolla. It also includes several outpatient sites located throughout San Diego County. The health system works closely with the university's School of Medicine and Skaggs School of Pharmacy to provide training to medical and pharmacy students and advanced clinical care to patients. For more information, see https://health.ucsd.edu/
View original content to download multimedia:
SOURCE Shadowbox, Inc.
|
https://www.wibw.com/prnewswire/2022/06/01/brendan-kremer-joins-shadowbox-board-directors/
| 2022-06-01T15:49:27Z
|
DUBLIN, June 13, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan Liposome Company, Ltd. (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, to commercialize TLC599, a TLC investigational product. TLC599 is an injectable compound in Phase 3 development for the treatment of osteoarthritis knee pain.
"TLC599 is fully aligned with our commitment to providing differentiated nonsurgical options to healthcare providers and their appropriate patients," said Patrick Barry, Executive Vice President and President, Global Commercial Operations at Endo. "This investigational product is highly synergistic with our existing orthopedic commercial capabilities and complements our current on-market and in-development orthopedic-focused opportunities."
"We are thrilled to be partnering with Endo once again," said George Yeh, President of TLC. "Endo's proven capabilities in the orthopedic space complement TLC's expertise in developing novel nanomedicines, and together, we hope to deliver life-enhancing therapies to meet an unmet need with a large patient base."
Endo currently expects to launch the differentiated branded product in the United States in 2025.
Under the terms of the agreement, TLC will primarily be responsible for the development of the product and EVL will primarily be responsible for obtaining regulatory approval and commercialization of the product in the United States. Upon receipt of regulatory approval, Endo will have exclusive rights to manufacture, market, sell and distribute the product in the United States. TLC will receive an upfront payment of $30 million and will be eligible to receive up to an additional $110 million based on the achievement of certain development, regulatory, and manufacturing milestones related to the initial indication for the treatment of osteoarthritis knee pain. TLC will be eligible to receive payments based on the achievement of certain commercial milestones and royalties based on the product's net sales in the United States. Additionally, TLC will be eligible to receive certain milestone payments for potential future indications.
The upfront payment of $30 million will be expensed in the second quarter as acquired in-process research and development. This expense was not reflected in Endo's second quarter 2022 financial guidance provided on May 5, 2022 as the transaction was signed after the date of the second quarter earnings release.
About TLC599
TLC 599 is an extended and controlled release liposomal formulated dexamethasone for chronic knee osteoarthritis (OA) pain. Single and repeated doses of current intraarticular anti-inflammatory treatments for OA have potentially toxic side effects and may lead to the destruction of cartilage filler proteins. Preclinical toxicity studies showed no marked cartilage damage after single and multiple doses of TLC599 when compared to current treatments. In a Phase II clinical trial, a single injection of TLC599 resulted in statistically significant and clinically meaningful improvement in WOMAC Pain and Function Subscales, and VAS Pain scores over placebo at 12, 16 and 24 weeks. Over half of the patients in the TLC599 group had a durable response, maintaining at least 30% pain reduction in both WOMAC and VAS pain scores at all visits through the 24 weeks. No serious or unexpected treatment related adverse events were reported, and most of the treatment related adverse events were mild to moderate in severity. EXCELLENCE, a pivotal Phase III clinical trial to evaluate the efficacy and safety of both single and repeated doses of TLC599, is nearing completion, with the last patient's last visit having taken place in January 2022. The compound may be investigated in the future for additional potential indications.
About Osteoarthritis
OA is the most common form of arthritis, affecting an estimated 32.5 million adults in the United States, according to the Centers for Disease Control and Prevention.1 Although OA can occur in any joints, it occurs most frequently in the hands, hips and knees. With OA, joint cartilage becomes worn and breaks down, and as a result, the bone surfaces can grind together and eventually begin to change. Common symptoms of OA include pain, stiffness and swelling, and they can worsen over time. In some cases, OA also can cause reduced function and disability. There is no cure for OA; however, symptom management options include behavior modification, drug therapy (oral, topical and injections within the joint) and knee replacement surgery.
About Endo
Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.
About TLC
TLC is a clinical-stage specialty pharmaceutical company dedicated to the research and development of novel nanomedicines that maximize the potential of its proprietary lipid-assembled drug delivery platform (LipAD®). TLC's deep experience with liposome science allows a combination of onset speed and benefit duration, improving active drug concentrations while decreasing unwanted systemic exposures. TLC's BioSeizer® technology is designed to enable local sustained release of therapeutic agents at the site of disease or injury; its NanoX® active drug loading technology has been proven in two approved drugs and is designed to alter the systemic exposure of a drug, potentially reducing dosing frequency and enhancing distribution of liposome-encapsulated active agents to the desired site. These technologies are versatile in the choice of active pharmaceutical ingredients, and scalable with respect to manufacturing. TLC has a diverse, wholly owned portfolio of therapeutics that target areas of unmet medical need in pain management, ophthalmology, and oncology.
Forward-Looking Statements
Certain information in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation including, but not limited to, the statements by Messrs. Barry and Yeh and any statements related to the expansion of Endo's product portfolio or the development, approval, commercialization, manufacturing, marketing, sale or distribution of any products. Statements including words or phrases such as "believe," "expect," "anticipate," "intend," "estimate," "plan," "will," "may," "look forward," "intend," "future," "potential" or similar expressions are forward-looking statements. All forward-looking statements in this press release reflect Endo's current expectations of future events based on existing trends and information and represent Endo's judgment only as of the date of this press release. Actual results may differ materially and adversely from current expectations based on a number of factors affecting Endo's businesses, including, among other things, the following: the outcome of our strategic review, contingency planning and any potential restructuring; the timing, impact or results of any pending or future litigation, investigations, proceedings or claims, including opioid, tax and antitrust matters; actual or contingent liabilities; settlement discussions or negotiations; the impact of competition including loss of exclusivity and generic competition; our ability to satisfy judgments or settlements or to pursue appeals including bonding requirements; our ability to adjust to changing market conditions; our inability to maintain compliance with financial covenants and operating obligations which would expose us to potential events of default under our outstanding indebtedness; our ability to incur additional debt or refinance our outstanding indebtedness; a significant reduction in our short-term or long-term revenues which could cause us to be unable to fund our operations and liquidity needs; the effectiveness of advertising and other promotional campaigns; unfavorable publicity regarding the misuse of opioids; and our ability to develop our product pipeline and to continue to develop the market for products. The occurrence or possibility of any such result has caused us to engage, and may result in further engagement, in strategic reviews that ultimately may result in our pursuing one or more significant corporate transactions or other remedial measures, including on a preventative or proactive basis. Those remedial measures could include a potential corporate reorganization, restructuring or bankruptcy filing involving all or a portion of our business, asset sales or other divestitures, cost-saving initiatives, corporate realignments or strategic partnerships. Some of these measures could take significant time to implement and others may require judicial or other third-party approval. Any such actions may be complex, could entail significant costs and charges or could otherwise negatively impact shareholder value, and there can be no assurance that we will be able to accomplish any of these alternatives on terms acceptable to us, or at all, or that they will result in their intended benefits. Therefore, the reader is cautioned not to rely on any forward-looking statements. Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law. Additional information concerning risk factors, including those referenced above, can be found in press releases issued by Endo, as well as Endo's public periodic filings with the U.S. Securities and Exchange Commission and with securities regulators in Canada, including the discussion under the heading "Risk Factors" in Endo's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or other filings with the U.S. Securities and Exchange Commission.
References:
- Centers for Disease Control and Prevention. (July 2020). Osteoarthritis (OA). U.S. Department of Health and Human Services. https://www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed on May 20, 2022.
View original content to download multimedia:
SOURCE Endo International plc
|
https://www.kxii.com/prnewswire/2022/06/13/endo-executes-agreement-with-tlc-commercialize-phase-3-orthopedic-product-treatment-osteoarthritis-knee-pain/
| 2022-06-13T10:56:28Z
|
ALEXANDRIA, Va., July 25, 2022 /PRNewswire/ -- Today, United Way Worldwide (UWW) announced the election of seven new trustees by United Way members at the Annual Meeting of the Members held on July 18, 2022.
"I am excited to welcome our newest trustees to the board," said President and CEO, Angela F. Williams. "Each trustee brings a unique perspective and passion to our mission that will collectively build upon our foundational work as we position United Way Worldwide for the future."
Remarking on the new trustees, Marc Bitzer, Chair of the Worldwide Board of Trustees, shared, "I am delighted to welcome a distinguished group of individuals and look forward to serving with them in the coming years. We have diligently ensured a UWW board that reflects a broad diversity of expertise and experience that will guide United Way into its next century of service and a renewed period of growth."
The trustees below began their three-year terms with United Way Worldwide effective July 18, 2022:
- Brian K. Hulseman-Abrams, Entrepreneur, CPA, and Attorney
- Juliana Azevedo, Latin America President, P&G Brazil
- The Honorable Elaine Chao, public servant, experienced leader, trailblazer, and former President of United Way of America
- Yuri Fulmer, Chairman, Fulmer, and Company
- Suneeth Katarki, Senior Partner, Indus Law
- Swati Mylavarapu, Managing Partner, Incite.org
- Francesco Vanni d'Archirafi, Chairman, Euroclear Holding, and Euroclear SA/NV
The Annual Meeting of the Members also marked the conclusion of six trustees' service from the Worldwide Board of Trustees and U.S.A. National Board:
- Dr. Juliette Tuakli, Worldwide Board of Trustees Immediate Past Chair
- Neeraj Mehta, U.S.A. National Board Immediate Past Chair and Worldwide Board of Trustees At-Large Member
- Luis Javier Castro, Worldwide Board of Trustees Secretary and Audit Committee Chair
- Susan Somersille Johnson, U.S.A. National Board At-Large Member
- Kate Quinn, U.S.A. National Board Nominating Committee Chair
- Byron Spruell, U.S.A. National Board At-Large Member
"We also want to recognize and thank those dedicated trustees whose service has come to an end," said Mr. Bitzer. "They served with distinction and commitment, including during a time of uncertainty and change, consistently meeting the challenges with thoughtful solutions and an unwavering commitment to our mission."
To learn more about the United Way Worldwide Board of Trustees and read trustee bios, click here.
United Way brings people together to build strong communities where everyone thrives. As the world's largest privately funded charity serving 95% of U.S. communities and 37 countries and territories, our humanitarian aid supports 48 million people every year. Through United Way, communities tackle tough challenges and work with private, public, and nonprofit partners to boost education, economic solutions, and health resources. United Way is the mission of choice for 2.5 million volunteers, 7.7 million donors, and 45,000 corporate partners in more than 1,100 communities worldwide in our second century of service. Together, we are building resilient, equitable communities across the globe. Learn more at UnitedWay.org. Follow us: @United Way and #LiveUnited.
Media Contact: Omoiye Kinney, Omoiye.Kinney@uww.unitedway.org.
View original content:
SOURCE United Way Worldwide
|
https://www.kxii.com/prnewswire/2022/07/26/united-way-worldwide-welcomes-seven-new-trustees/
| 2022-07-26T15:17:23Z
|
Dustin Olson will serve as the Company's second CEO
ORLANDO, Fla., June 30, 2022 /PRNewswire/ -- Today, PureCycle Technologies, Inc. (NASDAQ: PCT) announced three key leadership changes effective August 5, 2022, that are expected to propel the company's transition to a leading global manufacturing and technology company.
Mike Otworth, Chairman of the Board of Directors and CEO of PureCycle, will resign to return to Innventure, a company he helped found. Dustin Olson, PureCycle's current Chief Operating Officer and Chief Manufacturing Officer, is being promoted to the role of CEO and joining the Board of Directors effective August 5, 2022. Olson has been with PureCycle since 2021 leading manufacturing and operations. Dan Coombs, current member of PureCycle's Board of Directors, will be appointed, upon Mike's departure, to a newly created position of Executive Chairman of the Board of Directors.
Mike Otworth said, "I am an entrepreneur at heart, and am excited to see PureCycle's progress over the last seven years. Taking PureCycle from an early concept to a publicly traded company has been an honor. We successfully added deep operational experience to our Board and management team to drive the execution of our business plan. Dustin has proven to be effective, eager, and has unprecedented work ethic. Dustin will lead this team and company into the next phase and will make PureCycle teams past and present proud."
Dustin Olson has over 20 years of plastics, petrochemical and refining experience in the United States, Europe, and China. Before joining PureCycle, he led multiple LyondellBasell commercial and operational businesses, delivering substantial growth in volume and profitability.
Dustin Olson said, "I am honored and humbled with this appointment as PureCycle's next CEO. I am excited for the opportunity to lead PureCycle during this important time. We have a strong and dedicated team in place to help our efforts in scaling our technology and addressing the planet's plastic waste crisis."
Jeff Fieler, Board Member and chairman of the Nominating and Corporate Governance Committee, commented, "Dustin brings special talents, energy, deep industry experience with business and manufacturing processes, and a compelling vision that employees and customers can rally around. We believe Dustin is the right person to lead PureCycle forward toward project completion and full commercial operations."
Dan Coombs, former executive vice president for LyondellBasell and current member of PureCycle's Board of Directors, has deep industry and business experience with large new technology facility startups, and a strong background with supercritical fluids. He will provide invaluable insight to Dustin's teams through the startup and initial operations.
Dan Coombs, Board Member, PureCycle said, "It is an honor to be appointed as the Executive Chairman of PureCycle. Thanks to Mike's entrepreneurial spirit and passion for innovation and technology, PureCycle has built a clear path for long-term success. Dustin's continued dedication to PureCycle's mission and commitment to excellence makes him the right leader for our company. We look forward to continuing to work with him in this new role and know he will help us in our efforts to hit critical milestones."
PureCycle Contact
Anna Farrar
afarrar@purecycle.com
954.647.7059
About PureCycle Technologies
PureCycle Technologies LLC., a subsidiary of PureCycle Technologies, Inc., holds a global license for the only patented solvent-driven purification recycling technology, developed by The Procter & Gamble Company (P&G), that is designed to transform polypropylene plastic waste (designated as No. 5 plastic) into a continuously renewable resource. The unique purification process is designed to remove color, odor, and other impurities from No. 5 plastic waste resulting in an ultra-pure recycled (UPR) plastic that can be recycled and reused over and over again, changing our relationship with plastic. www.purecycle.com
Forward-Looking Statements
This press release contains forward-looking statements, including statements about the prospects of PCT. In addition, any statements that characterize future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on the current expectations of the management of PCT and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section of PCT's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 entitled "Risk Factors," those discussed and identified in public filings made with the U.S. Securities and Exchange Commission (the "SEC") by PCT and the following:
- PCT's ability to meet, and to continue to meet, applicable regulatory requirements for the use of PCT's UPR resin in food grade applications (both in the United States and abroad);
- PCT's ability to comply on an ongoing basis with the numerous regulatory requirements applicable to the UPR resin and PCT's facilities (both in the United States and abroad);
- expectations and changes regarding PCT's strategies and future financial performance, including its future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and PCT's ability to invest in growth initiatives;
- PCT's ability to scale and build the Ironton facility in a timely and cost-effective manner;
- PCT's ability to complete the necessary funding with respect to, and complete the construction of the Augusta facility, its first U.S. cluster facility located in Augusta, Georgia, in a timely and cost-effective manner;
- PCT's ability to sort and process polypropylene plastic waste at its plastic waste prep ("Feed PreP") facilities;
- PCT's ability to maintain exclusivity under the Procter & Gamble Company license;
- the implementation, market acceptance and success of PCT's business model and growth strategy;
- the success or profitability of PCT's offtake arrangements;
- the ability to source feedstock with a high polypropylene content;
- PCT's future capital requirements and sources and uses of cash;
- PCT's ability to obtain funding for its operations and future growth;
- developments and projections relating to PCT's competitors and industry;
- the outcome of any legal or regulatory proceedings to which PCT is, or may become a party, including the recently filed securities class action case;
- the ability to recognize the anticipated benefits of the previously announced business combination consummated on March 17, 2021;
- unexpected costs related to the business combination;
- geopolitical risk and changes in applicable laws or regulations;
- the possibility that PCT may be adversely affected by other economic, business, and/or competitive factors;
- changes in the prices and availability of labor (including labor shortages), transportation and materials, including significant inflation, and PCT's ability to obtain them in a timely and cost-effective manner;
- the potential impact of climate change on PCT, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms;
- operational risk; and
- the risk that the COVID-19 pandemic, including any new and emerging variants and the efficacy and distribution of vaccines, and local, state, federal and international responses to addressing the pandemic may have an adverse effect on PCT's business operations, as well as PCT's financial condition and results of operations.
Should one or more of these risks or uncertainties materialize or should any of the assumptions made by the management of PCT prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.
All subsequent written and oral forward-looking statements or other matters attributable to PCT or any person acting on their behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this press release. Except to the extent required by applicable law or regulation, PCT undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
View original content to download multimedia:
SOURCE PureCycle Technologies
|
https://www.mysuncoast.com/prnewswire/2022/06/30/purecycle-announces-key-leadership-changes-new-chief-executive-officer/
| 2022-06-30T22:10:53Z
|
How do you modernize a front porch?
Your home may be warm and inviting on the inside, but what about the front porch? This is the portion of a house that grabs the attention of visitors and passersby, so it’s vital that it has attractive curb appeal. What’s more, a warm and inviting porch will create a welcoming first impression for guests.
From the walls and the floor to the door, there are easy changes and additions you can make to give your front porch a contemporary, refreshed appearance. A few key items and a little imagination are all you need to make it a neighborhood inspiration.
Considerations before updating your front porch
Whether you have a specific look in mind for your front porch or you aren’t sure where to start, you have many options for giving it a new look. However, it’s best to begin with the basics. Give your porch a good cleaning, and touch up chipped or peeling paint.
Next, think about porch size. For example, if your porch is large, roomy furniture will create a cozy feel. When decorating a small porch, keep in mind that less is more. Too many furniture pieces, plants or other items can make a small space look cluttered. Instead, focus on the door and add wall art to make the space seem larger.
Additionally, let your personal decorative style guide you in accessorizing your porch. Do you love plants? Would you like to give your porch an artsy feel? Do you prefer minimalism when it comes to decor? The answers to these questions will guide you as you plan your porch makeover. Below are some ideas to get you started, followed by product suggestions for you to consider when giving your front porch a makeover.
Add front porch furniture
In addition to providing a comfortable place to relax, furniture makes a porch more aesthetically appealing. As mentioned above, choose pieces and sets that work well with your porch size.
Install railing
Adding a railing to a porch gives it a finished look as well as instant curb appeal. If the porch has steps, it also adds an element of safety. With a little DIY know-how, modern vinyl railing is a fairly straightforward install.
Focus on the door
Painting a front door is an easy update. Bold colors like yellow, bright green, true blue, deep red and even black are trending for homeowners who want an entryway that pops. Opt for exterior paint with a water, latex or acrylic resin base with a satin or semi-gloss finish for long-lasting results. Complete the new look with door decor or a door knocker for added appeal.
Include plants
Plants brighten the appearance of any porch and are always in style. Colorful pots or planters will complement flowers and greenery and look great around your entryway.
Bring out your artistic side
Wall art isn’t just for a home’s interior. Today, eclectic pieces that are made of weather-resistant materials are designed to be displayed on outdoor walls and are great for creating a focal point on a front porch.
Remember the floor
Nothing makes a porch feel homey and cozy like an outdoor area rug. Instead of a solid color, choose a rug with colorful patterns for a contemporary look.
Best items for a front porch makeover
Noble House 3-Piece Wood Bistro Set
This bistro set has a trim design, which makes it suitable for small porches. The chairs come with cream-colored cushions that complement the teak-brown wood construction.
Sold by Home Depot
Wade Logan Outdoor Sofa with Cushions
In addition to seating for three, this sofa has a modern design that will spruce up any front porch. It comes with a removable tray and two throw pillows.
Sold by Wayfair
Winston Porter Raybon 2-Person Porch Swing
The Raybon swing boasts sleek, curved lines for a modern twist on a front-porch essential. It seats two and has a 550-pound weight capacity.
Sold by Wayfair
Weatherables Naples White Vinyl Railing Kit
This vinyl railing stands up to the elements, is easy to clean and doesn’t require painting. Sections are available in various sizes and come with brackets.
Sold by Home Depot
Modern Masters Never Fades Front Door Paint
Never Fades paint lives up to its name, as it’s water-based and long-lasting. It also dries quickly so there’s no long wait to open and close a door. It comes in a wide selection of bold colors.
Sold by Amazon and Home Depot
Michael Healy Dragonfly Door Knocker
Add character to a front door with Michael Healy’s dragonfly door knocker that’s made by hand and signed by the artist. It’s crafted in solid brass and comes in a choice of brass or oiled bronze finishes.
Sold by Home Depot and Wayfair
Trendspot 12-Inch Diameter Blue Rivage Ceramic Planter
Crafted of durable ceramic, this gorgeous planter with saucer sports an appealing blue glaze with a geometric pattern that captures attention and complements greenery and blooms.
Sold by Home Depot
Verel Set of 2 Tall Outdoor Planters
These two planters are ideal for enhancing a front entryway— simply fill them with beautiful plants and place one on either side of the exterior door for an inviting, upscale appearance.
Sold by Amazon
Thirdshiftfab Enchanting Starry Night Tree of Life Metal Wall Art
This artist-created wall art is crafted of steel that’s coated with copper and resists the weather. The unique tree design makes it the perfect front porch conversation piece.
Sold by Etsy
George Oliver Deede Floral Area Rug
Regardless of the porch size or color scheme, this area rug has it covered with numerous sizes and colors to choose from. It’s constructed of durable, low-pile fibers that stand up to stains and frequent foot traffic.
Sold by Wayfair
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Sian Babish writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved.
|
https://cw33.com/reviews/br/home-br/decor-br/everything-you-need-for-a-front-porch-makeover/
| 2022-04-01T19:22:36Z
|
The Sal6830 provides non-invasive COVID-19 results in under 30 minutes
CHARLOTTESVILLE, Va., Aug. 17, 2022 /PRNewswire/ -- MicroGEM, a U.S.-based molecular biology company, today announced that Medline, a manufacturer and distributor of medical supplies to healthcare providers across the continuum of care, is now offering the MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test.
The partnership comes as the nation continues to average more than 100,000 new cases and nearly 500 COVID-related deaths a day, with new cases and hospitalizations driven by the Omicron BA.5 variant, according to the Centers for Disease Control and Prevention (CDC).
"Sal6830 is transforming the 'new normal' of living and working with COVID-19 by providing an easy, convenient saliva test that eliminates the discomfort of nasal swabs," said Geoff Stein, Director of Channel Partner Sales for MicroGEM. "Medline is a terrific choice as a partner, joining us in sharing the message that 'sticks up the nose' can be a thing of the past, and providing their deep and proven technical knowledge, support, and flexibility to quickly respond to customer needs and demands."
The Sal6830 leverages MicroGEM's proprietary point of care technology, which combines enriched intact virus, thermophilic enzymatic RNA extraction, and microscale high-speed RT-PCR to capture whole virus to detect SARS-CoV-2 in under 30 minutes. Sal6830's non-invasive saliva sampling, simple on-screen instructions, fast on-the-spot results, and portability provide an invaluable tool to quickly and accurately detect COVID-19 in settings ranging from healthcare centers, film production sets, and government and academic facilities, to mobile testing sites, retirement homes and long-term care communities.
Medline is well-positioned to introduce the Sal6830 to healthcare organizations and vulnerable communities, such as assisted living facilities, that have existing and emerging needs to quickly test and protect their staff, visitors, residents, and patients.
"It is important that we continue to look at new ways to help customers drive efficiency around the ebb and flow of COVID-19 testing," said Nicole Krpan, vice president of Medline's laboratory division. "Our partnership with MicroGEM expands our product portfolio to offer a saliva-based test for the first time. We expect this to help expand our partnerships with lab leaders to optimize their performance."
The Sal6830 SARS-CoV-2 Saliva Testing Kit's innovative cartridge design allows new targets to be added or replaced quickly, significantly reducing both assay and product development time. The company plans on seeking authorization to expand the test menu and ruggedize the system to address austere field conditions presented in military and disaster medicine use cases, and adapt the system for the precision medicine healthcare market with quantitative gene expression panels used as biomarkers.
MicroGEM has established a U.S.-based supply chain, with R&D pilot manufacturing facilities in Charlottesville, Virginia, large-scale test kit production facilities in Ogden, Utah, and instrument production facilities in Hudson, New Hampshire.
The MicroGEM Sal6830 Point of Care PCR System and the MicroGEM Sal6830 SARS-CoV-2 Saliva Test recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and have been funded in part by the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (RADx®) initiative to expedite the launch of the test with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92020C00015.
The MicroGEM Sal6830 SARS-CoV-2 Saliva Test has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories. This product has been authorized only for the detection of nucleic acid form SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
To learn more about Sal6830, visit www.microgembio.com/covid-19/contact.
About Medline
Medline is a healthcare company; a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Partnering with healthcare systems and facilities across the continuum of care, Medline provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the scale of one of the country's largest companies and the agility of a family-led business, Medline is able to invest in its customers for the future and rapidly respond to a dynamically changing market with customized solutions. Headquartered in Northfield, Ill., Medline has 30,000+ employees worldwide and does business in more than 125 countries and territories. Learn more about Medline at www.medline.com.
About MicroGEM
MicroGEM is democratizing molecular diagnostics by moving molecular techniques out of conventional, highly skilled laboratories to non-laboratory settings. The company's innovative enzymatic approach to nucleic acid extraction provides the foundation for efficient sample preparation suitable for PCR analysis. Recently awarded over $50 million by the National Institutes of Health, Rapid Acceleration of Diagnostics (RADx) initiative, MicroGEM has leveraged its RNA extraction capabilities to develop the MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test, representing the next generation of point-of-need solutions for the management of infectious diseases and other personalized medicine applications.
View original content to download multimedia:
SOURCE MicroGEM
|
https://www.mysuncoast.com/prnewswire/2022/08/17/preparing-continuing-battle-with-covid-microgem-partners-with-medline-equip-healthcare-providers-with-worlds-first-saliva-pcr-test-point-care/
| 2022-08-17T19:52:08Z
|
- Franchise deal inked between Knight Riders Group, majority owned by Bollywood superstar, Shah Rukh Khan and UAE's T20 League Chairman, Khalid Al Zarooni
- UAE's T20 League is Emirates Cricket Board's sanctioned, flagship professional T20 League
- As one of the most successful brands in T20 cricket globally, the Knight Riders are excited about the potential for professional T20 cricket in the UAE
DUBAI, UAE, May 12, 2022 /PRNewswire/ -- UAE's T20 League is delighted to announce that the Knight Riders Group has acquired the rights to own and operate the Abu Dhabi franchise and will set up Abu Dhabi Knight Riders (ADKR) as an integral part of the UAE's flagship T20 league.
Over the last decade, the Knight Riders Group has become a household name in T20 cricket. After establishing Kolkata Knight Riders (KKR) in 2008 in the Indian Premier League (IPL), the Knight Riders became owners of the Trinbago Knight Riders (TKR) in the Caribbean Premier League (CPL) in 2015. Recently, the Knight Riders Group made a significant investment in Major League Cricket (MLC) in the USA and intends to set up a franchise in the greater Los Angeles area.
This investment by the Knight Riders Group, which is led by Bollywood superstar, Shah Rukh Khan, along with Juhi Chawla & her husband Jay Mehta, will establish their 4th T20 franchise around the world in IPL, CPL, MLC and now in UAE's T20 league.
Mr. Shah Rukh Khan, commenting on the long-term agreement, said; "For several years now, we have been expanding the Knight Riders brand globally and closely watching the potential for T20 cricket in the UAE. We are excited about becoming part of UAE's T20 League, which no doubt will become hugely successful."
Khalid Al Zarooni, UAE's T20 League Chairman said; "The commitment to grow the T20 format and the expertise gathered by the Knight Riders Group, through their involvement in franchise cricket across the world, is undisputed. We are exceptionally pleased with their foresight to join forces with the UAE's T20 League and firmly believe it will elevate the reputation, and professionalism of the League throughout the cricket community."
Mr. Venky Mysore, CEO of KKR and Red Chillies Entertainment, said, "We feel fortunate to have been consistently recognized as a global brand in T20 cricket. As T20 cricket expands around the world, we are flattered by the regular invitations to play a major role in growing the sport across the world. We have had a keen interest in the developments in the UAE and our expansion is consistent with our long-term strategy".
FOR MORE DETAILS, CONTACT:
UAE's T20 League
Email: pr@plt20.com
Knight Riders Group contact:
Sneh Kulkarni
sneh@kkr.in
Achint Gupta
achint@kkr.in
View original content:
SOURCE UAE T20 League
|
https://www.kxii.com/prnewswire/2022/05/12/knight-riders-acquires-abu-dhabi-franchise-new-t20-league-uae/
| 2022-05-12T14:51:52Z
|
Fast Casual Dining Powerhouse with Deliciously-Crafted Menu Now Open
ALISO VIEJO, Calif., Sept. 8, 2022 /PRNewswire/ -- Capriotti's Sandwich Shop, known for its award-winning, hand-crafted cheesesteaks, turkey subs and more, debuted its newest location in Aliso Viejo at 27032 La Paz Rd. on September 6. Capriotti's brings the Aliso Viejo community its 45-year-old tradition of slow-roasting whole, all-natural turkeys in-house – and hand-pulling them every morning, along with other savory favorites like the made-from-scratch meatballs using premium, fresh ingredients.
Capriotti's is known for its wide array of sandwiches including 'The Bobbie,' made with fresh oven-roasted turkey, cranberry sauce, stuffing and mayo; 'The Capastrami,' made with hot pastrami, Swiss cheese, Russian dressing and homemade coleslaw; and cheesesteak varieties made with premium steak, chicken or Impossible™ plant-based meat with melted cheese and peppers. Among their many sandwiches they also offer a variety of salads, including the Caps Chopped Salad, Balsamic Chicken Salad, and more. The Aliso Viejo Capriotti's will offer a convenient order-ahead option, in addition to third-party delivery services. The new shop will also provide 20 new jobs to the Aliso Viejo community.
The new location is owned and operated by local entrepreneurs, and mother-son team, Haydee Docasar and Alec Martin. Docasar has a background as a physician, while her son spent time as a sous-chef in California and New Orleans. When the pandemic hit, they found themselves together again at their home in Orange County. Determined to start something new and exciting, the duo decided to bring three Capriotti's locations to the area, with the help of other family members.
"When we were discussing business opportunities, it was really important to Alec that we only use high quality and fresh ingredients," says Docasar. "With Capriotti's, we know we can provide great food to our community. The brand is passionate about their products and their people, so we're excited for our family to take part in that time-tested legacy."
Capriotti's fans in Aliso Viejo can download the CAPAddicts Rewards app on iOS and Android to earn and redeem rewards and score free food. The restaurant also features online ordering. The Aliso Viejo location also offers catering for any event, from corporate events to birthday parties, with items such as party trays featuring cold subs, box lunches or a hot homemade meatball bar.
Capriotti's is open from 10 am – 8 pm every day. For additional information, visit www.capriottis.com or call the location at 760-851-0531.
About Capriotti's Sandwich Shop
Founded in 1976, Capriotti's Sandwich Shop is an award-winning national franchised restaurant chain that remains true to its 45-year tradition of slow-roasting whole, all-natural turkeys in-house every day. Capriotti's fresh ingredients, homemade subs and unique menu items have won numerous accolades including being named one of the "10 Great Places for a Surprising Sandwich" by USA Today and many "Best of" awards across the country. Capriotti's cold, grilled and vegetarian subs, cheese steaks and salads are available at more than 100 locations across the U.S. Capriotti's signature sub, The Bobbie®, was voted "The Greatest Sandwich in America" by thousands of readers across the country and reported by AOL.com. Capriotti's fans can also download the CAPAddicts Rewards app for iOS and Android, where they can earn and redeem rewards. For more information, visit capriottis.com. Like Capriotti's on Facebook, follow on Twitter or Instagram.
Media Contact: Olivia Quarrier, Fishman PR | oquarrier@fishmanpr.com | 765-606-7442
View original content to download multimedia:
SOURCE Capriotti's Sandwich Shop
|
https://www.wibw.com/prnewswire/2022/09/08/mother-son-team-bring-award-winning-sandwich-shop-aliso-viejo-first-three/
| 2022-09-08T17:09:21Z
|
BERLIN (AP) — Fearing Russia might cut off natural gas supplies, the head of Germany’s regulatory agency for energy called on residents Saturday to save energy and to prepare for winter, when use increases.
Federal Network Agency President Klaus Mueller urged house and apartment owners to have their gas boilers and radiators checked and adjusted to maximize their efficiency.
“Maintenance can reduce gas consumption by 10% to 15% ,” he told Funke Mediengruppe, a German newspaper and magazine publisher.
Mueller said residents and property owners need to use the 12 weeks before cold weather sets in to get ready. He said families should start talking now about “whether every room needs to be set at its usual temperature in the winter — or whether some rooms can be a little colder.”
The appeal came after Russia reduced gas flows to Germany, Italy, Austria, the Czech Republic and Slovakia earlier this month, as European Union countries scramble to refill storage facilities with the fuel used to generate electricity, power industry and heat homes in the winter.
Russian state-owned energy company Gazprom blamed a technical problem for the reduction in natural gas flowing through Nord Stream 1, a pipeline which runs under the Baltic Sea from Russia to Germany.
The company said equipment getting refurbished in Canada was stuck there because of Western sanctions over Russia’s war in Ukraine.
German leaders have rejected that explanation and called the reductions a political move in reaction to the European Union’s sanctions against Russia after its attack on Ukraine.
Germany is dealing with “a quasi economic warfare conflict” against the backdrop of the Russian invasion of Ukraine, said Vice Chancellor Robert Habeck, who is also Germany’s economy and climate minister and responsible for energy.
The Russian calculation is to “destroy the unity and solidarity of the country” through high energy prices in Germany, Habeck said at an event organized by the weekly newspaper Die Zeit on Saturday, according to German news agency dpa.
Habeck warned last month that a “blockade” of the pipeline is possible starting July 11, when regular maintenance work is due to start. In previous summers, the work has entailed shutting Nord Stream 1 for about 10 days, he said.
The question is whether the upcoming regular maintenance of the Nord Stream 1 gas pipeline will turn into “a longer-lasting political maintenance,” the energy regulator’s Mueller said.
If the gas flow from Russia is “to be lowered for a longer period of time, we will have to talk more seriously about savings,” he said.
According to Mueller, in the event of a gas supply stoppage, private households would be specially protected, as would hospitals or nursing homes.
“I can promise that we will do everything we can to avoid private households being without gas,” he said, adding: “We learned from the coronavirus crisis that we shouldn’t make promises if we’re not entirely sure we can keep them.”
He said his agency “does not see a scenario in which there is no more gas coming to Germany at all.”
Also on Saturday, German chemical and consumer goods company Henkel said it was considering encouraging its employees to work from home in the winter as a response to a possible supply shortage.
“We could then greatly reduce the temperature in the offices, while our employees could heat their homes to the normal extent,” Henkel CEO Carsten Knobel told daily newspaper Rheinische Post.
Hamburg’s state government’s senator for the environment also expressed concern and said he couldn’t rule out that the northern German city would need to limit hot water for private households in the event of a gas shortage.
“In an acute gas shortage emergency, hot water could only be made available at certain times of the day,” Jens Kerstan told weekly newspaper Welt am Sonntag.
Last month, economy minister Habeck activated the second phase of Germany’s three-stage emergency plan for natural gas supplies, warning that Europe’s biggest economy faced a “crisis” and storage targets for the winter were at risk.
___
Follow AP’s coverage of the Russia-Ukraine war at https://apnews.com/hub/russia-ukraine
|
https://cw33.com/business/ap-business/regulator-urges-germans-to-prepare-for-possible-gas-shortage/
| 2022-07-02T21:44:29Z
|
BEIJING, July 21, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it has partnered with China United Property Insurance Company Limited ("CIC") and Yong An Insurance ("Yong An") to launch "Waterdrop Blue Ocean", a series of customized and cost-effective critical illness products with a waiver on health declarations, further expanding its user group beyond healthy customers to cover customers with pre-existing medical conditions.
The waiver on health declaration is a breakthrough in critical illness insurance
In October 2021, China Banking and Insurance Regulatory Commission ("CBIRC") unveiled a directive guidance on further enriching health insurance product supply, in which the regulator encourages insurance companies to appropriately relax the threshold requirements for insurance applicants, and provide reasonable coverage for the elderly with pre-existing conditions and chronic diseases.
Currently, typical health insurance products in China mainly target healthy customers while products available for customers with pre-existing conditions only cover certain categories of illnesses, or partially lower their thresholds on insurance purchase. Although people with pre-existing conditions have a stronger needs of insurance protections, their growing demand has been notably unattended.
Mr. Wei Ran, a partner of Waterdrop, commented, "To address this issue, we have been collaborating closely with our insurance partners to promote product innovation, including insurance products to customers with pre-existing conditions. Today, we are pleased to jointly launch the 'Waterdrop Blue Ocean' with CIC and Yong An, a series of cost-effective customized critical illness product with a waiver on health declarations, dedicated to customers with pre-existing medical conditions."
Mr. Shangjun Nie, vice president of China United Property Insurance and general manager of its Beijing branch, commented, "As the first of its kind in the industry, the launch of the 'Waterdrop Blue Ocean' series is a pioneering initiative and adds great significance to the development of the entire online health insurance sector."
Mr. Xiong Liu, executive vice president of Yong An, commented, "Many elderly and consumers with chronic diseases were hesitant to purchase health insurance products as they worried about an incomplete disclosure of their health conditions to the insurance company would adversely affect their future insurance claims. 'Waterdrop Blue Ocean' has waived the health declaration of customers, allowing them to enjoy a more convenient and intelligent insurance service."
The waiver on health declaration will not result in tougher claim criteria
During the development phase, Waterdrop, CIC, and Yong An Insurance have listened to users' opinions extensively. The launch of "Waterdrop Blue Ocean" has waived the health declaration of customers but ensure the risks are controllable at the same time.
Mr. Hui Teng, chief actuary of Waterdrop, commented, "The underwriting risk for consumers with pre-existing conditions could be relatively higher. However, through the expansion of the underwriting population, and the strengthening of our claims review capabilities and our actuarial estimation of insurance claims, we are capable of diversifying and minimizing the underwriting risks."
The "Waterdrop Blue Ocean" critical illness product series is available for any insured person ranging from 30 days after birth to 60 years old, and it is on a yearly renewable basis up to the age of 80. It provides extensive coverage for a total of 193 mild, moderate, and critical illnesses with a maximum of two claims on critical illnesses in the first year, and offers extended coverage such as optional benefits for ICU inpatient treatment, specific organ transplants, ECMO treatment, and off-site medical referrals. In regards to insurance claims, the criteria of the "Waterdrop Blue Ocean" series are in line with those of other critical illness products that require health declarations and the claim process remains as efficient as other critical illness products.
In terms of insurance premium, for instance, a 40-year-old male can purchase "Waterdrop Blue Ocean No. 1" at an annual premium of RMB679, with maximum benefits of RMB150,000 on critical illnesses and a maximum of two claims in the first year. Similarly, a 40-year-old female can purchase "Waterdrop Blue Ocean No.2" at an annual premium of RMB1,452, with maximum benefits of RMB300,000 on critical illnesses and a maximum of two claims in the first year.
Mr. Ran said, the launch of the new product showcases Waterdrop's commitment to the mission of "leveraging internet technologies to make insurance protection more inclusive and accessible to the public, and bring insurance and healthcare service to billions". Going forward, Waterdrop will continue co-developing more inclusive insurance products with more industry partners to satisfy the protection needs of more people.
About Waterdrop Inc.
Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.
Safe Harbor Statement
This press release contains statements that may constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. Statements that are not historical facts, including statements about Waterdrop's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop's filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For investor inquiries, please contact:
Waterdrop Inc.
Xiaojiao Cui
IR@shuidi-inc.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-1380-111-0739
E-mail: Eyuan@christensenir.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com
View original content:
SOURCE Waterdrop Inc.
|
https://www.mysuncoast.com/prnewswire/2022/07/21/waterdrop-launches-industrys-first-customized-critical-illness-insurance-product-with-waiver-health-declarations/
| 2022-07-21T11:12:54Z
|
TALLAHASSEE, Florida (WFOR) — Florida is taking Walgreens to court in an effort to hold it accountable for what it claims was the company’s role in the state’s opioid crisis.
So far the state has recovered more than $3 billion from other pharmaceutical companies in its opioid litigation, but Walgreens was not one of the companies.
“It’s time for Walgreens to face accountability for their part in fueling the opioid crisis, and my team is prepared to vigorously try our strong case against them,” said state Attorney General Ashley Moody.
Jury selection for the trial in New Port Richey is set for April 5th, opening statements are likely to occur on or about April 11.
In court filings, the state highlighted what it said was concerning evidence surrounding Walgreens’s dispensing and distribution of opioids in Florida.
According to the filings, “a Walgreens drug distribution center sold 2.2 million tablets to a single Walgreens pharmacy in tiny Hudson, a roughly six-month supply for each of its 12,000 residents… In some cases, Walgreens increased orders by as much as 600% in the space of just two years, including, for example, supplying a town of 3,000 with 285,800 orders of oxycodone in a one-month period.”
The Office of the Attorney General will outline additional facts and figures concerning Walgreens’s role in creating and fueling the deadly opioid crisis during next week’s trial.
Moody recently announced that they had secured more than $870 million for opioid abatement from former defendants in the state’s case: CVS Health Corporation, CVS Pharmacy, Inc., Teva Pharmaceuticals Industries Ltd., and Allergan PLC.
Additionally, Attorney General Moody announced the finalization of the state’s agreement with Endo Health Solutions.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.
Whether your cup of tea is a craft beer from a local brewery, classic cars and trucks or a train excursion, there are options on things to do this weekend in the area. Local students also will be competing in a robotics tournament to qualify for state championships next weekend. Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/state-taking-walgreens-to-court-for-its-alleged-role-in-opioid-crisis/article_84f44d85-de16-5622-9614-357c3d1f665b.html
| 2022-04-01T01:02:33Z
|
Enterprise-wide data transformation and governance project to help nation's second largest gas distribution company increase organization-wide data usage and meet government's decarbonization objective
SAN MATEO, Calif. and LONDON, July 12, 2022 /PRNewswire/ -- Talend, a global leader in data integration and management, announced today that SGN, the UK's second largest gas distribution network company, has selected Talend to drive its cross-organizational data initiatives. The energy company will use Talend to drive a strong data culture throughout its business and power its data transformation and digitalization plans to support the UK government's Net Zero decarbonization objective. Running in an AWS environment, Talend will help SGN operationalize its data governance strategy, supporting regulatory requirements and greater access, understanding, and usage of its data across the organization.
Operating across Scotland and in the south of England, SGN provides gas to 5.9 million homes and businesses. Driven by innovation and customer centricity, the company has been investing in technologies to modernize pipe networks and provide intelligent services through IoT and automation. In 2021, the UK government released its digitalization strategy for the energy sector, highlighting the importance of data and technology to achieve decarbonization and meet its Net Zero objective by 2050. To realize this goal, SGN selected Talend to control and govern data while enabling access and better usage of data by the business.
To address one of the regulatory requirements around data interoperability, SGN is building a system of trust by creating an enterprise view and catalog of its data. The use of Talend's data governance solutions will support SGN in complying with new and evolving regulatory mandates for energy data, in particular with the digital transformation of the energy networks and the need for robust, credible, and interoperable data to feed these solutions.
"Data will play a key role in the innovation that will drive the future of energy and the future of energy sources. We have a number of innovative projects to identify how we are going to use hydrogen on our networks, how we prioritize our network upgrades so that it supports the Net Zero hydrogen targets, and how we optimize our program, so it is the most efficient for the future of gas and gas networks," explains Shuchi Nagar, Head of Architecture and Data at SGN.
The success of this broader digitalization programme also includes developing greater data literacy across the organization. Bringing the entire organization around data and driving a common understanding of the data is key. The implementation of Talend solutions enables the data team to gain more visibility and provide opportunities for their colleagues to interact with data and provide their insights and knowledge across the business.
"One of the benefits that the Talend platform provides us with is the opportunity to change the perception of data as a conceptual asset that people can't see or touch necessarily, particularly when we are talking in the context of governing and managing our data to deliver value," adds Gabrielle Barnard, Head of Information Management at SGN.
SGN also required a solution that integrates with different internal applications and offers the scalability and power of SaaS. "Our ecosystem is largely AWS and SaaS applications; our best of breed strategy is cloud first and this was a key criterion in selecting Talend," says Nagar.
"Healthy data that is accessible and available to everyone fosters a common understanding of data and helps organizations quickly innovate and meet evolving policies and regulations," said Gareth Vincent, SVP/GM EMEA at Talend. "We're honored that SGN has selected us to play a critical role in ensuring their data supports the drive toward meeting the decarbonization objectives set by the UK government."
For more details on Talend Data Fabric and Talend's complete portfolio of solutions, visit www.talend.com.
Talend, a global leader in data integration and data management, is taking the work out of working with data.
Talend offers the only end-to-end platform that combines enterprise-grade data integration, integrity, and governance capabilities to unify data across any cloud, hybrid, or multi-cloud environment. With Talend's no-code and low-code modules, data experts and business users actively collaborate to make data more discoverable, usable, and valuable organization-wide. Over 7,250 customers around the world rely on Talend for healthy data and a healthy business. Top analyst firms and industry media recognize Talend as a leader in data management software.
For more information, please visit www.talend.com and follow us on LinkedIn.com and Twitter @Talend.
View original content to download multimedia:
SOURCE Talend Inc.
|
https://www.mysuncoast.com/prnewswire/2022/07/12/sgn-selects-talend-support-uks-net-zero-target/
| 2022-07-12T11:28:07Z
|
Police: Alliance-area man stabbed to death in Louisville park. Two juveniles arrested
LOUISVILLE − A 22-year-old man from the Alliance area was stabbed to death in Wildwood Park and two juveniles were later arrested, according to statements issued Tuesday evening by city police.
The first statement posted on Louisville Police's Facebook page at 8:37 p.m. did not say when the killing took place. It said the department was not identifying the victim at that time because his family had not yet been notified. A message was left for a police supervisor seeking more details.
More:Fire hydrant stolen in Louisville
An update posted on Facebook by police at 10:34 p.m. Tuesday said, "Two juveniles have been taken into custody and are being booked into the Multi-County Juvenile Attention Center on homicide related charges."
In the original statement, police said the man "was stabbed in the chest following an altercation at Wildwood Park at 500 Stertzbach Avenue. The altercation involved several juveniles." At least one suspect fled the scene before police arrived.
Reach Robert at robert.wang@cantonrep.com. Twitter: @rwangREP.
|
https://www.cantonrep.com/story/news/2022/09/14/police-alliance-area-man-stabbed-and-murdered-in-louisville-park/69493546007/
| 2022-09-14T05:22:51Z
|
AGNC Investment Corp. Declares Second Quarter Dividends on Preferred Stock
Published: Jun. 9, 2022 at 3:01 PM CDT|Updated: 1 hour ago
BETHESDA, Md., June 9, 2022 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) ("AGNC" or the "Company") announced today that its Board of Directors has declared cash dividends for the second quarter 2022 on its 7.00% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the "Series C Preferred Stock") underlying its outstanding depositary shares (Nasdaq: AGNCN), 6.875% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the "Series D Preferred Stock") underlying its outstanding depositary shares (Nasdaq: AGNCM), 6.50% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the "Series E Preferred Stock") underlying its outstanding depositary shares (Nasdaq: AGNCO) and 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the "Series F Preferred Stock") underlying its outstanding depositary shares (Nasdaq: AGNCP).
For further information or questions, please contact Investor Relations at (301) 968-9300 or IR@AGNC.com.
ABOUT AGNC INVESTMENT CORP.
AGNC Investment Corp. is an internally-managed real estate investment trust that invests primarily in residential mortgage-backed securities for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise or a U.S. Government agency. For further information, please refer to www.AGNC.com.
CONTACT:
Investor Relations - (301) 968-9300
View original content:
SOURCE AGNC Investment Corp.
The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.
|
https://www.wibw.com/prnewswire/2022/06/09/agnc-investment-corp-declares-second-quarter-dividends-preferred-stock/
| 2022-06-09T21:20:47Z
|
Virtual and in-person sessions complement healthcare company's focus on education to drive new clinical thinking
Northfield, Ill., May 31, 2022 /PRNewswire/ -- Medline today announced skin health and wound care workshops in 2022 to help drive standardization of care and empower frontline caregivers across the continuum of care. Offered throughout the year, Medline has created in-person and virtual compression workshops for outpatient wound centers and virtual boot camps for post-acute care providers on complex skin health topics, ranging from prevention of skin breakdown to wound etiologies and appropriate treatments.
"It will take time to fully assess the impact of the COVID-19 pandemic on skin health management, but we have learned that successful organizations continue to empower their staff," said Amin Setoodeh, senior vice president of skin health and clinical services for Medline. "Medline strives to be more than just a medical supplier, and we are fortunate to have a robust clinical team at Medline to arm healthcare providers with essential skin and wound care knowledge to help their organizations run better."
The acute and post-acute care education is an extension of Medline's dedication to building knowledge and confidence in clinicians, and the sessions are led by Medline clinicians who have extensive experience in the healthcare industry.
- Post-acute care skin health boot camps: The Medline Post-Acute Skin Health Solution team has designed a curriculum for all levels of care expertise that focuses on how to properly assess and document wounds, measure wounds, and provide essential patient and family education. The sessions, which range in length from one hour to half-day, are divided into three series based on level of expertise. Learn more about the post-acute skin health boot camps.
- Acute care compression workshops: Geared toward outpatient wound centers, the workshops are designed to drive best practices for applying compression therapy in treating patients with venous disease. With 80-90% of lower extremity wounds being venous in origin, the curriculum focuses on contributing factors and characteristics of venous disease, advancements in compression therapy, and hands-on training to practice skills learned during the workshop. Fill out the form to learn more about the compression workshops.
Medline's commitment to education beyond skin health
Medline continues to create educational opportunities to enhance staff engagement and optimize patient care outcomes. In addition to the focus on skin health, Medline's online continuing education (CE) platform, Medline University, saw a 30% year-over-year growth in monthly users in 2021, with new courses in development in 2022 to address self-care for nurses, telehealth and workplace violence and incivility in nursing.
Read more about Medline's focus on empowering clinicians through education at https://newsroom.medline.com/caregiver-readiness/the-role-of-workforce-education-in-retaining-and-attracting-healthcare-staff.
About Medline
Medline is a healthcare company; a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Partnering with healthcare systems and facilities across the continuum of care, Medline provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the scale of one of the country's largest companies and the agility of a family-led business, Medline is able to invest in its customers for the future and rapidly respond to a dynamically changing market with customized solutions. Headquartered in Northfield, Ill., Medline has 30,000+ employees worldwide and does business in more than 125 countries and territories. Learn more about Medline at www.medline.com.
Facebook
Twitter
LinkedIn
YouTube
View original content to download multimedia:
SOURCE Medline
|
https://www.mysuncoast.com/prnewswire/2022/06/01/medline-launches-skin-health-compression-workshops-frontline-caregivers/
| 2022-06-01T01:42:53Z
|
So long, Internet Explorer. The browser is finally retiring
SAN FRANCISCO (AP) — Internet Explorer is finally headed out to pasture.
As of Wednesday, Microsoft will no longer support the once-dominant browser that legions of web surfers loved to hate — and a few still claim to adore. The 27-year-old application now joins BlackBerry phones, dial-up modems and Palm Pilots in the dustbin of tech history.
IE’s demise was not a surprise. A year ago, Microsoft said that it was putting an end to Internet Explorer on June 15, 2022, pushing users to its Edge browser, which was launched in 2015.
The company made clear then it was time to move on.
“Not only is Microsoft Edge a faster, more secure and more modern browsing experience than Internet Explorer, but it is also able to address a key concern: compatibility for older, legacy websites and applications,” Sean Lyndersay, general manager of Microsoft Edge Enterprise, wrote in a May 2021 blog post.
Users marked Explorer’s passing on Twitter, with some referring to it as a “bug-ridden, insecure POS” or the “top browser for installing other browsers.” For others it was a moment for 90′s nostalgia memes, while The Wall Street Journal quoted a 22-year-old who was sad to see IE go.
Microsoft released the first version of Internet Explorer in 1995, the antediluvian era of web surfing dominated by the first widely popular browser, Netscape Navigator. Its launch signaled the beginning of the end of Navigator: Microsoft went on to tie IE and its ubiquitous Windows operating system together so tightly that many people simply used it by default instead of Navigator.
The Justice Department sued Microsoft in 1997, saying it violated an earlier consent decree by requiring computer makers to use its browser as a condition of using Windows. It eventually agreed to settle the antitrust battle in 2002 over its use of its Windows monopoly to squash competitors. It also tangled with European regulators who said that tying Internet Explorer to Windows gave it an unfair advantage over rivals such as Mozilla’s Firefox, Opera and Google’s Chrome.
Users, meanwhile, complained that IE was slow, prone to crashing and vulnerable to hacks. IE’s market share, which in the early 2000s was over 90%, began to fade as users found more appealing alternatives.
Today, the Chrome browser dominates with roughly a 65% share of the worldwide browser market, followed by Apple’s Safari with 19%, according to internet analytics company Statcounter. IE’s heir, Edge, lags with about about 4%, just ahead of Firefox.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.kxii.com/2022/06/15/so-long-internet-explorer-browser-is-finally-retiring/
| 2022-06-15T02:28:46Z
|
John Fetterman will win Pennsylvania Democratic Senate primary, CNN projects
By Dan Merica, CNN
John Fetterman will win the Pennsylvania Democratic Senate primary, CNN projects, capping a bizarre final few days of the campaign after the lieutenant governor suffered a stroke last week.
Fetterman checked into a hospital in Lancaster, Pennsylvania, on Friday as he was on his way to a campaign event. He was found to have had a stroke. Fetterman has been in the hospital ever since, and he underwent a nearly three-hour surgery on Tuesday to implant a pacemaker that includes a defibrillator.
While the hospital stay injected a level of uncertainty into the race, Fetterman had long been the frontrunner, holding a steady polling lead over US Rep. Conor Lamb and state Rep. Malcolm Kenyatta.
And nearly all Pennsylvania Democratic voters CNN spoke to in the final days of the campaign — including when Fetterman was in the hospital — said the stroke would not change their vote.
For the lieutenant governor, who lost in the primary when he ran for Senate in 2016, the win is the cap on a high-profile rise from small town mayor to statewide elected official. Fetterman served as mayor of Braddock, a small town near Pittsburgh, from 2006 to 2019, when he became lieutenant governor.
Fetterman is difficult to pin down politically and looks nothing like a traditional politician, something that set him apart from his primary opponents.
The candidate is often described as a progressive populist and holds positions that span the spectrum of the Democratic Party: He opposed the defund the police effort, made legalizing marijuana central to his time as lieutenant governor and backed universal health care plans.
But Fetterman told CNN in April that he was not a liberal.
“I don’t mean to nitpick, but I wouldn’t categorize myself as progressive,” Fetterman told CNN’s Manu Raju. “I consider myself a Democrat that’s running on the same platform of ideas that every other Democrat in this race is running on. And I can’t think of a Democrat running nationally that’s running on anything functionally different in that regard.”
Fetterman has also said Senate candidates in Pennsylvania are “going to embrace Joe Biden.”
Fetterman’s uniqueness goes beyond being rhetorical. Standing at 6-foot, 8 inches and better known for wearing shorts and Carhartt hoodies than ties and suits, Fetterman’s unique look has set him apart on the national stage, endearing him to his most loyal supporters.
A Biden adviser told CNN on Tuesday that “there are big similarities between John Fetterman and Joe Biden,” including a focus on organizing, an appeal to working class voters and a concern for unions. Where they differ, the adviser added, “You cannot compare with their Republican opponents.”
Plus, the adviser joked, “I saw the President walking around in shorts and a Carhartt earlier.”
While Fetterman — surrounded by his dad, brother and his campaign manager — watched the results come in from his hospital in Lancaster, his supporters gathered in Pittsburgh to cheer the win, look toward the general election and listen to a speech from Gisele Barreto Fetterman, the candidate’s wife.
Whether Fetterman’s appeal can help Democrats win back blue collar voters who have left the party in recent years remains an open question. And Lamb, his top primary opponent, made questioning Fetterman’s ability to reach these voters central to his campaign.
“Those people don’t care how we dress. They’re not going to make their decision based on how we dress. They’re going to make it based on issues,” Lamb told CNN days before the primary. “I’m someone who you know can beat Republicans in these high stakes situations cause I’ve done it three times. He never has.”
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
|
https://localnews8.com/politics/cnn-us-politics/2022/05/17/john-fetterman-will-win-pennsylvania-democratic-senate-primary-cnn-projects/
| 2022-05-18T08:49:11Z
|
NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Medscape Education, the leading destination for continuous professional development for healthcare professionals, has launched Building Bridges Between Mental Health and Wellness, a learning center focusing on mental health and wellness for both patients and clinicians.
Guided by an expert steering committee, Building Bridges Between Mental Health and Wellness provides resources that explore the interconnectivity of mental and physical health.
"Mental health matters," said Hansa Bhargava, M.D., Chief Medical Officer, Medscape Education. "Mental health and wellness are intertwined. When a patient has exacerbated mental health issues, there is also an impact on their physical health and risk of disease. Medscape Education is elevating this important topic through education. Through accessible and engaging activities, we are encouraging physicians to connect to the conversation about mental health and wellness to help eradicate stigma and address a growing and concerning issue."
Building Bridges Between Mental Health and Wellness takes an interprofessional approach, providing continuing education and resources across therapeutic areas and conditions, including:
- Insights and interviews from healthcare experts
- Education for multiple specialties and healthcare team members
- Patient education resources
- Clinical tools, resources, and references
An additional patient-focused resource center provides education and materials for patients and caregivers to manage their mental health and facilitate shared decision-making with their clinicians.
Medscape Education collaborates with partners such as The Anxiety & Depression Association of America, The JED Foundation and The National Alliance on Mental Illness (NAMI) to offer important resources from these organizations to Medscape members. Patients and caregivers gain similar access through WebMD Education. Through these collaborations and others, education and tools will broadly reach healthcare professionals and patients to improve overall care and well-being.
The Building Bridges Between Mental Health and Wellness for healthcare providers is available at https://www.medscape.org/sites/advances/mentalhealthandwellness.
The Mental Health and Well-Being Resource Center for patients and caregivers is available at: https://education.webmd.com/viewcollection/36690
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.
About WebMD Health Corp.
WebMD, an Internet Brands company, is at the heart of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms, and health-focused publications, WebMD delivers leading-edge content and digital services that enable and improve decision-making, support and motivate health actions, streamline and simplify the healthcare journey, and improve patient care.
The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, Krames, PulsePoint, The Wellness Network, SanovaWorks, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.
View original content to download multimedia:
SOURCE Medscape Education
|
https://www.kxii.com/prnewswire/2022/08/18/medscape-education-invites-clinicians-connect-conversation-with-new-mental-health-wellness-learning-center/
| 2022-08-18T16:25:26Z
|
BIRMINGHAM, Ala., July 18, 2022 /PRNewswire/ -- New Capital Partners (NCP), a private equity firm in Birmingham, Alabama, today announces that it has hired Will Saxton as a Principal of the firm. Saxton most recently served as a Director at Arlington Capital Advisors, a boutique Investment Bank in Birmingham, where he led the Debt Capital Markets Group in originating and executing capital placements in the alternative credit market for middle market sponsor-backed and founder-owned businesses.
Prior to his work at Arlington, Saxton worked in the Financial Sponsors / Leveraged Finance Group at Credit Suisse in New York, where he executed over $30 billion of transactions for Private Equity clients. Prior to CS, Will was a Judge Advocate (JAG) attorney in the United States Marine Corps. Will attended undergrad the University of Tennessee and also holds JD and MBA degrees from the University of Arkansas and University of Virginia, respectively.
"We couldn't be more excited to have Will join our team at New Capital Partners," said James Outland, Managing Partner at NCP. "Will has a strong track record of sourcing, evaluating, and executing deals across a broad industry set, and we look forward to having him continue to do the same for NCP in our chosen sectors and markets," Outland said.
Saxton said, "I am very excited to join the New Capital Partners team. I have known of NCP's presence in the market for many years and have always admired the success they have had as investors and operators. I look forward to working with the entire NCP team to partner with founders, owners, and management teams to build great companies."
New Capital Partners is a private equity firm comprised of former operators headquartered in Birmingham, Alabama. NCP makes investments in niche technology and services companies in the healthcare, financial and business services industries. Leveraging their extensive operational experience, NCP helps create significant value in portfolio companies by cultivating true partnerships with management teams and focusing on one core goal: Building Great Companies. For more information, please visit www.newcapitalpartners.com.
View original content to download multimedia:
SOURCE New Capital Partners
|
https://www.mysuncoast.com/prnewswire/2022/07/18/new-capital-partners-hires-will-saxton-principal/
| 2022-07-18T19:12:14Z
|
Supreme Court rules against states barring parents who select schools that provide religious instruction from participating in Student-Aid Program
WASHINGTON, June 21, 2022 /PRNewswire/ -- Today, in Carson v. Makin, the Supreme Court of the United States ruled 6-3 that states cannot discriminate against parents who select schools that provide religious instruction from participating in student-aid programs. First Liberty Institute and Institute for Justice (IJ) argued the case at the Supreme Court in December.
In response to today's landmark ruling, Kelly Shackelford, President, CEO, and Chief Counsel for First Liberty Institute said, "We are thrilled that the Court affirmed once again that religious discrimination will not be tolerated in this country. Parents in Maine, and all over the country, can now choose the best education for their kids without fearing retribution from the government. This is a great day for religious liberty in America."
Today's opinion overturns a Maine law that banned families from an otherwise generally available student-aid program if they choose to send their children to schools that teach from a religious perspective. For school districts that do not maintain a high school, Maine pays students' tuition at the public or private school of the family's choice. Until today's ruling, families were prohibited from using the scholarship program to attend religious schools.
First Liberty Institute is a non-profit public interest law firm and the largest legal organization in the nation dedicated exclusively to defending religious freedom for all Americans.
View original content:
SOURCE First Liberty Institute
|
https://www.kxii.com/prnewswire/2022/06/23/supreme-court-protects-religious-liberty-landmark-maine-school-choice-decision/
| 2022-06-23T17:44:37Z
|
METALLICA, CHARLIE PUTH, JONAS BROTHERS, MÅNESKIN, MARIAH CAREY, MICKEY GUYTON AND ROSALÍA SET TO PERFORM AT GLOBAL CITIZEN FESTIVAL IN NEW YORK'S CENTRAL PARK
PRIYANKA CHOPRA JONAS TO HOST GLOBAL CITIZEN FESTIVAL: NYC
USHER, SZA, STORMZY, GYAKIE, H.E.R., SARKODIE, STONEBWOY AND TEMS TO PERFORM AT GLOBAL CITIZEN FESTIVAL IN BLACK STAR SQUARE IN ACCRA, GHANA
GLOBAL CITIZEN FESTIVAL CALLS FOR WORLD LEADERS TO EMPOWER GIRLS, CLOSE THE CLIMATE FINANCE GAP, ALLEVIATE THE GLOBAL FOOD CRISIS, AND RELIEVE CRUSHING DEBTS NOW
Tickets to the festivals are free and can be earned by downloading the Global Citizen app or visiting www.globalcitizen.org to take action on the campaign's issues.
Proudly supported by Global Partners: Accenture, Cisco, Citi, Delta Air Lines, Harith General Partners, P&G, Verizon and YouTube, and NYC Campaign Partner World Wide Technology
World Leaders supporting the campaign include Ursula von der Leyen, President of the European Commission; Mia Mottley, Prime Minister of Barbados; Nana Akufo-Addo, President of Ghana; Hakainde Hilchilema, President of Zambia; Amina Mohammed, Deputy Secretary General of the United Nations; Dr. Natalia Kanem, Executive Director of UNFPA; Andrej Plenković, Prime Minister of Croatia; Pedro Sánchez, Prime Minister of Spain; Frank Bainimara, Prime Minister of Fiji; Ingrida Šimonytė, Prime Minister of Lithuania; Nancy Pelosi, Speaker of the U.S. House of Representatives; Stanley Kakubo, Minister of Foreign Affairs of Zambia; Chuck Schumer, U.S. Senate Majority Leader; Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization; Ban Ki-moon, Former UN Secretary General; Elizabeth Cousens, President and CEO of the UN Foundation; Meryame Kitir, Minister of Development Cooperation and Urban Policy of Belgium; Marcelo Ebrard Casaubon, Secretary of Foreign Affairs of Mexico; Peter Sands, Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria; and more
Broadcasting and streaming from Accra and New York City on ABC, ABC News Live, FX, Hulu, iHeartRadio, TimesLIVE, Twitter, YouTube and more
Press Kit: Click here for artwork, press assets, quotes and social assets
NEW YORK and ACCRA, Ghana, Aug. 11, 2022 /PRNewswire/ -- International advocacy organization Global Citizen today announced the lineups for the 10th anniversary Global Citizen Festival, taking place in New York City's Central Park, presented by Citi and Cisco, and Black Star Square in Accra, Ghana, presented by Harith General Partners, on Saturday, September 24, 2022.
Since it began lighting up Central Park's Great Lawn in 2012, the Global Citizen Festival has become the world's longest-running global campaign calling for an end to extreme poverty that unites millions of voices, amplified by the world's biggest artists, demanding world leaders take action NOW.
Globally, the disproportionate impact of the Covid-19 pandemic has pushed nearly 100 million more people into extreme poverty and is reversing recent trends of shrinking inequality, leading to the loss of at least three years of progress. Without urgent action NOW this backsliding will only worsen. Russia's invasion of Ukraine has aggravated the situation further, with as many as 323 million people now facing acute hunger, and 1.2 billion people now live in nations experiencing a perfect storm of food, energy, and financial crises. If we don't take action NOW, as many as 200 million more people may be plunged into extreme poverty by November.
The 2022 Global Citizen Festival will call on world leaders at the United Nations General Assembly and ahead of the G20 and COP27 in November to step up and invest $600 million into the future of women and girls, close the annual $10 billion climate financing shortfall, deliver $500 million to help African farmers respond to the global food crisis, and provide urgent relief from crushing debts to End Extreme Poverty NOW.
With two stages in international cultural capitals, New York City and Accra, Ghana, the 2022 Global Citizen Festival will be broadcast and streamed on ABC, ABC News Live, FX, Hulu, iHeartRadio, TimesLIVE, Twitter, YouTube, and more. ABC News Live's broadcast will air on Saturday, September 24, and a primetime special, Global Citizen Festival: Take Action NOW, will air on ABC on Sunday, September 25 at 7:00 pm ET / 6:00 pm CT. Additional tune in details to follow in the coming weeks.
Performers on the Central Park stage will include Metallica, Charlie Puth, Jonas Brothers, MÅNESKIN, Mariah Carey, Mickey Guyton and Rosalía with more to be announced. Global Citizen Festival: NYC will be hosted by actor, producer, author, and Global Citizen Ambassador Priyanka Chopra Jonas.
Marking the 65th anniversary of Ghana's independence and the 20th anniversary of the African Union, Accra's iconic Black Star Square will see live performances from Usher, SZA, Stormzy, Gyakie, H.E.R., Sarkodie, Stonebwoy and TEMS with more to be announced.
"Decades of systemic and political failures have led humanity into the midst of converging and rapidly deteriorating crises – climate, hunger, health, war and conflict. The most marginalized populations are paying the price of the stagnant inaction of our leaders, and now millions of lives, and the future of our planet, are at stake. We refuse to just stand by and watch! We refuse to accept the starvation of multitudes when solutions are readily at hand. We demand a secure future for girls everywhere. We demand governments keep their promises on climate funding. We demand relief from debts unjustly crushing economies. And we demand action NOW, while there's still time to change our collective trajectory." – Hugh Evans, Co-Founder and CEO, Global Citizen
Global Citizen is calling for world leaders, major corporations and philanthropic foundations to take to the Global Citizen Festival stages and announce new commitments to End Extreme Poverty NOW, including:
Deploy Financing NOW and immediately meet the total goal of reallocating $100 billion in IMF Special Drawing Rights (SDRs), by making up the $40B shortfall.
SDRs are a type of reserve asset mostly sitting unused by the world's wealthiest countries. These rights can immediately provide new and affordable financing relief for countries at high risk of financial and debt distress.
There are 69 eligible low-income countries who stand to benefit from the reallocation of SDRs, many of which are in Africa. During the pandemic, many of these governments spent more on debt repayments than on education, health and social protection benefits combined. This funding is needed NOW to ensure governments have what they need to invest in strengthening health systems and pandemic preparedness, and the nutrition, welfare, and education of their citizens. Denmark, Norway, Ireland, Belgium, Sweden, Luxembourg, Austria, Portugal, Korea, and Sweden can transfer their Special Drawing Rights to the developing countries that desperately need them right now.
Take Climate Action NOW and fulfill the $100 billion per year promises made in the Paris Agreement.
Africa accounts for just 3-4 percent of global emissions, yet finds itself on the frontlines of the effects of climate change. Extreme temperatures and droughts, such as those in Somalia, threaten to make a mockery of our attempts to end extreme poverty and protect the planet. African countries and businesses stand ready to invest in green jobs and infrastructure, but they need genuine partnership to deliver.
Having not contributed to the problem, it is unjust to expect that Africa shifts to renewable and clean energy without support from the wealthiest countries, who have indeed industrialized using fossil fuels over the past 150 years. Rich countries like Germany, Italy, the US, Canada and Australia must fulfill the promise that was meant to be delivered by 2020 and close the annual $10 billion shortfall.
Empower Girls NOW and provide critical investments into girls' education, sexual and reproductive health and economic empowerment.
In the last two years, more than 47 million women and girls have been pushed back into extreme poverty, and the pandemic has forced millions of girls out of the classroom and into unpaid care work.
The US, UK, the European Commission, France, Germany and Italy can change this by pledging $600 million in financial support towards UNFPA, Education Cannot Wait and the Child Care Incentive Fund, launched this year by the White House. This will support new policies addressing the expansion of paid parental leave, including obligatory paternity leave, access to contraception and education.
Mitigate a Global Food System Meltdown NOW by providing $500 million for Africa's farmers to make the most of the current planting season and fund the local production of fertilizers, tools, and equipment they need to produce more food.
Africa is currently experiencing horrific food shortages as a result of Russia's unjust invasion of Ukraine. Yet the continent has enough arable land to feed the world, let alone its own citizens.
Germany, the UK, the European Commission, Denmark, Norway, Sweden and Belgium need to band together and provide funding to agencies like the International Fund for Agricultural Development (IFAD), the Global Agriculture and Food Security Program and CGIAR to urgently equip farmers with the resources they need. Failure to do so NOW will make the present hunger crisis far worse over the coming year, as food supplies diminish and prices soar even higher.
Throughout the campaign, Global Citizen will continue to defend and promote advocacy, ensuring marginalized voices are heard and leaders are held accountable to deliver on their promises. Global Citizen will elevate citizens' voices, especially from the Global South; defend the right of anyone to speak freely, dissent, and organize without fear of reprisals or violence; and call on corporations to refrain from using litigation to silence activists on the frontline. Without such efforts to champion the causes of those in peril, the achievement of our campaign goals will continue to be deprioritized by those in power.
The 2022 Global Citizen Festival campaign is supported by governments and world leaders including: Ursula von der Leyen, President of the European Commission; Mia Mottley, Prime Minister of Barbados; Nana Akufo-Addo, President of Ghana; Hakainde Hichilema, President of Zambia; Amina Mohammed, Deputy Secretary General of the United Nations; Dr. Natalia Kanem, Executive Director of UNFPA; Andrej Plenković, Prime Minister of Croatia; Pedro Sánchez, Prime Minister of Spain; Frank Bainimara, Prime Minister of Fiji; Ingrida Šimonytė, Prime Minister of Lithuania; Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization; Ban Ki-moon, Former UN Secretary General; Elizabeth Cousens, President and CEO of the UN Foundation; Nancy Pelosi, Speaker of the U.S. House of Representatives; Stanley Kakubo, Minister of Foreign Affairs, Zambia; Chuck Schumer, U.S. Senate Majority Leader; Meryame Kitir, Minister of Development Cooperation and Urban Policy, Belgium; Marcelo Ebrard Casaubon, Secretary of Foreign Affairs of Mexico; Anne Tvinnereim, Minister for International Development, Norway; Government of Luxembourg; Kingdom of the Netherlands; Peter Sands, Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria; Yasmine Sherif, Executive Director, Education Cannot Wait; Erna Solberg, Former Prime Minister of Norway; Linda Thomas-Greenfield, US Ambassador to the UN; Ertharin Cousin, Founder, Managing Director and CEO, Food Systems for the Future.
"Ghana is honoured to host this year's edition of the Global Citizens Festival. I look forward to welcoming each and everyone of you to Accra, capital of the country at the centre of the world. Together, let us join hands and help accelerate progress towards the realization of the SDGs. We owe to the next generation to live in a world free from poverty, disease and the degradation of the environment. The time to help make a change is now. We must align forces to make an impact in Africa, and help end extreme poverty. I have called colleague African leaders to join me in September, and help break these systemic barriers that have been affecting our people. Let us build a strong foundation for future generations." – H.E. Nana Akufo-Addo, President of Ghana
"While communities face injustices, crises and inequalities in the world, we simply cannot give up the fight and solidarity to end poverty. We need all voices in calling for a better future for everyone, everywhere. Now is the time for ambitious action. Together, with Global Citizen, we can keep the promise of the Sustainable Development Goals." — Amina Mohammed, United Nations Deputy Secretary General
"This year we have strongly felt the impacts of climate change across international conflicts, global health, and economic crisis, raising the level of inequality higher than before. However, together our mission is possible. It is more important than ever that the world comes together to demand action from global leaders with a unified voice, NOW. Global Citizens must champion political and financial solutions, like climate and agricultural adaptation, that center the most vulnerable members of our global community and plant the seeds for dignified and prosperous futures." – Ban Ki-moon, 8th Secretary-General of the United Nations & Ban Ki-moon Center for Global Citizens Co-chair
"All over the world we are seeing the ravaging effects of the climate crisis, and the disastrous results of political inaction – of not hearing or empowering the victims of poverty and disenfranchisement, of not allowing countries to work in collaboration to protect the global public good. NOW is the time for ordinary people to take action and fight, and for world leaders to listen and act, because their lives and livelihoods are at stake." — Mia Mottley, Prime Minister of Barbados
"An urgent, collective, and concerted effort is required to make progress toward ending extreme poverty. I am encouraged by the call to action issued by Global Citizen and I call upon leaders from around the world to add their voices, as we cannot afford to sit back and watch the status quo continue. It is time to break down the systemic barriers that have kept people in poverty and indeed, time to act to protect future generations from climate change." — Hakainde Hichilema, President of Zambia
"We live in perilously difficult times and it is our duty to fight hunger, poverty, discrimination, illness and effects of climate change. We need to pull together all our resources to ensure that the most vulnerable citizens can live in dignity and safety. I thus fully support the tireless efforts by Global Citizen to continue uniting us in this vital joint action." – Andrej Plenković, Prime Minister of Croatia
"The COVID-19 pandemic has shown that all countries must have equitable access to the tools and technologies needed to prepare for, prevent, detect and respond rapidly to outbreaks and other health emergencies. This is why the World Health Organization brought public and private partners together to launch the innovative mRNA Technology Transfer Hub based in South Africa, with more than a dozen low- and middle-income countries joining so far. I welcome Global Citizen's support for this crucial initiative to diversify and expand manufacturing of life-saving vaccines, so that the world is better prepared to prevent and respond more equitably to infectious diseases and the next pandemic threat." – Dr. Tedros Adhanom Ghebreyesus, Director-General, World Health Organization
The 2022 Global Citizen Festival and the End Extreme Poverty NOW campaign are supported by a coalition of the world's leading brands and companies including Global Partners Accenture, Cisco, Citi, Delta Air Lines, Harith General Partners, P&G, Verizon and YouTube. Global Citizen Festival: NYC Campaign Partner, World Wide Technology, has deepened their commitment to sustainability by signing the UN's Race to Zero in line with the Science Based Targets initiative, answering Global Citizen's call on corporations to make science-based targets.
As Patron of Global Citizen's work in Africa, Tshepo Mahloele, Founder & Executive, of Harith General Partners, supports Global Citizen's growth across Africa to reach more audiences and help achieve equity in places with high rates of extreme poverty. Global Citizen Festival: NYC is also honored to have the support of Mayor Adams, 110th Mayor of New York City.
Co-chairs of Global Citizen and of this campaign include: Julie Sweet, Chair and CEO of Accenture; Chuck Robbins, Chair and CEO of Cisco; Jane Fraser, CEO of Citi; Ed Bastian, CEO of Delta Air Lines; Lorraine Twohill, CMO of Google; Marc Pritchard, CBO of P&G; and Hans Vestberg, Chairman and CEO of Verizon. Global Citizen's co-chairs are private sector leaders making commitments in support of the UN's Global Goals. They support Global Citizen's campaigns while helping to drive deeper engagement within the private sector.
Policy partners supporting the campaign include: Action Against Hunger, ALLIED, BRAC, Ban Ki Moon Center for Global Citizens, Center for Environmental Peacebuilding, CGIAR, CIVICUS, charity: water, Conservation International, EarthRights, Education Cannot Wait, Focus 2030, Ford Foundation, Foreign Policy Community of Indonesia, Freedom House, Front Line Defenders, Fund for Global Human Rights, Gavi, The Vaccine Alliance, Gerando Falcões, The Global Fund to Fight AIDS, TB and Malaria, Global Health Advocates France, Legal Empowerment Fund, International Disability Alliance, IFAD, International Organization for Migration, International Rescue Committee, International Service for Human Rights, LISC, Namati, NPX, One Acre Fund, OutRight Action International, Pandemic Action Network, People's Vaccine Alliance, Peace Boat, Re:wild, Rotary International, Science Based Target initiative, Social Gastronomy Movement, UN Foundation, UNFPA, UN Joint SDG Fund, UN Office for the Coordination of Humanitarian Affairs, World Benchmarking Alliance, World Business Council for Sustainable Development, World Health Organization, and WHO Foundation.
Global Citizen Festival has gratefully received in-kind support from leading media companies, including: AIM GROUP, Bandsintown, BellaNaija, Billboard, Boo! Media, Branded Cities, Captivate, Clear Channel Outdoor, DDP Outdoor, Global OOH, GSTV, The Hollywood Reporter, iHeartRadio, Intersection, Interstate Outdoor, JC Decaux, MX, New Tradition, OAAA, Orange Barrel Media, Penske Media, Rolling Stone, Seen Media, Six Flags Theme Parks, Spotify, Variety, VIBE, Volta, The Wall Street Journal and YFM.
Tickets to the festivals are free and can be earned by downloading the Global Citizen app or visiting www.globalcitizen.org to take action on the campaign's issues. For each action taken, users earn points that can be redeemed for tickets to the festivals.
For more information about the 2022 Global Citizen Festival, visit www.globalcitizen.org, and follow @glblctzn on Instagram, Tik Tok, Twitter, and YouTube.
Press Kit:
Click here for artwork, press assets, quotes and social assets
Contact:
Global Citizen Inquiries: media@globalcitizen.org
Media and Credential Inquiries: Sunshine Sachs Morgan & Lylis for Global Citizen gc@sunshinesachs.com
View original content to download multimedia:
SOURCE Global Citizen
|
https://www.wibw.com/prnewswire/2022/08/11/global-citizen-announces-lineups-2022-global-citizen-festival-new-york-city-amp-accra-ghana-september-24/
| 2022-08-11T04:37:34Z
|
NEW YORK, May 13, 2022 /PRNewswire/ -- Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant shareholder of Global Cord Blood Corporation (the "Company" or "Global Cord") (NYSE: CO), today announced that the Grand Court of the Cayman Islands (the "Court") granted injunction order (the "Order") to stop Global Cord Blood's planned acquisition of Cellenkos, Inc. ("Cellenkos"). Blue Ocean's investment in Global Cord Blood represents an ownership position of approximately 65% of the Company's shares.
The injunction order was obtained on an ex parte basis. There will be a further hearing in respect of this Order on 24 May 2022 (the "Return Date"). Until after the Return Date or further Order of the Court, Global Cord must not
- take any steps, enter into any arrangements or close on the Material Definitive Agreement to acquire any shares in Cellenkos, Inc announced by the Company on 29 April 2022 (the "Transaction") or any ancillary or related transactions, pending the holding of an Extraordinary General Meeting at which approval of the Transaction is properly put to the Company's members (the ''EGM'') or the determination of the winding up petition dated 3 May 2022 (the "Petition");
- cause, whether by itself or otherwise, the issue, transfer, sale or other dealing with any of its shares, whether related or unrelated to the Transaction, pending the EGM or the determination of the Petition;
- distribute any funds or enter into any financial arrangement pursuant to in relation to the Transaction pending the EGM or the determination of the Petition;
- in any way dispose of, deal with, or diminishing the value of, any of the Company's assets in excess of US$1,000,000.00 in aggregate, without the approval of the Court, pending the EGM or the determination of the Petition.
Shareholders of Global Cord who wish to support the continuation of the Order and the Petition filed by Blue Ocean are encouraged to contact FTI Consulting to find out how they can register their support ahead of the hearing on the Return Date.
Blue Ocean firmly believes the transaction is not in the best interests of the Company or its shareholders due to the following reasons:
- No discernible long-term value at Cellenkos – no commercially marketable product pipeline.
- Unjustifiable purchase price – fundraising that occurred at the same time as the Company's valuation of Cellenkos indicated a fair value of US $28.67 per share, compared to the Company's valuation of Cellenkos of US $329.70 per share.
- Massive dilution of shareholders – existing shareholders will be diluted by over 50% as the consideration of the transaction involves both cash and a substantial equity stake in the Company.
- Conflicted governance in the transaction process – Cellenkos management is closely tied to the Company's Board, representing a significant conflict of interest.
- Total disregard for shareholder perspectives – the Company failed to consult with its key stakeholders prior to the announcement and refused to run an EGM to vote on the transaction.
To safeguard the best interests of all shareholders of the Company, Blue Ocean intends to take all possible steps to prevent the proposed acquisition, including endeavoring to convene an EGM to pass a special resolution to terminate the proposed acquisition. Blue Ocean urges any shareholders of the Company who share any concerns regarding the proposed acquisition to reach out immediately and join forces to protect all existing shareholders of the Company.
FTI Consulting
View original content:
SOURCE Blue Ocean Structure Investment Company Ltd.
|
https://www.kxii.com/prnewswire/2022/05/13/blue-ocean-successfully-applied-injunction-stop-global-cord-blood-acquiring-cellenkos-following-cayman-islands-court-ruling/
| 2022-05-13T19:51:17Z
|
VANCOUVER, BC, April 7, 2022 /PRNewswire/ - Zacatecas Silver Corp. ("Zacatecas" or the "Company", (TSXV: ZAC) (OTC: ZCTSF) (Frankfurt: 7TV) is pleased to report multiple silver and gold assays from ongoing diamond drilling at the Panuco North and Panuco Central Veins. The recent high-grade assay results at Panuco North, including 1.25m at 1440 g/t AgEq (1423.2 g/t Ag and 0.23 g/t Au), occur relatively close to surface while the vein remains open at depth and along strike.
- Angled diamond drilling at Panuco North targeted the down-dip strike extension of near surface mineralization reported by Zacatecas on the February 16, 2022.
- Panuco North results include:
- Drilling continues and more assay results are pending.
Dr. Chris Wilson, Chief Operating Officer and a Director of Zacatecas comments, "The most recent round of drilling in the south-eastern part of the Panuco North Vein has continued to intercept robust silver grades over down-hole widths of up to 5.96 metres. Although most holes targeted the down-dip extension of the near surface high grade silver mineralization intercepted in the initial scout drilling program, drilling has only tested the uppermost parts of the vein to a maximum downhole depth of 107 m (approximately 90 m vertical). Mineralization is open in all directions and depth potential is excellent."
Mineralization at Panuco North is of an intermediate sulphidation epithermal type, characterized by two main veins and several vein splays, with similar orientation to other silver-gold-base metal veins in the Zacatecas region. Vein textures, gangue mineralogy and metal signature of the near surface mineralization intercepted in drill holes at Panuco Central are consistent with the uppermost part or "top" of an intermediate sulphidation system (Figure 1). Similar veins at Zacatecas, and intermediate sulphidation deposits within the broader Mexican silver belt, and worldwide, have demonstrated vertical extents of between to 400 to >600 vertical metres. Mineralization at Panuco North has excellent depth potential and only the uppermost part of the south-eastern extension of the vein has been tested.
Dr. Wilson, further comments, "Mineralization at Panuco North has intercepted silver equivalent grades that are generally higher than the silver equivalent grade of the current Panuco resource estimate. Moreover, mineralization is being intercepted generally over wider widths. This is significant and further outlines the exploration potential of Panuco North."
Following the recent grant of 27 additional drill pads (see news release on March 23, 2022), Zacatecas will be able to test the depth extension of mineralization at south-eastern Panuco North over a strike length of 600 m, and to complete a maiden drill program along the central part of the Panuco North vein over a strike length of 1.4 km.
Assay results for six closely spaced holes (PAN 2022-026, 028, 029, 030, 032, and 033) drilled in the northwest of the Panuco North returned narrow zones of low-grade silver-gold mineralization. These holes tested shallow surface workings over a strike of 200 m strike to a maximum vertical depth of 60 m. Vein textures and metal signatures are consistent with the uppermost part of an intermediate sulphidation system. The vein has not been tested below these depths and remains open at depth.
At the Panuco Central Vein, seven angled diamond drill holes (totalling 1385 m) were drilled in the Panuco Central Vein system to test up-dip extension of mineralization included in the Panuco Resource Estimate. Results have been received for five holes and include 2.25 m @ 185 g/t Ag Eq (50 g/t Ag and 1.8 g/t Au) from 120.57 m downhole (Hole PAN2022-038) including: 0.49 m @ 545 g/t Ag Eq (156 g/t Ag and 5.18 g/t Au) from 120.57 m downhole; and 2.30 m @ 161 g/t Ag Eq (156 g/t Ag and 0.07 g/t Au) from 103.44 m downhole (Hole PAN2022-040).
The results of these holes are highly significant as the near surface (<150 m vertical) portion of the Panuco Central vein has never been tested above the current resource. Zacatecas is currently applying for additional drill pads to test the near surface extension of the entire Panuco Central Vein.
Additional drilling is required to determine true widths as all hole intercepted veins at an oblique angle. The assays are not capped. Assumptions used in USD for the silver equivalent calculation were metal prices of $24/oz silver, $1,800/oz gold and 100% recovery. At Panuco North drill holes PAN 2022-026, 028, 029, 030, 032 and 033 returned narrow zones of low-grade silver-gold mineralization and hole PAN 2022-027 did not encounter any significant mineralization. At Panuco central holes PAN 2022-036 and 037 returned narrow zones of low-grade silver-gold mineralization and holes PAN 2022-034 and 035 did not encounter any significant mineralization.
Zacatecas follows industry-recognized standards of Best Practice and Quality Assurance/Quality Control. Samples are submitted to ALS in batches of 20 — comprising 16 half cut core samples, one field blank, two certified reference material standards and one staged duplicate. Samples are sealed in plastic bags using single use tie-locks and delivered to ALS Zacatecas — thereby ensuring chain of custody. Since the ALS facility in Zacatecas is only a preparation facility, sample pulps were sent to ALS Ireland for fire assay. To date all batches have passed QAQC and blanks and CRM's were within acceptable tolerance limits. All diamond holes were drilled HQ diameter. Core recovery across all veins was better than 98%.
The contents of this news release have been reviewed and approved by Chris Wilson, B.Sc. (Hons), PhD, FAusIMM (CP), FSEG, Chief Operating Officer of Zacatecas. Dr. Wilson is a Qualified Person as defined by NI 43-101 and is responsible for all technical information in this news release.
The Zacatecas silver property is located in Zacatecas state, Mexico, within the highly prospective Fresnillo silver belt, which has produced over 6.2 billion ounces of silver. The company holds 7,826 hectares (19,338 acres) of ground that is highly prospective for low-sulphidation and intermediate-sulphidation silver base metal mineralization and potentially low-sulphidation gold-dominant mineralization. On December 15, 2021, Zacatecas announced a mineral resource estimate at the Panuco deposit consisting of 2.7 million tonnes at 187 grams per tonne (g/t) silver equivalent (AgEq) (171 g/t silver (Ag) and 0.17 g/t gold (Au)) for 16.4 million ounces AgEq (15 million ounces silver and 15,000 ounces gold).
The property is 25 kilometres (km) southeast of MAG Silver Corp.'s Juanicipio mine and Fresnillo PLC's Fresnillo mine. The property shares common boundaries with Pan American Silver Corp. claims and El Orito, which is owned by Endeavour Silver. There are four main high-grade silver target areas within the Zacatecas concessions: the Panuco deposit, Muleros, El Cristo and San Manuel-San Gill. The property also includes El Oro, El Orito, La Cantera, Monserrat, El Penon, San Judas and San Juan silver base metal vein targets. These targets are unexplored.
Additionally, Zacatecas has recently announced a transaction to acquire the Esperanza Gold Project from Alamos Gold Inc. Esperanza is an advanced stage, attractive low-cost, low-capital-intensity and low-technical-risk growth project located in Morelos state, Mexico. Alamos has progressed the project through advanced engineering, including metallurgical work, while also focusing on stakeholder engagement, including building community relations.
To date, significant core and reverse circulation drilling has occurred at the Esperanza gold project, resulting in a total of 389 drill holes for 69,716 metres. Four targets adjacent to or close to the historical resource were identified to potentially expand the historical resource. The project also hosts seven regional exploration targets, largely untested, that also merit drill testing.
Alamos reported in its most recent annual information form a resource estimate of a measured and indicated resource of 34,352,000 tonnes at 0.98 g/t gold and 8.09 g/t silver for 1,083,366 ounces of gold and 8,936,201 ounces of silver and inferred resource of 718,000 tonnes at 0.80 g/t gold and 15.04 g/t silver for 18,375 ounces of gold and 347,192 ounces of silver. The Company considers this to be an historical resource for the purposes of National Instrument 43-101. Resource blocks were defined using with dimensions of 10 metres (m) by 10 m by five m. The estimation of grades was performed with the ordinary kriging method on capped composites. An added step in the estimation strategy was the utilization of the dynamic anisotropy technique in Vulcan's unfolding options. This added capability allows for a more realistic outcome of the estimated grade's spatial distribution as it follows the folded shape of the deposit. Assumptions used in the resource include the following metal prices: gold price of $1,400 (U.S.) per ounce (oz) and silver price of $22 (U.S.) per oz. The resource assumed the following economic assumptions: recovery of 60.4 per cent at 0.2 g/t to 71.9 per cent at 1.6 g/t for gold, 25 per cent for silver, $2.60-per-tonne mining costs, 64-cents-per-tonne general and administrative costs, $4.20-per-tonne milling costs and a pit slope of 45 degrees. The Company considers the resource relevant due to its identification and modelling of the Esperanza deposit.
The Company has not done sufficient work to classify the resource as a current mineral resource or mineral reserves and the Company is not treating the historical estimate as current mineral resources or mineral reserves. Although the resource estimate is considered reliable, the Company will resample a portion of the drill core for the purpose of carrying out a new resource estimate. Furthermore, additional data verification, including resurveying of select diamond drill holes collars; review of graphic drill core logs, comparison of these logs with remaining half-cut core and a cross check of select geological logs agonist database entries; and a check of original assay certificates against the assays and drill hole database.
On behalf of the Company
Bryan Slusarchuk
Chief Executive Officer and Director
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Zacatecas cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by many material factors, many of which are beyond their respective control. Such factors include, among other things: risks and uncertainties relating to Zacatecas' limited operating history, its proposed exploration and development activities on is Zacatecas Properties and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Zacatecas does not undertake to publicly update or revise forward-looking information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE Zacatecas Silver Corp.
|
https://www.kxii.com/prnewswire/2022/04/07/zacatecas-reports-multiple-high-grade-silver-drill-intercepts-panuco-north-including-125m-1440-gt-ageq-hole-pan2022-042-435m-375-gt-ageq-hole-pan2022-44/
| 2022-04-07T09:29:47Z
|
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Attention Weber Inc. ("Weber") (NYSE: WEBR) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's August 2021 initial public offering.
If you suffered a loss on your investment in Weber, contact us about potential recovery by using the link below. There is no cost or obligation to you.
ABOUT THE ACTION: The class action against Weber includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) Weber was reasonably likely to implement price increases; (2) as a result, consumer demand for Weber's products was reasonably likely to decrease; (3) due to the resulting inventory buildup, Weber was reasonably likely to run promotions to "enhance retail sell through"; (4) the foregoing would adversely impact Weber's financial results; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
DEADLINE: September 27, 2022
Aggrieved Weber investors only have until September 27, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:
SOURCE The Law Offices of Vincent Wong
|
https://www.wibw.com/prnewswire/2022/09/12/class-action-alert-law-offices-vincent-wong-remind-weber-investors-lead-plaintiff-deadline-september-27-2022/
| 2022-09-12T11:10:34Z
|
LONDON, May 18, 2022 /PRNewswire/ -- Deteriorating global macroeconomic conditions, combined with heightened geopolitical uncertainty and lingering COVID-19 lockdowns in China, fuel persistently high inflation, market volatility, and rising yields, and pose an increasingly challenging outlook for credit, S&P Global Ratings said today in a report "Global Credit Conditions Special Update: Inflation, War, And COVID Drag On."
"For now, credit ratings are showing resilience as they benefit from still largely growing economies, consumption supported by household savings, and record corporate cash balances," said Alexandra Dimitrijevic, S&P Global Ratings Global Head of Analytical Research and Development. "Rating actions globally in April and May were balanced, outside of countries directly impacted by the conflict, and the net outlook bias, which speaks to forward-looking rating trends, remains close to neutral. The distress ratio for U.S. speculative-grade borrowers, an indicator of future default trends, is increasing but remains well below the five-year average."
"Credit ratings could come under more pressure if the situation persists for more than one or two quarters, or deteriorates further, as households struggle with falling real incomes and rising energy and food prices, businesses face weaker demand conditions and margin erosion, and financing conditions ratchet tighter. Defaults could start picking up toward the end of the year as we get into 2023."
Our interim credit conditions update follows S&P Global economists' downward revisions to global macroeconomic base-case forecasts, reflecting that key forecast assumptions are likely to play out over a longer period and be more damaging than we previously expected. The conflict between Russia and Ukraine and growing tensions with NATO are more protracted than expected. Inflation remains stubbornly high, fueled by food and rising commodity prices. The Chinese authorities are continuing to lock down major cities and regions to stem COVID-19. And the U.S. Federal Reserve and other major central banks are ramping up their fight to rein in inflation pressures.
From a credit perspective, this represents a wind shift as credit prospects become more challenging. While widespread concerns relating to recessionary scenarios in advanced economies have not been realized so far, they are a growing downside risk for later in the year and into 2023, particularly if the war in Ukraine drags on and escalates, or the authorities struggle to contain the pandemic in China. The Fed is also treading a fine line in reining back inflation without destabilizing financial markets, undermining confidence, or triggering a hard landing for the economy.
This report does not constitute a rating action.
Media Contacts:
Michelle James, London +44 (0)7971 123 692
michelle.james@spglobal.com
S&P Global Ratings is the world's leading provider of independent credit ratings. Our ratings are essential to driving growth, providing transparency and helping educate market participants so they can make decisions with confidence. We have more than 1 million credit ratings outstanding on government, corporate, financial sector and structured finance entities and securities. We offer an independent view of the market built on a unique combination of broad perspective and local insight. We provide our opinions and research about relative credit risk; market participants gain independent information to help support the growth of transparent, liquid debt markets worldwide.
S&P Global Ratings is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies and governments to make decisions with confidence. For more information, visit www.spglobal.com/ratings.
View original content to download multimedia:
SOURCE S&P Global
|
https://www.wibw.com/prnewswire/2022/05/18/inflation-war-covid-drag-global-credit-conditions-report-says/
| 2022-05-18T17:10:18Z
|
As one of America's Fastest-Growing Companies, Itasca keeps momentum from prior years.
WEST DES MOINES, Iowa, Aug. 17, 2022 /PRNewswire/ -- Itasca Retail is pleased to be recognized for the 3rd consecutive year and 4th time overall for its outstanding performance in the past year. The list of honorees represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segment—its independent businesses. The companies on the 2022 list have not only been successful, but have demonstrated resilience amid supply chain woes, labor shortages and ongoing COVID-19 challenges.
"To be honored once again by Inc. 5000 magnifies the hard work our team members and partners have put into ensuring the continued success of our valued customers," said Itasca President, Jeff Kennedy. "We are so grateful to our growing family of grocery retailers, who have been instrumental in our achievements over the years and look forward to servicing them and others for many years to come."
The software uses historical sales data along with current shelf and selling conditions to calculate the exact right order amounts for tens of thousands of items at any time of the day. Pairing this with state-of-the art DSD receiving functionality ensures each store always has the right stock levels to fulfill shopper demand. The system combines sophisticated algorithms and machine learning along with deep understanding of the North American grocery replenishment process to generate impressive gains in sales and productivity, while reducing inventory, food waste and labor.
"The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated," says Scott Omelianuk, editor-in-chief of Inc. "Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today."
Itasca Retail is a leading provider of inventory technology that enables grocers to become more efficient as retailers. Our customers use the Itasca platform to optimize sales, reduce waste, and meet challenges in adapting to changing consumer shopping habits, labor shortages, and new supply-chain trends. Itasca's growing family of retailers include Wegmans, Sobeys, PriceChopper/Market 32, Tops Markets, Raley's, Weis Markets, Lunds & Byerlys, Cardenas Markets, Brookshire Brothers, and Kroger. For more information, visit us at https://www.itasca-retail.com/.
Media Contacts:
Itasca Retail
West Des Moines, IA
Jason Wirl
jwirl@itasca-retail.com
208-863-2603
View original content to download multimedia:
SOURCE Itasca Retail
|
https://www.wibw.com/prnewswire/2022/08/17/itasca-retail-makes-inc-5000-list-4th-time/
| 2022-08-17T13:44:59Z
|
WASHINGTON (AP) — A man armed with a machete once broke into Stephen Breyer’s vacation home in the Caribbean and took $1,000. Ruth Bader Ginsburg had her purse snatched on a Washington street. David Souter was assaulted by several men while he was jogging.
Supreme Court justices have not been immune to violent crime. But this past week’s late-night incident at Justice Brett Kavanaugh’s suburban Washington home, where authorities said a man armed with a gun and knife threatened to kill the justice, reflects a heightened level of potential danger not just for members of the nation’s highest court, but all judges.
One proposal pending in Congress would provide additional security measures for the justices, and another would offer more privacy and protection for all federal judges.
Round-the-clock security given to the justices after the leak of the draft opinion in a major abortion case may well have averted a tragedy.
But the situation had much in common with other recent incidents that ended with the shooting death of a former judge in Wisconsin last week and the killing in 2020 of the son of a federal judge at their home in New Jersey. Troubled men, harboring a warped desire for vengeance and equipped with guns, turned their threats into action.
“We’re seeing these threats increase in number and intensity. That’s a sign. That’s a signal,” said U.S. District Judge Esther Salas, whose son was killed nearly two years ago in the attack that also wounded her husband.
Kavanaugh’s would-be attacker is Nicholas John Roske, 26, of Simi Valley, California, authorities said in charging him with the attempted murder of a justice. Clad in black, he arrived by taxi outside Kavanaugh’s Maryland home around 1 a.m. Wednesday.
He spotted two U.S. Marshals who were guarding the house and walked in the other direction, calling 911 to say he was having suicidal thoughts and also planned to kill Kavanaugh, according to court documents. Roske said he found the justice’s address on the internet.
When police searched a backpack and suitcase he was carrying, they said they found a Glock 17 pistol, ammunition, a knife, zip ties, duct tape and other items Roske said he was going to use to break into the house. He said he bought the gun to kill Kavanaugh.
Roske told police he was upset by the leaked draft opinion in the abortion case and by the school shooting in Uvalde, Texas, and believed Kavanaugh would vote to loosen gun control laws, according to documents filed in federal court in Maryland.
Last week, Wisconsin authorities said Douglas Uhde, 56, shot John Roemer, a former county judge, in a targeted attack against a judge who had once sentenced him to prison. Roemer was found zip-tied to a chair. Uhde had shot himself and later died.
In July 2020, lawyer Roy Den Hollander showed up at Judge Salas’ home posing as a FedEx delivery person. Den Hollander fatally shot Salas’ 20-year-old son, Daniel Anderl, and wounded her husband, Mark Anderl. The judge was in another part of the home at the time and was not injured.
Den Hollander, 72, was a men’s rights lawyer with a history of anti-feminist writings. He was found dead of a self-inflicted gunshot wound the day after the ambush, when police said they found a document with information about a dozen female judges from across the country, half of whom are Latina, including Salas.
Authorities believe Den Hollander also was tracking Supreme Court Justice Sonia Sotomayor, Salas said in a televised interview last year, because they found a manila folder with information about Sotomayor when they searched a locker belonging to Den Hollander.
Over the years, Supreme Court justices have called on Congress to provide more money for their security. But at the same time, the justices often shrugged off protection when it was offered. When Justice Antonin Scalia died on a hunting trip in Texas in 2016, for example, he did not have a security detail with him.
In recent years, the court has stepped up security for the justices. The court routinely refuses to discuss protection for the nine justices, but Justice Amy Coney Barrett said earlier this year that she was not prepared for how much more extensive security is now than when she worked for Scalia in the late 1990s.
Sotomayor likes to walk among guests at her public appearances, often joking about the armed officers who are there to protect her. “The guys up here. The big guys with stuff around their waist and things. They’re here to protect you from me,” she said to laughter at an event this year. “They get nervous if you get up unexpectedly. … Please don’t make them nervous.”
House Speaker Nancy Pelosi, D-Calif., said Thursday that the House would take up a bill with bipartisan support that already has passed the Senate that would expand protection to the members of the justices’ immediate families.
Gabe Roth of the court reform group Fix the Court said in his view the justices “need Secret Service-level protection, which has only become more obvious this week. I’ve said it for years.”
A separate bill, named in memory of Salas’ son, would provide more privacy and protections for all federal judges, including scrubbing personal information from the internet, to deal with mounting cyberthreats. The U.S. Marshals Service, which protects about 2,700 federal judges and thousands more prosecutors and court officials, said there were 4,511 threats and inappropriate communications in 2021, compared with 926 such incidents in 2015.
The legislation, also widely supported by lawmakers in both parties, has been blocked by Sen. Rand Paul, R-Ky., who wants it to apply to members of Congress as well.
Sen. Bob Menendez, D-N.J., the bill’s author, said the Kavanaugh incident and Roemer’s death in Wisconsin make plain the need for the legislation. “Our bill is the only existing proposal to protect the personal information of judges and their families,” Menendez said in an email.
A similar bill in the House has not even gotten a hearing.
“We talk a lot about what can be done. How about we stop arming the public with information they are using to kill us? How about we do that?” Salas said Friday in an interview with The Associated Press.
The internet has made it much easier to find personal information pertaining to judges, and everyone else.
But even before the digital age, judges were sometimes the targets of people who harbored grudges about their treatment in the criminal justice system. In a book, retired Texas Judge Susan P. Baker details 42 judges, including three at the federal level, who were murdered or otherwise met suspicious ends in the 20th century.
In the past 17 years, three close relatives of federal judges have been killed in attacks at the judges’ homes, including Salas’ son. In 2005, U.S. District Judge Joan Lefkow returned from work to find her husband and mother shot dead in the basement of her Chicago home. The killer was a homeless electrician who had lost a medical malpractice suit in her courtroom.
U.S. District Judge Roslynn R. Mauskopf, who heads the office responsible for federal courts administration, said the incident at Kavanaugh’s house is just the most recent reminder that “threats against judges are real and they can have and have had dire consequences.”
|
https://cw33.com/news/politics/ap-politics/kavanaugh-incident-could-lead-to-more-security-for-judges/
| 2022-06-11T20:43:43Z
|
High school senior signs letter of intent, but not for sports or academics
MONTGOMERY COUNTY, Ky. (WKYT/Gray News) – A high school senior in Kentucky signed a unique letter of intent this week -- a plumbing company.
With that signature, Jacob Bradley has a full-time job lined up for him after graduating from Montgomery County High School.
“His dad and I are just over the moon,” his mother Angie Bradley told WKYT. “Actually, he’s a great kid and we are very lucky.”
Jacob gained plumbing experience at Fast Flow through a co-op program offered at his school.
“It’s just more of my style,” Bradley said. “I was never really wanting to be an accountant or sit down. I enjoy working with my hands a lot and just the environment and those types of people.”
Trade workers are in high demand across the country, so schools are adopting co-op programs to show students the options available.
Many community colleges partner with high schools to get kids interested and prepared for a future career.
“This is something that we have done several times for our athletes who are attending college upon graduation, but this is something new here at Montgomery County High School, but I hope that this will continue,” said Lacy Gross, a counselor at Montgomery County High School.
Copyright 2022 WKYT via Gray Media Group, Inc. All rights reserved.
|
https://www.wibw.com/2022/05/19/high-school-senior-signs-letter-intent-not-sports-or-academics/
| 2022-05-19T17:29:06Z
|
NEW YORK, June 27, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Natera, Inc. ("Natera" or the "Company") (NASDAQ: NTRA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Natera and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On January 1, 2022, The New York Times published a detailed report calling into question the accuracy of certain prenatal tests manufactured by Natera and other diagnostic testing companies. Among other things, The New York Times reported that Natera's positive results for several genetic disorders were incorrect more than 80 percent of the time.
On this news, the price of Natera common stock fell $5.35 per share, or approximately 6% over two trading days, from a close of $93.39 per share on December 31, 2021, to close at $88.04 per share on January 4, 2022.
Less than two weeks later, on January 14, 2022, the Campaign for Accountability— a nonprofit watchdog group—filed a complaint with the U.S. Securities and Exchange Commission requesting an investigation as to whether "Natera repeatedly claimed – in marketing materials and earnings calls – that [its] tests are much more reliable than it appears they really are."
On this news, the price of Natera common stock fell $6.29 per share, or more than 9%, from a close of $67.37 per share on January 14, 2022, to close at $61.08 per share on January 18, 2022.
Then, on March 9, 2022, Hindenburg Research ("Hindenburg") issued an investigative report (the "Hindenburg Report") alleging, among other things, that "Natera's revenue growth has been fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers."
On this news, the price of Natera common stock fell as much as $28.65 per share, or more than 52%, from a close of $54.75 per share on March 8, 2022, to an intra-day low of $26.10 per share on March 9, 2022.
On March 14, 2022, a jury found that Natera had intentionally and willfully misled the public by utilizing false advertisements to market Prospera in violation of the federal Lanham Act, the Delaware Deceptive Trade Practices Act, and Delaware common law. Among other things, the jury found that Natera's marketing falsely claimed that Prospera was more accurate than the competing kidney transplant testing offered by CareDx, Inc. ("CareDx"). Ultimately, the jury awarded CareDx $44.9 million in monetary damages.
On this news, Natera common stock fell as much as $8.81 per share, or approximately 22.5%, from an intra-day high of $39.13 per share on March 14, 2022, to close at $30.32 per share on March 15, 2022.
On April 19, 2022, the U.S. Food and Drug Administration ("FDA") issued a safety communication "to educate patients and health care providers and to help reduce the inappropriate use of" non-invasive prenatal tests ("NIPTs"). The FDA cautioned that statements about NIPTs' reliability and accuracy "may not be supported with sound scientific evidence" and revealed the existence of "cases where a screening test reported a genetic abnormality and a confirmatory diagnostic test later found that the fetus was healthy." The FDA suggested that patients discuss benefits and risks with a healthcare provider before deciding to undergo NIPT or making any pregnancy-related decisions on the basis of NIPT results. In addition, the FDA advised health care providers that they should not rely on NIPT results alone to diagnose chromosomal abnormalities or disorders.
On this news, the price of Natera common stock fell as much as $1.53 per share, or approximately 3.9%, from an intra-day high of $39.63 per share on April 19, 2022, to close at $38.10 per share on April 20, 2022.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980
View original content to download multimedia:
SOURCE Pomerantz LLP
|
https://www.kxii.com/prnewswire/2022/06/28/shareholder-alert-filing-deadline-today-pomerantz-law-firm-investigates-claims-behalf-investors-natera-inc-ntra/
| 2022-06-28T02:47:11Z
|
DETROIT (AP) — Two crashes involving Teslas apparently running on Autopilot are drawing scrutiny from federal regulators and point to a potential new hazard on U.S. freeways: The partially automated vehicles may not stop for motorcycles.
The National Highway Traffic Safety Administration sent investigation teams to two crashes last month in which Teslas collided with motorcycles on freeways in the darkness. Both were fatal.
The agency suspects that Tesla’s partially automated driver-assist system was in use in each. The agency says that once it gathers more information, it may include the crashes in an broader probe of Teslas striking emergency vehicles parked along freeways. NHTSA also is investigating over 750 complaints that Teslas can brake for no reason.
The first crash involving a motorcyclist happened at 4:47 a.m. July 7 on State Route 91, a freeway in Riverside, California. A white Tesla Model Y SUV was traveling east in the high occupancy vehicle lane. Ahead of it was a rider on a green Yamaha V-Star motorcycle, the California Highway Patrol said in a statement.
At some point, the vehicles collided, and the unidentified motorcyclist was ejected from the Yamaha. He was pronounced dead at the scene by the Fire Department.
Whether or not the Tesla was operating on Autopilot remains under investigation, a CHP spokesman said.
The second crash happened about 1:09 a.m. July 24 on Interstate 15 near Draper, Utah. A Tesla Model 3 sedan was behind a Harley-Davidson motorcycle, also in an HOV lane. “The driver of the Tesla did not see the motorcyclist and collided with the back of the motorcycle, which threw the rider from the bike,” the Utah Department of Public Safety said in a prepared statement.
The rider, identified as Landon Embry, 34, of Orem, Utah, died at the scene. The Tesla driver told authorities that he had the vehicle’s Autopilot setting on, the statement said.
Michael Brooks, acting executive director of the nonprofit Center for Auto Safety, called on NHTSA to recall Tesla’s Autopilot because it is not recognizing motorcyclists, emergency vehicles or pedestrians.
“It’s pretty clear to me, and it should be to a lot of Tesla owners by now, this stuff isn’t working properly and it’s not going to live up to the expectations, and it is putting innocent peole in danger on the roads,” Brooks said.
Since 2016, NHTSA has sent teams to 39 crashes in which automated driving systems are suspected of being in use, according to agency documents. Of those, 30 involved Teslas, including crashes that caused 19 deaths.
Brooks criticized the agency for continuing to investigate but not taking action. “What the Hell are they doing while these crashes continue to occur?” he asked. “Drivers are being lured into thinking this protects them and others on the roads, and it’s just not working.”
Musk has eliminated use of radar from his systems and relies solely on cameras and computer memory. Brooks and other safety advocates say the lack of radar hurts vision in the darkness.
Messages were left seeking comment from Tesla, which has disbanded its media relations department.
Tesla has said that Autopilot and “Full Self-Driving” cannot drive themselves, and that drivers should be ready to intervene at all times.
In a June interview, new NHTSA Administrator Steven Cliff said the agency is intensifying efforts to understand risks posed by automated vehicles so it can decide what regulations may be necessary to protect drivers, passengers and pedestrians. There are no federal regulations that directly cover either self-driving vehicles or those with partially automated driver-assist systems such as Autopilot.
The agency also says the technology holds great promise of reducing traffic crashes.
NHTSA also has ordered all automakers and tech companies with automated driving systems to report all crashes. The agency released the first batch of data in June showing that nearly 400 crashes were reported over a 10-month period, including 273 with Teslas. But it cautioned against making comparisons, saying that Tesla’s telematics allow it to gather data in real time, much faster than other companies.
Tesla’s Autopilot keeps cars in their lane and a distance behind other vehciles. The company also is using selected owners to test “Full Self-Driving” software, which is designed to complete a route on its own with human supervision. Eventually, Tesla CEO Elon Musk says the cars will drive themselves, enabling a fleet of autonomous robotaxis that will boost Tesla’s earnings. In 2019, Musk had pledged to have the robo-taxis running in 2020.
He said at the company’s annual shareholders’ meeting Thursday that “Full Self-Driving” is greatly improved, and he expects to make the software available by the end of the year to all owners who request it.
_______
AP News Researcher Rhonda Shafner in New York and writer Stefanie Dazio in Los Angeles contributed to this report.
|
https://cw33.com/technology/ap-technology/us-agency-probes-tesla-crashes-that-killed-2-motorcyclists/
| 2022-08-05T20:29:36Z
|
Parents of child who died from fentanyl charged with murder
SANTA ROSA, Calif. (AP) - Prosecutors in Northern California have filed murder charges against the parents of a 15-month-old who died in May after she ingested fentanyl authorities believe her mother had been using.
The Press Democrat reports that prosecutors on Thursday also charged 26-year-old Evan Frostick and 23-year-old Madison Bernard with child cruelty and alleged their actions willfully caused the suffering of a child.
Investigators believe 15-month-old Charlotte Frostick ingested the fentanyl by touching it and possibly putting her hands in her mouth or eyes.
The Sonoma County Coroner’s Office determined last month that “acute fentanyl intoxication” caused her death, The Associated Press reports.
According to the coroner’s report, Bernard used fentanyl and went to sleep while drugs and paraphernalia were on the bed she shared with Charlotte inside their apartment.
Frostick is being represented by the Sonoma County Public Defender’s office. They didn’t immediately returned a message seeking comment Friday.
It was not immediately known if Bernard has an attorney who can speak on her behalf.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.mysuncoast.com/2022/08/07/parents-child-who-died-fentanyl-charged-with-murder/
| 2022-08-07T06:36:14Z
|
NEW YORK, June 29, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Teladoc Health, Inc..
Shareholders who purchased shares of TDOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: October 28, 2021 to April 27, 2022
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) increased competition, among other factors, was negatively impacting Teladoc's BetterHelp and chronic care businesses; (ii) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, Teladoc's revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (iv) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: August 5, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/teladoc-health-inc-loss-submission-form/?id=29287&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TDOC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 5, 2022. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content:
SOURCE The Gross Law Firm
|
https://www.mysuncoast.com/prnewswire/2022/06/29/shareholder-alert-gross-law-firm-notifies-shareholders-teladoc-health-inc-class-action-lawsuit-lead-plaintiff-deadline-august-5-2022-nyse-tdoc/
| 2022-06-29T17:20:49Z
|
Fifth consecutive annual dividend increase
HARTFORD, Conn., Aug. 18, 2022 /PRNewswire/ -- Virtus Investment Partners, Inc. (NASDAQ: VRTS), which operates a multi-manager asset management business, today announced that its Board of Directors has approved a quarterly common stock cash dividend of $1.65 per share. This is the company's fifth consecutive annual increase of its quarterly dividend and represents a 10% increase from the previous quarterly dividend of $1.50 per share.
"This increase in our dividend reflects the strength of our balance sheet and free cash flow generation," said George R. Aylward, president and chief executive officer. "We are committed to delivering value to our shareholders by balancing our capital priorities of investing in growth, returning capital, and maintaining an appropriate level of leverage."
The third quarter 2022 common stock dividend will be paid on November 15, 2022 to shareholders of record at the close of business on October 31, 2022.
Future declarations of dividends will be subject to the approval of the Board of Directors.
Virtus Investment Partners (NASDAQ: VRTS) is a distinctive partnership of boutique investment managers singularly committed to the long-term success of individual and institutional investors. We provide investment management products and services from our affiliated managers, each with a distinct investment style and autonomous investment process, as well as select subadvisers. Investment solutions are available across multiple disciplines and product types to meet a wide array of investor needs. Additional information about our firm, investment partners, and strategies is available at virtus.com.
This press release contains statements that are, or may be considered to be, forward-looking statements. All statements that are not historical facts, including statements about our beliefs or expectations, are "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may be identified by such forward-looking terminology as "expect," "estimate," "plan," "intend," "believe," "anticipate," "may," "will," "should," "could," "continue," "project," or similar statements or variations of such terms. Our forward-looking statements are based on a series of expectations, assumptions and projections about our company, are not guarantees of future results or performance, and involve substantial risks and uncertainty, including assumptions and projections concerning our assets under management, cash inflows and outflows, operating cash flows, our ability to expand distribution and product offerings, and future credit facilities, for all forward periods. All of our forward-looking statements are as of the date of this release only. The company can give no assurance that such expectations or forward-looking statements will prove to be correct. Actual results may differ materially.
View original content to download multimedia:
SOURCE Virtus Investment Partners, Inc.
|
https://www.kxii.com/prnewswire/2022/08/18/virtus-investment-partners-increases-quarterly-common-stock-dividend-10-165-per-share/
| 2022-08-18T11:52:45Z
|
LAS VEGAS, April 19, 2022 /PRNewswire/ -- Southwest Gas Holdings, Inc. (NYSE: SWX) ("Southwest Gas" or the "Company") today issued the following statement commenting on an open letter to Southwest Gas stockholders published by Carl Icahn on April 19, 2022.
Our one and only objective is to maximize value for stockholders by expeditiously conducting a review of strategic alternatives. As we stated in our press release, Mr. Icahn is welcome to be part of the sale process and we are confident that he will realize that this is a competitive process, overseen by a committee of independent directors, in which the only "preferred buyer" cited by Mr. Icahn will be the party that provides the best value for stockholders.
On April 18, 2022, Southwest Gas announced that, as a result of the receipt of an indication of interest well in excess of Carl Icahn's $82.50 per share offer, the Southwest Gas Board has authorized the review of a full range of strategic alternatives to maximize stockholder value.
Lazard is serving as financial advisor to Southwest Gas and Morrison & Foerster LLP and Cravath, Swaine & Moore LLP are serving as legal advisors.
Southwest Gas Holdings, Inc., through its subsidiaries, engages in the business of purchasing, distributing and transporting natural gas, and providing comprehensive utility infrastructure services across North America. Southwest Gas Corporation, a wholly owned subsidiary, safely and reliably delivers natural gas to over two million customers in Arizona, California and Nevada. The Company's MountainWest subsidiary provides natural gas storage and interstate pipeline services within the Rocky Mountain region. Centuri Group, Inc., a wholly owned subsidiary, is a strategic infrastructure services company that partners with regulated utilities to build and maintain the energy network that powers millions of homes and businesses across the United States and Canada.
This communication does not constitute a solicitation of any vote or approval in connection with the 2022 annual meeting of stockholders of Southwest Gas Holdings, Inc. (the "Company") (the "Annual Meeting"), scheduled to be held May 12, 2022. In connection with the Annual Meeting, the Company has filed a definitive proxy statement with the U.S. Securities and Exchange Commission ("SEC"), which the Company has furnished to its stockholders in connection with the Annual Meeting. The Company may furnish additional materials in connection with the Annual Meeting. BEFORE MAKING ANY VOTING DECISION, WE URGE STOCKHOLDERS TO READ THE PROXY STATEMENT (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND WHITE PROXY CARD AND OTHER DOCUMENTS WHEN SUCH INFORMATION IS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE ANNUAL MEETING. The proposals for the Annual Meeting are being made solely through the definitive proxy statement. In addition, a copy of the definitive proxy statement may be obtained free of charge from www.swgasholdings.com/proxymaterials. Security holders also may obtain, free of charge, copies of the proxy statement and any other documents filed by Company with the SEC in connection with the Annual Meeting at the SEC's website at http://www.sec.gov, and at the Company's website at www.swgasholdings.com.
Important Information for Investors and Stockholders: This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. In response to the tender offer for the shares of the Company commenced by IEP Utility Holdings LLC and Icahn Enterprises Holdings L.P., the Company has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC. INVESTORS AND STOCKHOLDERS OF SOUTHWEST GAS HOLDINGS ARE URGED TO READ THE SOLICITATION/RECOMMENDATION STATEMENT AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and stockholders may obtain a free copy of these documents free of charge at the SEC's website at www.sec.gov, and at the Company's website at www.swgasholdings.com. In addition, copies of these materials may be requested from the Company's information agent, Innisfree M&A Incorporated, toll-free at (877) 825-8621.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, without limitation, statements regarding Southwest Gas Holdings, Inc. (the "Company") and the Company's expectations or intentions regarding the future. These forward-looking statements can often be identified by the use of words such as "will", "predict", "continue", "forecast", "expect", "believe", "anticipate", "outlook", "could", "target", "project", "intend", "plan", "seek", "estimate", "should", "may" and "assume", as well as variations of such words and similar expressions referring to the future, and include (without limitation) statements regarding expectations with respect to a separation of Centuri, the future performance of Centuri, Southwest Gas's dividend ratios and Southwest Gas's future performance. A number of important factors affecting the business and financial results of the Company could cause actual results to differ materially from those stated in the forward-looking statements. These factors include, but are not limited to, the timing and amount of rate relief, changes in rate design, customer growth rates, the effects of regulation/deregulation, tax reform and related regulatory decisions, the impacts of construction activity at Centuri, whether we will separate Centuri within the anticipated timeframe and the impact to our results of operations and financial position from the separation, the potential for, and the impact of, a credit rating downgrade, the costs to integrate MountainWest, future earnings trends, inflation, sufficiency of labor markets and similar resources, seasonal patterns, the cost and management attention of ongoing litigation that the Company is currently engaged in, the effects of the pending tender offer and proxy contest brought by Carl Icahn and his affiliates, and the impacts of stock market volatility. In addition, the Company can provide no assurance that its discussions about future operating margin, operating income, COLI earnings, interest expense, and capital expenditures of the natural gas distribution segment will occur. Likewise, the Company can provide no assurance that discussions regarding utility infrastructure services segment revenues, EBITDA as a percentage of revenue, and interest expense will transpire, nor assurance regarding acquisitions or their impacts, including management's plans or expectations related thereto, including with regard to Riggs Distler or MountainWest. Factors that could cause actual results to differ also include (without limitation) those discussed under the heading "Risk Factors" in the Company's most recent Annual Report on Form 10-K and in the Company's and Southwest Gas Corporation's current and periodic reports, including our Quarterly Reports on Form 10-Q, filed from time to time with the SEC. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its Web site or otherwise. The Company does not assume any obligation to update the forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.
Participants in the Solicitation: The directors and officers of the Company may be deemed to be participants in the solicitation of proxies in connection with the Annual Meeting. Information regarding the Company's directors and officers and their respective interests in the Company by security holdings or otherwise is available in its most recent Annual Report on Form 10-K filed with the SEC and the definitive Proxy Statement on Schedule 14A filed with the SEC in connection with the Annual Meeting. Additional information regarding the interests of such potential participants is included in other relevant materials filed with the SEC.
Contacts
For investor information, contact: Boyd Nelson, (702) 876-7237, boyd.nelson@swgas.com; or Innisfree M&A Incorporated, Scott Winter/Jennifer Shotwell/Jon Salzberger, (212) 750-5833.
For media information, contact: Sean Corbett, (702) 876-7219, sean.corbett@swgas.com; or Joele Frank, Wilkinson Brimmer Katcher, Dan Katcher / Tim Lynch, (212) 355-4449.
View original content:
SOURCE Southwest Gas Holdings, Inc.
|
https://www.wibw.com/prnewswire/2022/04/19/southwest-gas-issues-statement-reiterating-objective-strategic-alternatives-process-maximize-value-stockholders/
| 2022-04-19T16:56:05Z
|
Security tightens at the Baseball World Cup
Published: Sep. 10, 2022 at 11:57 PM EDT|Updated: 37 minutes ago
SARASOTA, Fla. (WWSB) - The 18 and under baseball world cup is underway, and security is a top concern.
The event takes place at LECOM Park in Bradenton and Ed Smith Stadium in Sarasota. Players and fans from around the globe have traveled to the Suncoast for the event.
Local law enforcement, security guards, and stadium personnel are on hand to ensure the experience is safe and fun for everyone involved.
Spencer Latimer, a fan of Team Canada stated, “I feel safe, they drop our bags and put our phones in before we walked through the metal detector. It was good”.
Fifty games will be played over the course of nine days.
Copyright 2022 WWSB. All rights reserved.
|
https://www.mysuncoast.com/2022/09/11/security-tightens-baseball-world-cup/
| 2022-09-11T04:36:33Z
|
DALLAS (KDAF) — Who’s up for an early morning sugar rush? Inside DFW is going to take you on a trip to the sweetest place in Texas and maybe even on earth!
It’s always a celebration over at the Sugar Factory and as you may know it’s iconic and everyone loves it from the locals to visiting celebrities. Inside DFW went to find out why.
“With more than a decade serving up decadent sweets and treats around the world, we are so excited to bring our fun, high energy brand to the state of Texas. Sugar Factory’s food, drinks and atmosphere offers entertainment for guests of all ages, making Uptown Dallas’s family-friendly community a perfect fit,” shares partner Larry Rudolph. “From our larger-than-life goblets, to our photo op walls and our friendly staff, every element of Sugar Factory American Brasserie Dallas is designed to give guests a one-of-a-kind, Instagrammable and interactive experience.”
They’ve got everything from appetizers, soups and salads, sandwiches, monster burgers, pastas, sides and more. Oh, and of course, they’ve got an insane array of sugar, sugar and more sugar.
- Old Fashioned Milkshakes
- Insane Milkshakes
- A full dessert menu
- Sundaes to share
- Hot chocolate
- Last but not least their larger than life cocktail goblets
The Dallas location opened up to the public in the fall of 2021, “The family-friendly, high-energy, celebration destination known for its sweets and treats will be located in Uptown Dallas at 1900 Cedar Springs Road. The world-famous restaurant promises a memorable experience for kids, adults and everyone in between.”
|
https://cw33.com/lifestyle/inside-dfw/inside-look-at-the-hype-around-dallas-sugar-factory/
| 2022-05-12T22:04:24Z
|
- Actively enrolling participants in our Phase 2/3 clinical trial for the potential treatment of progressive NF2-mutated meningiomas
- On track to initiate our Phase 2 clinical trial for the potential treatment of FAP in the third quarter of 2022
- U.S. FDA granted Recursion Fast Track designation and the European Commission granted Recursion Orphan Drug Designation for REC-4881 for the potential treatment of FAP
- On track to initiate our Phase 1 clinical trial for the potential treatment of Clostridium difficile colitis in the second half of 2022
SALT LAKE CITY, Aug. 9, 2022 /PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business updates and financial results for its second quarter ending June 30, 2022.
"Recursion continues to make progress in advancing its clinical programs, including initiating a Phase 2 trial for NF2-mutated meningiomas and receiving U.S. FDA Fast Track and European Commission Orphan Drug designations for REC-4881 for the potential treatment of FAP," said Chris Gibson, Ph.D., Co-Founder & CEO at Recursion. "In the context of continued capital markets friction we are increasingly focusing our pipeline around rapidly deliverable oncology programs. We also continue to lead the digital transformation of drug discovery by building additional capabilities into our Recursion OS platform, including scaling our transcriptomics hit validation platform to up to 13,000 near-whole exomes per week and advancing our ChemOS systems by preparing to install our scalable and automated drug metabolism and pharmacokinetics platform. Across our diverse platform that spans target and hit discovery through optimization and translation, we have now generated and control over 16 petabytes of proprietary biological and chemical data and 2.4 trillion predicted biological and chemical relationships, helping us turn the bespoke, artisanal, and serial process of drug discovery into a search and validation problem."
Summary of Business Highlights
- Internal Pipeline
- Transformational Collaborations
- Recursion OS
Second Quarter 2022 Financial Results
- Cash Position: Cash, cash equivalents, and investments were $515.4 million as of June 30, 2022.
- Revenue: Total revenue, consisting primarily of revenue from collaborative agreements, was $7.7 million for the second quarter of 2022, compared to $2.5 million for the second quarter of 2021. The increase was due to revenue recognized from our Roche-Genentech collaboration.
- Research and Development Expenses: Research and development expenses were $38.4 million for the second quarter of 2022, compared to $29.6 million for the second quarter of 2021. The increase in research and development expenses was primarily due to an increased number of pre-clinical assets being validated and increased clinical costs as studies progressed.
- General and Administrative Expenses: General and administrative expenses were $21.2 million for the second quarter of 2022, compared to $13.9 million for the second quarter of 2021. The increase in general and administrative expenses was due to the growth in size of the company's operations, including an increase in salaries and wages of $1.8 million, a fixed asset write-down of $2.8 million, increased rent expense of $1.0 million, and other administrative costs associated with operating a public company.
- Net Loss: Net loss was $65.6 million for the second quarter of 2022, compared to a net loss of $43.4 million for the second quarter of 2021.
About Recursion
Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.
Media Contact
Media@Recursion.com
Investor Contact
Investor@Recursion.com
Consolidated Statements of Operations
Consolidated Balance Sheets
Forward-Looking Statements
This document contains information that includes or is based upon "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding early and late stage discovery, preclinical, and clinical programs; licenses and collaborations; prospective products and their potential future indications and market opportunities; Recursion OS and other technologies; business and financial plans and performance; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as "plan," "will," "expect," "anticipate," "intend," "believe," "potential," "continue," and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; the impact of the COVID-19 pandemic and force majeure events; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading "Risk Factors" in our filings with the U.S. Securities and Exchange Commission, including our most recent Quarterly Report on Form 10-Q and our Annual Report on Form 10-K. All forward-looking statements are based on management's current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.
View original content to download multimedia:
SOURCE Recursion
|
https://www.wibw.com/prnewswire/2022/08/09/recursion-provides-business-updates-reports-second-quarter-2022-financial-results/
| 2022-08-09T20:30:32Z
|
BRIDGEWATER, N.J., Aug. 3, 2022 /PRNewswire/ -- Sanofi announces three appointments to key leadership roles for U.S. General Medicines and its North American Vaccines and Consumer Healthcare businesses.
Olivier Bogillot becomes Head of U.S. General Medicines. Bogillot, most recently President of Sanofi France, will lead the business unit responsible for serving the Diabetes, Cardiovascular and Transplant communities effective September 1.
Bogillot joined Sanofi in 2015, and has held various positions within the company, including as Executive Director of Global Policy based in the U.S. and Chief of Staff to the CEO. In March 2020, he was appointed President of Sanofi France, where he has led the Strategic Committee and the Country Council of Sanofi France, coordinating all the activities of the French subsidiary and representing the Group to French Authorities and professional organizations.
Bogillot held key roles in market access at Merck KGaA, Amgen and Bristol-Myers Squibb before being appointed Chief of Staff to the Director at the Greater Paris Regional Health Agency in 2009. He subsequently joined the Presidency of the French Republic in 2011, as advisor for health, dependency, and social policies.
He holds a PhD in Economics (University of Lyon I), a master's degree in Health Economics and Public Health and a degree in Molecular Biology and Physiology.
Deborah Glasser is the new Head of Vaccines, North America, responsible for the company's industry-leading vaccines business in the U.S. and Canada.
Before taking on the role at Sanofi on June 20, Glasser spent the prior 13 years at Biogen in the company's U.S., European and global organizations. Most recently, she served as Senior Vice President for the U.S. Alzheimer's Franchise.
Prior to that, Glasser held a number of positions with increasing responsibility across Biogen, including: Global Vice President and Asset Lead for Biogen's Spinal Muscular Atrophy portfolio, Global Commercial Lead for Alzheimer's, and Head of Global Marketing for Biosimilars. Glasser has also led in-line marketing teams within Biogen's U.S. Multiple Sclerosis business.
Before Biogen, Glasser held roles of increasing responsibility in sales, market research and brand marketing with Abbott Labs, now AbbVie.
Glasser earned her MBA in Marketing and Finance from the University of Chicago Booth School of Business and her BA with honors from Tufts University.
Andrew Loucks will take over as Head of North America Consumer Healthcare, effective August 8. Loucks will be responsible for commercial operations in the US and Canada for Sanofi's consumer healthcare portfolio.
Loucks joins Sanofi from Sensory Cloud Inc., where he was CEO and a Board member of the Boston-based consumer health & technology company.
Prior to Sensory Cloud, Loucks was President of Keurig Appliances and Away From Home Coffee Systems and a member of the Keurig Dr Pepper Executive Leadership Team. Loucks also served on the Board of Directors for two early-stage entrepreneurial companies.
Prior to Keurig Dr Pepper, Loucks was President of Frozen Foods Kellogg Company, where he was a member of the Global Leadership Team and North American Leadership Team, and previously served as the Vice President Marketing, Innovation & Nutrition for Kellogg Canada.
Prior to joining Kellogg Canada, Loucks spent several years working in various sales and marketing roles within Unilever.
Loucks completed his studies in business administration at Wilfrid Laurier University, Waterloo, Canada. He also completed the General Manager/Country Manager Executive Program at Harvard Business School.
Bogillot, Glasser and Loucks will join Sanofi's U.S. Country Council, which will continue to be led by Carole Huntsman, Head of Specialty Care North America and U.S. Country Lead.
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Contacts
Evan Berland| + 1 215 432 0234 | evan.berland@sanofi.com
View original content:
SOURCE Sanofi
|
https://www.kxii.com/prnewswire/2022/08/03/sanofi-appoints-new-heads-us-general-medicines-north-america-vaccines-consumer-healthcare/
| 2022-08-03T19:53:09Z
|
A once obscure Michigan elections panel is back in the spotlight after rejecting a ballot initiative asking voters whether abortion rights should be enshrined in the state’s constitution and another to expand voting in the state.
The Michigan Board of State Canvassers deadlocked 2-2 on party lines on both initiatives Wednesday.
Abortion rights supporters have already said they will ask the state Supreme Court to intervene to place the measure on the November ballot. The organization backing the voting measure is expected do the same.
The board last came under national scrutiny in November 2020 when then-President Donald Trump and his supporters tried to convince Republican members not to certify Democrat Joe Biden’s victory in the state. One GOP member abstained, but the other joined Democrats in voting to certify.
It highlighted the possibility that the panel — charged with largely clerical duties, not investigating elections — could become another hyperpartisan battleground.
The stakes of the abortion rights proposal are particularly high. Its backers are aiming to negate a 91-year-old state law that would ban abortion in all instances except to save the life of the mother.
Michigan’s 1931 law — which abortion opponents had hoped would be triggered by a conservative majority on the U.S. Supreme Court overturning Roe vs. Wade in June — remains blocked after months of court battles.
WHAT IS THE BOARD OF STATE CANVASSERS?
Michigan’s state constitution of 1850 created the board to handle administrative duties before and after an election. The board’s structure has changed over time.
Current law provides for four members — two from each political party that earned the most votes in the latest secretary of state election. Michigan’s 1908 Constitution was the first to mandate that a majority of the board could not be made up of members of the same political party. There’s no process to break a 2-2 deadlock; typically that leads to a court challenge.
Election experts say similar structures arose elsewhere during the Progressive Era as reformers hoped a system of “mutual policing” would cut down on the influence of party machines on election outcomes.
Since then, federal courts have gained more legal authority to examine evidence and question witnesses, and to address claims related to state-level elections, said Kevin Johnson, executive director of the Election Reformers Network. The nonpartisan group advocates for ranked choice voting and independent redistricting among other election reforms.
“Mutual policing is a system that becomes risky in a hyperpartisan environment, so it needs some new thinking,” Johnson said.
WHAT DOES THE BOARD DO?
Michigan courts have repeatedly described the board’s responsibilities as administrative or clerical, while Michigan’s elected secretary of state is the chief election official.
But the board’s potential to dramatically influence elections has come to the fore in recent years.
According to the National Conference of State Legislatures, Hawaii, Illinois, Maryland, North Carolina, New York, Oklahoma, South Carolina, Virginia and Wisconsin have a board or a commission that fully oversees elections. Most of those states require a certain numbers of members from each major political party, according to NCSL research.
Key responsibilities of the Michigan board include: canvassing and certifying statewide elections, judicial elections and legislative elections that cross county lines; conducting statewide office recounts; and approving electronic voting systems.
The board meets after elections to determine official results based on reports from local clerks. The board members do not audit election results or investigate accusations of fraud.
The board also has a significant role in statewide ballot proposals. Aided by state elections staff, it reviews petitions seeking to put a proposal on ballots and approves the exact language that voters will see on those ballots.
Christopher Thomas, director of the Michigan Bureau of Elections for 36 years until retiring in 2017, said that process became more heated during his career as attorneys representing battling groups sought to win board members over, largely playing to their political alliances.
“It’s unfortunate,” Thomas said. “I’ve heard board members say they’re there to represent their party, and I found that so antithetical to their purpose.”
Still, prior to 2020, the dynamic rarely captured wide public attention.
WHAT CHANGED?
Following the 2020 presidential election, then-President Donald Trump and his allies targeted Michigan’s Board of State Canvassers as part of a broad and futile attempt to challenge his loss in several states. Trump and his backers, despite no evidence of fraud, demanded that the board refuse to certify the results.
But ultimately, one Republican board member joined two Democrats in certifying Joe Biden’s 154,000 vote victory in Michigan. The other Republican board member abstained from voting.
Election experts worry the unsuccessful attempt has fueled efforts to further politicize Michigan’s canvassing system, pointing to people with a history of backing Trump’s unproven claims of fraud getting appointed to county-level canvassing slots.
That heightens the chance of local canvassing boards deadlocking or members refusing to vote, undercutting voters’ confidence in the system and even risking “agitation or spillover into the streets,” said Johnson, with the Election Reformers Network.
WHO’S ON THE BOARD NOW?
State parties provide a list of potential candidates to Michigan’s governor, who selects a member from those options. Four-year terms are staggered.
Both Republicans who held the party’s seats in 2020 are gone. Aaron Van Langevelde, who voted to certify the results despite pressure from Trump supporters, was not nominated again by the state GOP when his term ended that winter. The board member who abstained from a vote in 2020, Norman Shinkle, resigned in June to run for a state legislative seat.
Gov. Gretchen Whitmer selected Tony Daunt from three nominees submitted by the GOP to replace Van Langevelde. Daunt, a longtime party activist, was an outspoken critic of Trump’s bid to challenge the 2020 results.
Whitmer appointed Richard Houskamp, another longtime activist, to replace Shinkle. Houskamp told the Detroit Free Press in July that he hadn’t seen any evidence of fraud in the 2020 election and that continuing to make those claims “is not healthy for the country.”
One of the two Democrats who voted to certify the 2020 election results is still on the board: Jeannette Bradshaw, an electrician and elected leader within Detroit’s International Brotherhood of Electrical Workers.
The other, Julie Matuzak, resigned in December 2020 after 10 years on the board. Mary Ellen Gurewitz, an attorney who represented Michigan Democrats before the board in 2020, was appointed to replace her.
|
https://cw33.com/news/u-s-news/ap-us-headlines/ap-abortion-vote-returns-spotlight-to-obscure-michigan-board/
| 2022-09-01T03:50:48Z
|
SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Cloocus, a leading cloud experts group specialized in Microsoft, today announced it has won the Country of the Year 2022 Microsoft Partner of the Year Award. The company was honored among a global field of top Microsoft partners for demonstrating excellence in innovation and implementation of customer solutions based on Microsoft technology.
"The partner of the Year Award is awarded to the partner that has shown the highest performance in Microsoft business. Receiving this award for the second consecutive year, I feel great responsibility to strive more," said Steve Hong, the CEO of Cloocus. "We will do our best to become a partner with the best technology to support 3 Cloud – Azure, Microsoft365, and Dynamics365 & Power Platform."
The Microsoft Partner of the Year Awards recognize Microsoft partners that have developed and delivered outstanding Microsoft-based applications, services and devices during the past year. Awards were classified in various categories, with honorees chosen from a set of more than 3,900 submitted nominations from more than 100 countries worldwide. Cloocus was recognized for providing outstanding and services in Korea.
Despite being founded for only three years, Cloocus has grown in a rapid pace this year. Since its earlier stage, Cloocus has heavily invested in Microsoft's cloud technology and acquired "Azure Expert MSP," which is Microsoft's top global technology grade. Among the Korean partners, it holds the most advanced specialization certifications, which is the highest grade of Azure technology per specific workloads, for Cloud Migration, Hybrid Cloud, Security, Application Modernization, Data & AI, and more. By utilizing the latest technologies of "Azure Digital Twin Platform," "Azure Databricks," and "Azure Machine Learning" for its recent project with Hyundai Motor Group, it has proven its exceptional expertise in Data and AI services.
An e-approval solution optimized for Korean work environments, "ClooWorks," has also been launched based on Microsoft Teams. As the first Microsoft Cloud Center of Excellence (CCoE) partner in Korea, it is recruiting partners to do its Microsoft business together and is striving to expand its Microsoft-based cloud ecosystem. With Microsoft Korea, Cloocus opened the "Global Tech Hub" in Busan to strengthen strategic cooperation in expanding its regional cloud business.
Furthermore, Cloocus is also actively engaged in Microsoft Enabler Program to implement an inclusive workplace for disabilities in the APAC region.
"I am honored to announce the winners of the 2022 Microsoft Partner of the Year Awards," said Nick Parker, corporate vice president of Global Partner Solutions at Microsoft. "These partners were outstanding among the exceptional pool of nominees and I'm continuously impressed by their innovative use of Microsoft Cloud technologies and the impact for its customers."
Microsoft Partner of the Year Awards are announced annually prior to the company's global partner conference, Microsoft Inspire, which will take place on July 19-20 this year. Additional details on the 2022 awards are available on the Microsoft Partner Network blog: https://blogs.partner.microsoft.com/mpn/congratulations-to-the-2022-microsoft-partner-of-theyear-awards-winners-and-finalists/. The complete list of categories, winners and finalists can be found at https://partner.microsoft.com/en-us/inspire/awards.
About Cloocus Co Ltd
Founded in 2019, Cloocus Co Ltd is recognized as a Microsoft Azure expert MSP (Managed Service Provider)(NASDAQ: MSFT) and currently houses the most Microsoft Azure experts in South Korea and is also recognized as Korea's first Cloud Modernization, AMP, and Azure Advanced Specializations partner with over 500+ clients.
Cloocus has been working tirelessly to serve customers from Enterprise to SMBs and startups of various industries including Hyundai Motor Group, SK Group, Hanwha Solutions, CJ, Netmarble, NC, PearlAbyss, Krafton, and more.
In July 2021, Cloocus was named as the winner of "Microsoft Partner of the Year 2021 Korea".
It has overseas offices in New York and Kuala Lumpur and will continue to expand its global business, mainly in Asia.
For further media inquiries please contact:
Jiyeon Ahn (E.jiyon@cloocus.com)
Dahyo Park (E.dhpark@cloocus.com)
View original content to download multimedia:
SOURCE Cloocus
|
https://www.kxii.com/prnewswire/2022/06/28/cloocus-recognized-winner-2022-microsoft-country-partner-year-second-consecutive-year/
| 2022-06-28T19:32:14Z
|
NICB President and CEO David Glawe to meet with IASIU President Celeste Dodson during IASIU Annual Conference
SAN DIEGO, Sept. 9, 2022 /PRNewswire/ -- The National Insurance Crime Bureau (NICB), the insurance industry's association dedicated to predicting, preventing, and prosecuting insurance crime, is continuing to strengthen its long standing partnership with the International Association of Special Investigation Units (IASIU). NICB President and CEO David Glawe will meet with IASIU President Celeste Dodson in San Diego to discuss emerging fraud trends and develop proactive solutions to address crimes impacting insurance policyholders.
On Monday, September 12 at 3:00 p.m. PT, Glawe and Dodson will reaffirm their organizations' joint mission to bring awareness during the IASIU Annual Conference in San Diego. As crime across the nation continues to increase, including the highest vehicle theft numbers since 2008, staggering catalytic converter thefts, and fraud exceeding $300 billion nationwide each year, California is experiencing some of the highest crime rates, and therefore, is the perfect place to address these issues.
"NICB is committed to our long partnership with IASIU," said Glawe. "Our partnership is organic in every sense, and is strengthened by our mutual mission of combatting insurance fraud and crime."
"NICB and IASIU's partnership is critical to our joint missions," said Dodson. "Together, we will continue to focus on advancing excellence in the insurance fraud fighting community through education, training, awareness, and connection."
NICB and IASIU will continue their valued partnership as they battle the ever-growing crime trends seen in the U.S. Using cutting-edge and predictive analysis, together, they will continue to evolve education, investigations, and fraud awareness as leaders in the industry.
REPORT FRAUD: Anyone with information concerning insurance fraud or vehicle theft can report it anonymously by calling toll-free 800.TEL.NICB (800.835.6422) or submitting a form on our website.
ABOUT THE NATIONAL INSURANCE CRIME BUREAU: Headquartered in Des Plaines, Ill., the NICB is the nation's leading not-for-profit organization exclusively dedicated to combatting and preventing insurance crime through Intelligence, Analytics, and Operations; Education and Crime Prevention; and Strategy, Policy, and Advocacy. The NICB is supported by more than 1,200 property and casualty insurance companies and self-insured organizations. NICB member companies wrote over $582 billion in insurance premiums in 2021, or more than 82% of the nation's property-casualty insurance. That includes more than 96% of the nation's personal auto insurance. To learn more, visit www.nicb.org.
View original content to download multimedia:
SOURCE National Insurance Crime Bureau
|
https://www.mysuncoast.com/prnewswire/2022/09/09/crime-increases-nationwide-nicb-iasiu-focus-fraud-awareness-investigation/
| 2022-09-09T15:32:06Z
|
GREENWICH, Conn., May 18, 2022 /PRNewswire/ -- Baptist Memorial Health Care's Brain & Spine Network Center of Excellence is expanding its collaboration with Cedar Gate Technologies (Cedar Gate), a leading value-based care performance management technology company.
The Brain & Spine Network Center of Excellence is a collaboration between Baptist and Semmes Murphey Clinic designed to provide a cost-saving and high-quality benefit for employees who suffer from back and neck pain and other neurological conditions. First offered to Baptist's employees and a select number of businesses, this Center of Excellence has proven to significantly reduce out-of-pocket costs by providing proven solutions and leveraging personalized care through assigned nurse navigators who assist in diagnosis, treatment, therapies, interventional pain management and, if required, surgical care and recovery. Initial outcomes for the center show that patients returned to work 14% more quickly than the national average, and 90% of patients reported satisfaction with their care.
"We're excited to offer our comprehensive Brain & Spine Network Center of Excellence to a wider base of employers and patients," said Kim Hallum-Stewart, system administrator of neurosciences for Baptist Memorial Health Care. "Cedar Gate's platform allows us to bring our vision to self-insured employers by providing value-based payment solutions, streamlined data integration and operational analytics, which serve as a foundation for us to scale and offer excellence in care to employers across our region."
Baptist recently broadened the use of Cedar Gates's platform from a singular specialized surgical specialty implementation to a multifaceted application to encompass the expanded vision for the Center of Excellence.
"Semmes-Murphey has a passion for saving lives, improving quality of life and advancing the field of neurosurgery," said John Lewis, Semmes Murphey CEO. "Cedar Gates's platform has given us the tools to integrate business operations, strengthen our partnership with Baptist and offer more employers the opportunity to participate in the Brain & Spine Network Center of Excellence."
Cedar Gate's payment technology enables the Brain & Spine Network to manage prospective bundled payment programs with automatic conversion of fee-for-service claims into a single, bundled claim.
"Value-based care is becoming increasingly recognized as the future of health care delivery and reimbursement in the U.S.," said Cedar Gate CEO, David B. Snow, Jr. "We are pleased these solutions helped meet Baptist's needs and allow for continued success."
The Brain & Spine Network Center of Excellence is focused on providing high-quality, patient-centered neurological care, emphasizing value for patients and employers. Baptist's Centers of Excellence measure outcomes and compare results with programs across the country. The Brain & Spine Network clinical team consistently achieves top rankings among its peers. Employers can choose from Baptist's service offerings to determine what will work best for their employee population. Baptist's Brain & Spine Network has a robust offering of services and can tailor those services to meet an employer's specific needs.
About Cedar Gate Technologies
Cedar Gate enables payers, providers, employers, and service administrators to excel at value-based care. Our unified technology and services platform enhances and automates data management activities to deliver employer and provider analytics, care management, and payment technology necessary to pursue every payment model and optimize performance in all lines of business. From primary care attribution, to bundled payments, to capitation, our platform is designed to improve clinical, financial, and operational outcomes for all.
Based in Greenwich, CT, Cedar Gate is private equity backed by GTCR, a leading Chicago-based private equity firm, Ascension Ventures, a strategic healthcare venture firm, and Cobalt Ventures, the investment subsidiary of BCBS of Kansas City. To learn more, visit www.cedargate.com.
About Baptist Memorial Health Care
One of the country's largest not-for-profit health care systems, Baptist Memorial Health Care offers a full continuum of care to communities throughout the Mid-South and Central Mississippi. The Baptist system comprises 22 affiliate hospitals in West Tennessee, North and Central Mississippi and East Arkansas; more than 5,400 affiliated physicians; Baptist Medical Group, a multispecialty physician group with more than 800 providers; home, hospice and psychiatric care; minor medical centers and clinics; a network of surgery, rehabilitation and other outpatient centers; and an education system highlighted by Baptist Health Sciences University (formerly Baptist College of Health Sciences).
About Semmes Murphey Clinic
Founded more than 100 years ago by Eustace Semmes, MD, and Francis Murphey, MD, Semmes Murphey Clinic has been a leader in the development of technology and procedures that improve the quality of care for patients with neurological and spine disorders. This continuing leadership has made the Semmes Murphey name instantly recognizable to physicians across the country and the world, many of whom refer their patients here for treatment.
Media Contact:
Luke Sheffield
anthonyBarnum Public Relations
luke.sheffield@anthonybarnum.com
View original content to download multimedia:
SOURCE Cedar Gate
|
https://www.kxii.com/prnewswire/2022/05/18/baptist-memorial-expand-brain-amp-spine-center-excellence-with-cedar-gate-technologies/
| 2022-05-18T13:42:10Z
|
Flexible online curriculum provides knowledge, skills, and certificates to help students succeed in rapidly-growing industry.
WORCESTER, Mass., July 13, 2022 /PRNewswire/ -- Green Flower, a California-based education company focused on the cannabis industry, announced four new online certificate programs in partnership with Worcester Polytechnic Institute (WPI).
These certificate programs focus on the cannabis industry in four areas; business, law and policy, agriculture and horticulture, and healthcare and medicine. Offered in an online format and open to anyone over the age 18, the programs are designed to help students gain industry-specific knowledge and experience related to the rapidly developing industry. WPI is the first Massachusetts higher education institution to partner with Green Flower to offer the programs.
"Green Flower is thrilled to announce the launch of our partnership with WPI to offer education programs related to the legal cannabis industry," said Daniel Kalef, Vice President of Higher Education University Partnerships at Green Flower. "We appreciate WPI working with us to expand opportunities in the cannabis industry for students in Worcester and beyond," said Kalef.
Massachusetts generated $1.65 billion in total cannabis sales last year, supporting more than 27,000 legal cannabis jobs. According to the Leafly 2021 Jobs Report, Massachusetts has the fifth largest cannabis jobs market in the country. In the US, cannabis jobs are projected to increase by 250 percent by 2028, making it the fastest-growing industry in the nation.
Each certificate program consists of three eight-week courses and takes six months to complete. Expert instructors with experience in the cannabis industry lead the courses and are selected, vetted, and provided by Green Flower.
The programs are now open for enrollment with classes starting on September 5. The cost is $2,950 per program, with payment plans and financing options available to provide the highest degree of affordability possible to all students.
Upon completion of a cannabis certificate program, students will receive a digital badge credential issued by The Green Flower Institute and Worcester Polytechnic University. Students will also receive access to Green Flower's robust employer network. For more information, visit cannabiseducation.wpi.edu.
Founded in 2014, Green Flower is the industry leader in cannabis education, empowering thousands of consumers, regulators, and professionals with the knowledge they need to succeed in the emerging cannabis industry today. Green Flower's content and technology platform powers the cannabis programs of top universities and colleges across the country, provides customized learning and compliance solutions for cannabis businesses of all sizes, and equips individuals with the skills and credentials necessary to make an impact in the modern cannabis industry.
Worcester Polytechnic Institute holds firm to its founding mission to provide an education that balances theory with practice. Its aim is to create a quality experience for its students and a positive impact for its partner communities. The university's curriculum features flexible, rigorous programs that are project-based and globally engaged. WPI faculty members work with students on interdisciplinary research with the goal of finding solutions to important and socially relevant problems.
Adam Summers
adam.summers@green-flower.com
708.223.2336
View original content to download multimedia:
SOURCE Green Flower
|
https://www.kxii.com/prnewswire/2022/07/13/green-flower-worcester-polytechnic-institute-partner-offer-cannabis-education-programs/
| 2022-07-13T16:05:47Z
|
NEW YORK, June 27, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October 28, 2021 and May 2, 2022, both dates inclusive (the "Class Period"), of the important than July 25, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Spero Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Spero Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=6561 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 25, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the data submitted in support of the New Drug Application ("NDA") of Tebipenem HBr, an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults, were insufficient to obtain U.S. Food and Drug Administration ("FDA") approval; (2) accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form; (3) the foregoing would necessitate a significant workforce reduction and restructuring of Spero Therapeutics's operations; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Spero Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=6561 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content:
SOURCE Rosen Law Firm, P.A.
|
https://www.mysuncoast.com/prnewswire/2022/06/28/rosen-leading-investor-counsel-encourages-spero-therapeutics-inc-investors-with-losses-secure-counsel-before-important-deadline-securities-class-action-spro/
| 2022-06-28T04:15:18Z
|
NEW YORK, June 27, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating GrandSouth Bancorporation (GRRB), relating to its proposed acquisition by First Bancorp. Under the terms of the agreement, GRRB shareholders will receive 0.910 shares of First Bancorp common stock per share they own. Click here for more information: https://www.monteverdelaw.com/case/grandsouth-bancorporation. It is free and there is no cost or obligation to you.
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in GRRB and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:
SOURCE Monteverde & Associates PC
|
https://www.kxii.com/prnewswire/2022/06/28/investor-alert-mampa-class-action-firm-announces-an-investigation-grandsouth-bancorporation-grrb/
| 2022-06-28T04:18:13Z
|
WASHINGTON, July 26, 2022 /PRNewswire/ -- As NASA prepares for the first integrated flight test of the Space Launch System (SLS) rocket and the Orion spacecraft to the Moon this summer as part of Artemis, the agency is moving toward a services contract model for long-term SLS hardware production and operations to reduce costs.
"SLS is not just a NASA investment, it has been a national investment. Through this contract approach, we are working to enable the use of this one-of-a-kind heavy lift capability to other customers," said Kathy Lueders, associate administrator for the Space Operations Mission Directorate at NASA Headquarters in Washington. "This approach will also allow NASA to streamline SLS production and operations under one contract, creating a more affordable and sustainable exploration framework for decades to come."
In a pre-solicitation notice for the Exploration Production and Operations Contract published Tuesday, NASA is proposing to transfer SLS production and associated testing, manufacturing, and transportation facilities from multiple existing hardware procurement contracts to a single launch service contract with Deep Space Transport LLC. Due to the proprietary nature of the processes for manufacturing of the SLS rocket, NASA does not expect to recover costs through competition associated with an alternate source's design, development, and testing. The notice conveys NASA's intended acquisition plan for a long-term SLS production and operations contract, to which industry may respond with feedback in accordance with the instructions in the pre-solicitation notice. An award is anticipated by Dec. 31, 2023.
The contractor would be responsible for producing hardware and services for up to 10 Artemis launches beginning with the Artemis V mission, and up to 10 launches for other NASA missions. NASA expects to procure at least one flight per year to the Moon or other deep-space destinations.
Spanning multiple centers and facilities, the NASA SLS workforce will continue to provide expertise for the first four Artemis missions and for future Artemis missions.
"We have a big job ahead of us to fly the first four Artemis missions and develop the new exploration upper stage," said Jody Singer, center director of NASA's Marshall Space Flight Center in Huntsville, Alabama. "While NASA transitions the contracting approach for long-term SLS operations, the talented team that brought the rocket to the launchpad will also be needed for other projects necessary for the agency's exploration missions."
NASA previously issued a request for information in October 2021 and conducted discussions with industry this year to inform the approach to maximize the long-term efficiency of the SLS rocket.
With Artemis, NASA will land the first woman and the first person of color on the lunar surface and establish long-term exploration at the Moon in preparation for human missions to Mars. SLS and NASA's Orion spacecraft, along with the commercial human landing system and the Gateway in orbit around the Moon, are NASA's backbone for deep space exploration. SLS is the only rocket that can send Orion, astronauts, and supplies to the Moon in a single mission.
For more on NASA's Space Launch System rocket, visit:
View original content to download multimedia:
SOURCE NASA
|
https://www.kxii.com/prnewswire/2022/07/26/nasa-prepares-space-launch-system-rocket-services-contract/
| 2022-07-26T22:53:33Z
|
Alabama corrections officer dead, inmate in custody after prison escape
LAUDERDALE COUNTY, Ala. (WAFF/Gray News) - After more than a week on the run, former corrections officer Vicky White, 56, is dead and murder suspect Casey White, 38, is in custody, WAFF reports.
The pair were caught in Evansville, Indiana, on Monday.
Authorities say U.S. Marshals were chasing Vicky White and Casey White when the Cadillac they were in crashed. Vicky White allegedly shot herself and later died at the hospital. Casey White surrendered to authorities after the crash. He suffered minor injuries.
The U.S. Marshals Service said when Casey White came out of the car, he said, “Please help my wife. She just shot herself in the head, and I didn’t do it.”
Lauderdale County Sheriff Rick Singleton said they have got a “dangerous man off of the street.”
“Casey White will not see the light of day again,” Singleton said.
He adds that there is no evidence at this time that anyone else was involved.
On April 29, the inmate and the former Assistant Director of Corrections were reported missing.
Vicky White and Casey White left the Lauderdale County Detention Center at 9:30 a.m. allegedly heading to the courthouse. Vicky White said she was taking Casey White to a mental health evaluation and then to seek medical care because she was not feeling well. Singleton later confirmed there was not a scheduled mental health evaluation.
Inmates told authorities that the two had a “special relationship” where Casey White received extra privileges, all from Vicky White. They first met in 2020 when Casey White was in Lauderdale County Jail. When he was moved to prison, they remained in contact. He returned to Lauderdale County Jail earlier this year.
Casey White was serving a 75-year prison sentence for attempted murder and other charges at the time of his escape. He was awaiting trial in the stabbing of a 58-year-old woman during a burglary in 2015. He could face the dealth penalty if convicted.
A warrant for Vicky White was issued May 2, charging her with permitting or facilitating escape in the first degree.
Authorities discovered Vicky White had bought a 2007 Ford Edge days before the pair ran off. She was also seen days before shopping for men’s clothing at Kohl’s and sold her house for below market value.
“This escape was obviously well planned and calculated. They had plenty of resources, cash, vehicles. They had everything they needed to pull this off,” Singleton said.
One week later, the 2007 Ford Edge was found in Bethesda, Tennessee, after it had apparently broken down.
A Ford F-150 was left abandoned at a car wash last week in Evansville, Indiana. The manager looked at the surveillance video and believed he saw Casey White. The U.S. Marshals were called in.
From there, the U.S. Marshals started narrowing their focus on Vicky White and Casey White being in Evansville, Indiana, where they were found on Monday.
Lauderdale County District Attorney Chris Connolly wants justice to be served.
“His capital murder case is set for June. Plan A would be to try him for June, but there are a lot of moving parts between then and now,” Connolly said.
Authorities say that Casey White will be extradited to Lauderdale County “very soon.”
He has a status hearing scheduled Tuesday.
Copyright 2022 WAFF via Gray Media Group, Inc. All rights reserved.
|
https://www.wibw.com/2022/05/10/alabama-corrections-officer-dead-inmate-custody-after-prison-escape/
| 2022-05-10T14:51:55Z
|
INDIANAPOLIS, June 27, 2022 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2022 of $0.98 per share on outstanding common stock.
The dividend is payable on Sept. 9, 2022 to shareholders of record at the close of business on Aug. 15, 2022.
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom. F-LLY
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For further discussion of risks and uncertainties relevant to Lilly's business that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
View original content to download multimedia:
SOURCE Eli Lilly and Company
|
https://www.kxii.com/prnewswire/2022/06/27/lilly-declares-third-quarter-2022-dividend/
| 2022-06-27T19:10:54Z
|
Homeownership company expands to Louisville market with partner Finish Line Realty, to offer certainty in the home transaction to buyers and sellers
NEW YORK, July 26, 2022 /PRNewswire/ -- Ribbon, the homeownership company, has expanded into Kentucky, a move that empowers Kentucky homebuyers to make all-cash offers with RibbonCash and guarantee closing.
Kentucky represents a major milestone of fifteen states of operation for Ribbon. Kentucky is the company's eighth expansion state this year alone - on its way to half of the U.S. by the end of 2022.
Considered a cornerstone of the American Dream, hopes of homeownership have dwindled for many in the face of rising interest rates, on top of increased competition from wealthy investors. At the end of 2021, total home sales skyrocketed to their highest annual level ($6.2 million) since 2006. In January, high prices and the lowest inventory of unsold homes (860,000 units) plagued the nation.
Home sales in Louisville rose 3.5% in June 2022 compared to last year, selling for a median price of $211,000. Homes sat on the market for 15 days - on par for a tight market compared to 16 days a year ago when competition was at its peak. With high mortgage rates causing additional disruption, buyers lean on real estate brokerages to get the most value for their purchase while sellers prioritize certainty in the transaction.
"Buyers in the market are swimming against a current of fluctuating costs, rising rates, and low inventory," said Shaival Shah, co-founder and CEO of Ribbon. "At Ribbon, we advocate for everyday people who want to own a home - not investors. We're leveling the playing field by equipping buyers with the most powerful offer in real estate and working directly with their agent and loan officer of choice. Further, sellers can feel confident that their deal will close, so they can move on to the next chapter."
RibbonCash Offers are guaranteed to close, providing sellers certainty even in the most competitive and volatile markets. And in a time of fluctuating interest rates, buyers utilizing Ribbon can shop around for the best mortgage rates, elevate their home purchase options, and bid with confidence for the home of their dreams using the most powerful offer in real estate.
As the only cash offer company that does not displace the local ecosystem, Ribbon works directly with real estate professionals and lenders who remain key advocates for buyers and sellers.
Ribbon will hold Kentucky-specific webinars on July 26th & 28th at 10am ET.
To ensure the broadest access for consumers, Ribbon is partnering with Finish Line Realty in Louisville, Kentucky. Through this partnership, Finish Line Realty can now provide all-cash, non-contingent offers on homes that pass inspection to its customers - empowering them to more effectively compete with the institutional investors snapping up residential homes and driving up prices beyond actual value.
"Finish Line Realty's goal is to help everyday buyers achieve their home ownership goals in Louisville's challenging housing market," said Scott Hack, Broker/Owner at Finish Line Realty. "Leveraging Ribbon's all-cash offers allows us to make the American Dream, with all its traditions, a reality for more of our clients."
With its growth into Kentucky, Ribbon now operates across the U.S. in 15 states. The company plans to expand to half of the U.S. by the end of 2022. For more information about Ribbon, visit www.ribbonhome.com.
Founded in 2017 in New York and Charlotte, Ribbon is on a mission to make homeownership achievable. Ribbon allows everyday families to compete on a level playing field with high-net-worth individuals and institutional buyers by upgrading their offers to winning RibbonCash Offers. As the leading real estate technology platform, Ribbon empowers agents, brokerages, and lenders to create a world-class experience for home buyers and sellers through powerful financial products and digital workflow software. Visit ribbonhome.com.
Finish Line Realty has been helping buyers and sellers in metro Louisville, Kentucky since 2011. As a tech-forward independent brokerage, the focus remains on offering or partnering with services and tools that give clients an advantage in the constant changing real estate market. The agents of Finish Line Realty strive to offer an experience that creates raving fans and clients for life. Learn more at louisvillerealestate.com.
Media Contact:
Charlie Ozuturk
Go-to-Market Communications Manager, Ribbon
charlie.ozuturk@ribbonhome.com
732.552.5080
Media Contact:
BLASTmedia for Ribbon
ribbon@blastmedia.com
317.806.1900
View original content to download multimedia:
SOURCE Ribbon
|
https://www.kxii.com/prnewswire/2022/07/26/ribbon-launches-kentucky-reaching-expansion-milestone-15-states/
| 2022-07-26T13:44:08Z
|
BATON ROUGE, La., Aug. 9, 2022 /PRNewswire/ -- First National Bankers Bank (FNBB), a leading provider of correspondent banking services in the southeastern United States announces its recent partnership with Aptys Solutions. FNBB serves more than 600 financial institutions with leading edge services designed to foster the growth and success of community banks in their markets. Aptys Solutions is the leading provider of cloud-based, end-to-end, digital payment solutions to over 5,000 financial institutions including faster payments, mobile P2P, wire, ACH, and check.
FNBB was looking for a strategic payments technology partner that could offer advanced payments solutions to meet its strategic goals to enhance their service offerings to its respondent bank customers. Aptys' multi-channel payments platform, PayLOGICS, was selected to further develop key functionalities including image cash letter, check adjustments and returns, and faster payments solutions.
PayLOGICS digital payment solutions will enhance its service offerings by enabling access to faster payments systems. Once implemented, PayLOGICS will power FNBB's ability to provide its respondent banks with settlement, liquidity management and funding agent services for The Clearing House Real Time Payment System, and The Federal Reserve Bank FedNow Instant Payments Service, when released.
The FNBB Faster Payments Service will set community financial institutions (FI) up for success in the rapidly expanding digital payments space by supporting multiple participation options from both private and Federal Reserve operated faster payment networks while offering liquidity management and around the clock transaction settlement posting. Integrated into FNBB's real-time correspondent system, NetLink, the functionality of PayLOGICS' will streamline the needed funding agent elements of these faster payments solutions, enabling community FIs access to RTP and the FedNow Service.
"The partnership with Aptys is an integral part of our strategy to enhance our image cash letter exchange service plus assisting our customers with their faster payment initiatives. PayLOGICS' automated liquidity management system will open the door for our shareholders and clients, regardless of size, to be able to work with FNBB as a settlement partner," said Pax Mogenson, President and CEO of FNBB.
Streamlining reconciliation and settlement across multiple payment channels is just one benefit of the PayLOGICS platform. Aptys provides versatile methods of payment creation offering customization for FNBB's clients. Additionally, it makes it easier to track and research payments, offering enhanced regulatory compliance and unprecedented customer support and expertise. As Aptys and FNBB collaborate on faster payments, this initial project will provide new capabilities to all participants by maintaining an online payment archive with consolidated payment data that is searchable via web-browser.
PayLOGICS' automates the management and funding of real-time transactions and it can provide a module for the funding agent and customer FI's to manage and reconcile the transactional data. "Real-time payments are the way things are going for the future of payment services," said Naseer Nasim, CEO of Aptys Solutions. "Providing comprehensive real-time payments solutions as a service fits right into our desire to empower digital transformation and offer technology solution differentiation for any financial institution."
About First National Bankers Bank
First National Bankers Bank (FNBB), the banking subsidiary of First National Bankers Bankshares, Inc., serves the correspondent banking needs of more than 600 community financial institutions across the southeastern United States. FNBB is committed to providing high-quality, innovative, and reliable correspondent services to help community financial institutions build efficiencies, grow their customer relationships, minimize risk and comply with regulations. FNBB, chartered in 1984, has offices in Baton Rouge, Louisiana, Birmingham, Alabama, Little Rock, Arkansas, Lake Mary Florida, Ridgeland, Mississippi, Shreveport, Louisiana and Memphis, Tennessee.
About Aptys Solutions
Aptys Solutions is the leading provider of electronic payment processing software for financial institutions. Aptys' payments platform processes nearly a billion ACH, check, and wire transactions annually for over 5,000 community banks and credit unions nationwide. By providing financial institutions with a unified electronic payments platform, the company helps financial institutions offer differentiating payment products that increase efficiencies, reduce friction, manage compliance, and reduce risk. Aptys Solutions is dedicated to driving faster payments, streamlining operations, and creating revenue for correspondents and their customers. For more information, visit www.aptyssolutions.com.
View original content to download multimedia:
SOURCE First National Bankers Bankshares, Inc.
|
https://www.wibw.com/prnewswire/2022/08/09/first-national-bankers-bank-announces-partnership-with-aptys-solutions/
| 2022-08-09T15:52:33Z
|
NEW YORK (AP) — The virus that causes polio has been found in New York City’s wastewater in another sign that the disease, which hadn’t been seen in the U.S. in a decade, is quietly spreading among unvaccinated people, health officials said Friday.
The presence of the poliovirus in the city’s wastewater suggests likely local circulation of the virus, health authorities from the city, New York state and the federal government said.
The authorities urged parents to get their children vaccinated against the potentially deadly disease.
“The risk to New Yorkers is real but the defense is so simple — get vaccinated against polio,” New York City Health Commissioner Dr. Ashwin Vasan said. “With polio circulating in our communities there is simply nothing more essential than vaccinating our children to protect them from this virus, and if you’re an unvaccinated or incompletely vaccinated adult, please choose now to get the vaccine. Polio is entirely preventable and its reappearance should be a call to action for all of us.”
Dr. José R. Romero, director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases, said, “This is sobering; we know polio spreads silently, and it’s likely that there are many people infected with polio and shedding the virus in these communities. This is also an urgent and living reminder of the importance of vaccination.”
New York City is being forced to confront polio as city health officials are struggling to vaccinate vulnerable populations against monkeypox and adjusting to changing COVID-19 guidelines.
“We are dealing with a trifecta,” Mayor Eric Adams said Friday on CNN. “COVID is still very much here. Polio, we have identified polio in our sewage, and we’re still dealing with the monkeypox crisis. But the team is there. And we’re coordinating and we’re addressing the threats as they come before us, and we’re prepared to deal with them with the assistance of Washington, D.C.”
The announcement about the discovery of the polio virus in New York City comes shortly after British health authorities reported finding evidence the virus has spread in London but found no cases in people. Children ages 1-9 in London were made eligible for booster doses of a polio vaccine Wednesday.
In New York, one person suffered paralysis weeks ago because of a polio infection in Rockland County, north of the city. Wastewater samples collected in June in both Rockland and adjacent Orange County were found to contain the virus.
CDC officials said the virus identified in wastewater samples collected in New York City did not contain enough genetic material to determine if they were linked to the Rockland County patient.
Most people infected with polio have no symptoms but can still give the virus to others for days or weeks. Vaccination offers strong protection, and authorities urged people who haven’t gotten the shots to seek one immediately.
Based on past outbreaks, it is possible that hundreds of people in the state have gotten polio and don’t know it, officials said.
Polio was once one of the nation’s most feared diseases, with annual outbreaks causing thousands of cases of paralysis. The disease mostly affects children.
Vaccines became available starting in 1955, and a national vaccination campaign cut the annual number of U.S. cases to less than 100 in the 1960s and fewer than 10 in the 1970s, according to the Centers for Disease Control and Prevention.
A small percentage of people who contract polio suffer paralysis. The disease is fatal for 5-10% of those paralyzed.
All schoolchildren in New York are required to have a polio vaccine, but Rockland and Orange counties are both known as centers of vaccine resistance.
According to the CDC’s most recent childhood vaccination data, about 93% of 2-year-olds had received at least three doses of polio vaccine. But the rate is only 80% in New York state, and is far lower in the area around where the polio case was reported — just 60% in Rockland County and 59% in Orange County, according to state data.
|
https://cw33.com/health/ap-health/polio-detected-in-nycs-sewage-suggesting-virus-circulating/
| 2022-08-12T18:34:16Z
|
Zombie Foreclosures Up 3 Percent from First to Second Quarter of 2022 as Foreclosure Activity Increases 13 Percent; Increase in Empty Properties Facing Foreclosure Marks First Gain in a Year; Zombie Properties Still Represent Just One of Every 13,200 Residential Properties in U.S. and Remain Down Annually
IRVINE, Calif., June 2, 2022 /PRNewswire/ -- ATTOM, a leading curator of real estate data nationwide for land and property data, today released its second-quarter 2022 Vacant Property and Zombie Foreclosure Report showing that 1.3 million (1,304,007) residential properties in the United States sit vacant. That represents 1.3 percent, or one in 76 homes, across the nation.
The report analyzes publicly recorded real estate data collected by ATTOM — including foreclosure status, equity and owner-occupancy status — matched against monthly updated vacancy data. (See full methodology below). Vacancy data is available for U.S. residential properties at https://www.attomdata.com/solutions/marketing-lists/.
The report also reveals that 259,166 residential properties in the U.S. are in the process of foreclosure in the second quarter of this year, up 12.7 percent from the first quarter of 2022 and up 15.9 percent from the second quarter of 2021. This is also the third straight quarter that the count of pre-foreclosure properties has gone up since a nationwide foreclosure moratorium, imposed early during the Coronavirus pandemic, was lifted at the end of July 2021.
Among those pre-foreclosure properties, 7,569 sit vacant in the second quarter of 2022, meaning that the number of zombie-foreclosure properties went up quarterly by 2.8 percent.
"The incidence of zombie-foreclosures tends to be higher in cases where the foreclosure process has dragged on for many months and sometimes even for years," said Rick Sharga, executive vice president of market intelligence at ATTOM. "We're now seeing properties where the borrower was already in default prior to the government's moratorium re-enter the foreclosure process, and undoubtedly some of these homes will have been vacated over the past 26 months."
The number of zombie-foreclosures does remain down 6.3 percent from a year ago and continues to represent just a tiny segment of the nation's total stock of 99.7 million residential properties. Just one of every 13,171 homes in the second quarter of 2022 are vacant and in foreclosure, meaning that most neighborhoods have none. The portion of pre-foreclosure properties that have been abandoned into zombie status also continues to decline, down from 3.6 percent a year ago to 3.2 percent in the first quarter of 2022 and 2.9 percent in the second quarter of this year.
But the recent increase in zombie properties is the first since the moratorium ended. The portion of all residential properties sitting empty in the foreclosure process has grown 1.9 percent in the second quarter, up from one in 13,424 in the first quarter of this year.
The upward second-quarter foreclosure trends – in both overall and zombie-property counts - add to a list of measures showing how the decade-long U.S. housing market boom remains strong but also faces a possible slowdown this year.
Median single-family home prices have shot up 17 percent over the past year and typical home-seller profits remain historically high, at nearly 50 percent. Homeowner equity continues rising, greatly limiting the likelihood that homeowners facing foreclosure will simply walk away from their homes.
"According to our equity report, almost 90 percent of homeowners in foreclosure have positive equity," Sharga added. "Having equity gives financially-distressed homeowners an opportunity for a relatively soft landing – selling their home at a profit rather than losing everything to a foreclosure. That factor alone should keep the number of zombie-foreclosures from rising too much."
The median home value nationwide went up just 3 percent from the third quarter of last year to the first quarter of this year and home-seller profits have ticked down in 2022. At the same time, investment returns for speculators who flip properties have hit their lowest point since 2008. Beyond that, an estimated 1.5 million to 2 million homeowners fell behind on mortgages after the pandemic wiped out millions of jobs prior to the economy recovering last year.
A total of 7,569 residential properties facing possible foreclosure have been vacated by their owners nationwide in the second quarter of 2022, up slightly from 7,363 in the first quarter of 2022 but still down from up from 8,078 in the second quarter of 2021.
Amid numbers that remain extremely low, the biggest increases from the first quarter of 2022 to the second quarter of 2022 in states with at least 50 zombie foreclosures are in Michigan, (zombie properties up 74 percent, from 54 to 94), Arizona (up 56 percent, from 32 to 50), Georgia (up 29 percent, from 62 to 80), Nevada (up 26 percent, from 68 to 86) and Iowa (up 17 percent, from 132 to 155).
The biggest quarterly decreases among states with at least 50 zombie foreclosures are in Massachusetts (zombie properties down 13 percent, from 62 to 54), Missouri (down 13 percent, from 63 to 55), New Jersey (down 7 percent, from 275 to 257), New Mexico (down 3 percent, from 78 to 76) and New York (down 2 percent, from 2,074 to 2,041).
The vacancy rate for all residential properties in the U.S. has dropped to 1.31 percent in the second quarter of 2022 (one in 76 properties). That's down from 1.37 percent in the first quarter of 2022 (one in 73) and from 1.42 percent in the second quarter of last year (one in 70).
States with the biggest annual drops are Tennessee (down from 2.42 percent of all homes in the second quarter of 2021 to 1.55 percent in the second quarter of this year), Oregon (down from 1.84 percent to 1.01 percent), Maryland (down from 1.67 percent to 1.05 percent), Wisconsin (down from 1.36 percent to 0.76 percent) and Minnesota (down from 1.54 percent to 0.95 percent).
- Among metropolitan statistical areas in the U.S. with at least 100,000 residential properties and at least 100 properties facing possible foreclosure in the second quarter of 2022, the highest zombie rates are in Peoria, IL (11.3 percent of properties in the foreclosure process are vacant); Wichita, KS (11.2 percent); Cleveland, OH (9.5 percent); Syracuse, NY (8.9 percent) and South Bend, IN (8.6 percent).
- Aside from Cleveland, the highest zombie-foreclosure rates in major metro areas with at least 500,000 residential properties and at least 100 homes facing foreclosure in the second quarter of 2022 are in Baltimore, MD (8.3 percent of homes in the foreclosure process are vacant); Portland, OR (6.5 percent); Indianapolis, IN (5.9 percent) and Pittsburgh, PA (5.9 percent).
- In the 164 metro areas analyzed for this report, those where zombie homes represent the largest shares of all residential properties in the second quarter of 2022 are Cleveland, OH (one in 1,426 homes are empty and facing foreclosure); Peoria, IL (one in 1,565); Albany, NY (one in 1,725); Syracuse, NY (one in 2,195) and Rochester, NY (one in 2,964).
- Among the 27.9 million investor-owned homes throughout the U.S. in the second quarter of 2022, about 905,000 are vacant, or 3.2 percent. The highest levels of vacant investor-owned homes are in Indiana (6.9 percent), Kansas (5.8 percent), Oklahoma (5.3 percent), Alabama (5.1 percent) and Ohio (5 percent).
- Among the roughly 3,300 foreclosed, bank-owned homes in the U.S. during the second quarter of 2022, 10.8 percent are vacant. In states with at least 50 bank-owned homes, the largest vacancy rates are in Pennsylvania (19.9 percent vacant), Indiana (17.2 percent), Texas (16.4 percent), Ohio (16 percent) and Illinois (15.9 percent).
- The highest zombie-foreclosure rates in U.S. counties with at least 500 properties in the foreclosure process during the second quarter of 2022 are in Broome County (Binghamton), NY (11.8 percent of pre-foreclosure homes are empty); Cuyahoga County (Cleveland), OH (10.8 percent); Onondaga County (Syracuse), NY (9.4 percent); Pinellas County (Clearwater), FL (9.3 percent); and Oneida County, NY (outside Syracuse) (8.3 percent).
- The lowest zombie rates among counties with at least 500 properties in foreclosure in the second quarter of 2022 are in Contra Costa County, CA (outside Oakland) (no pre-foreclosure homes are empty); Hudson County, NJ (outside New York, NY) (0.3 percent); Atlantic County (Atlantic City), NJ (0.4 percent); Mecklenburg County (Charlotte), NC (0.5 percent) and Sacramento County, CA (0.6 percent).
- Among 424 counties with at least 50,000 residential properties, those with the largest portion of total homes in zombie foreclosure status in the second quarter of 2022 are Broome County (Binghamton), NY (one of every 648 properties); Cuyahoga County (Cleveland), OH (one in 933); Peoria County, IL (one in 1,144); Suffolk County (eastern Long Island), NY (one in 1,165) and Oneida County, NY (outside Syracuse) (one in 1,437).
ATTOM analyzed county tax assessor data for about 99 million residential properties for vacancy, broken down by foreclosure status and owner-occupancy status. Only metropolitan statistical areas with at least 100,000 residential properties and counties with at least 50,000 residential properties were included in the analysis. Vacancy data is available at https://www.attomdata.com/solutions/marketing-lists/.
ATTOM provides premium property data to power products that improve transparency, innovation, efficiency and disruption in a data-driven economy. ATTOM multi-sources property tax, deed, mortgage, foreclosure, environmental risk, natural hazard, and neighborhood data for more than 155 million U.S. residential and commercial properties covering 99 percent of the nation's population. A rigorous data management process involving more than 20 steps validates, standardizes, and enhances the real estate data collected by ATTOM, assigning each property record with a persistent, unique ID — the ATTOM ID. The 20TB ATTOM Data Warehouse fuels innovation in many industries including mortgage, real estate, insurance, marketing, government and more through flexible data delivery solutions that include bulk file licenses, property data APIs, real estate market trends, property reports and more. Also, introducing our newest innovative solution, that offers immediate access and streamlines data management – ATTOM Cloud.
Media Contact:
Christine Stricker
949.748.8428
christine.stricker@attomdata.com
Data and Report Licensing:
datareports@attomdata.com
View original content to download multimedia:
SOURCE ATTOM
|
https://www.mysuncoast.com/prnewswire/2022/06/02/vacant-zombie-properties-rising-second-quarter-amid-jump-foreclosure-activity/
| 2022-06-02T05:02:20Z
|
SAN DIEGO, April 25, 2022 /PRNewswire/ -- Qualcomm Incorporated today announced the appointment of Jim Cathey as Chief Commercial Officer, Qualcomm Technologies, Inc., joining Qualcomm's executive committee. Cathey's appointment will be effective immediately and he will report directly to Cristiano Amon, President and CEO of Qualcomm Incorporated.
"Jim's leadership has been integral to cultivating, strengthening, and expanding key partner's relationships while augmenting our regional sales and customer support capabilities. His contribution to Qualcomm's success over the years has been significant," said Cristiano Amon, President, and CEO of Qualcomm. "I'm pleased to have Jim join Qualcomm's executive committee as Chief Commercial Officer as we continue to grow the business into new industries and execute on the largest opportunities in Qualcomm's history."
Cathey joined Qualcomm in 2006 and prior to this appointment was senior vice president and president of Global Business for Qualcomm Technologies, Inc. with overall responsibility for all go-to-market activities, including global sales and business development, account management, carrier partnerships, sales operations, distribution channels, as well as assisting with in-country relationships. Prior, Cathey was president of Qualcomm Technologies businesses in Asia Pacific and India, after holding the positions of president of Qualcomm Technologies operations in Japan, and country manager in Taiwan. Before joining Qualcomm, Cathey served as an executive at Micron Technology and MicroDisplay, as well as the head of Investor Relations for PixTech.
Cathey holds seventeen patents and is on board of directors at CTIA. Cathey earned a Bachelor of Business Administration in Marketing from Boise State University. Cathey sits on the board of San Diego Harbor Police Foundation.
About Qualcomm
Qualcomm is the world's leading wireless technology innovator and the driving force behind the development, launch, and expansion of 5G. When we connected the phone to the internet, the mobile revolution was born. Today, our foundational technologies enable the mobile ecosystem and are found in every 3G, 4G and 5G smartphone. We bring the benefits of mobile to new industries, including automotive, the internet of things, and computing, and are leading the way to a world where everything and everyone can communicate and interact seamlessly.
Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of our engineering, research, and development functions, and substantially all of our products and services businesses, including our QCT semiconductor business.
Qualcomm Contacts:
Pete Lancia, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com
Mauricio Lopez-Hodoyan, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com
View original content to download multimedia:
SOURCE Qualcomm Incorporated
|
https://www.mysuncoast.com/prnewswire/2022/04/25/qualcomm-appoints-jim-cathey-chief-commercial-officer/
| 2022-04-25T13:34:44Z
|
- Second-Quarter 2022 Financial Results
- Reported Revenues Grew 1%, and Organic Revenues1,2 Grew 6%, Driven by Strong Performance in Vision Care and Surgical Segments
- Reaffirmed 2022 Full-Year Revenue and Adjusted EBITDA (non-GAAP)1 Guidance Ranges
VAUGHAN, ON, Aug. 4, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company", "we" or "our"), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2022 financial results.
"In the second quarter, Bausch + Lomb delivered strong results that demonstrate the advantages of our integrated eye care platform, the durability of our leading brands and the ability of our teams to simultaneously execute on business performance and drive innovation," said Joseph C. Papa, CEO, Bausch + Lomb. "Our Consumer business performed exceptionally well with three of our leading franchises – LUMIFY®, Biotrue® solutions and PreserVision® vitamins – each achieving a record-high market share in its respective category."
- Launched Revive™ Custom Soft Contact Lenses in the United States
- Launched XIPERE®3 (triamcinolone acetonide injectable suspension), a therapy that uses the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, in the United States; additionally, XIPERE® received its permanent J-code, a reimbursement code used by commercial insurers and government payers, which became effective for provider billing on July 1, 2022
- Submitted a New Drug Application to the U.S. Food and Drug Administration for NOV034 (perfluorohexyloctane), an investigational treatment with a proposed indication of treating the signs and symptoms of dry eye disease associated with Meibomian gland dysfunction
- Launched Biotrue® Hydration Plus Multi-Purpose Solution in the United States
- Bausch + Lomb INFUSE®/ULTRA® ONE DAY daily disposable silicone hydrogel contact lenses are now available in approximately 25 countries, including recent launches in Cyprus and Norway
- Launched LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%) in Canada
- Enrolled first patient in a study evaluating the safety and efficacy of the Technolas® TENEO™ excimer laser in the United States for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for hyperopia with astigmatism5
- Entered into strategic agreements with Sanoculis, an Israel ophthalmic medical device start-up company, designed to address unmet needs in glaucoma, including an equity investment in Sanoculis, an exclusive European distribution agreement for Sanoculis' Minimally Invasive Micro Sclerostomy ("MIMS®"), which is an innovative minimally invasive surgical procedure for the treatment of glaucoma, and an option agreement to purchase all of the assets of Sanoculis
Total reported revenues were $941 million for the second quarter of 2022, as compared to $934 million in the second quarter of 2021, an increase of $7 million, or 1%. Foreign exchange had an unfavorable impact on revenues by $46 million in the second quarter of 2022. Revenue increased organically1,2 by approximately 6% compared to the second quarter of 2021.
Revenues by segment were as follows:
Second-Quarter 2022
Vision Care segment revenues were $589 million for the second quarter of 2022, as compared to $556 million for the second quarter of 2021, an increase of $33 million, or 6%. Excluding the unfavorable impact of foreign exchange of $29 million, the segment increased organically1,2 by approximately 11% compared to the second quarter of 2021, primarily due to higher sales of LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%), Biotrue® solutions franchise and Ocuvite® + PreserVision®, partially offset by decreased sales in the Contact Lens business in China driven by COVID-19 lockdowns that continued into the second quarter of 2022.
Surgical segment revenues were $184 million for the second quarter of 2022, as compared to $185 million for the second quarter of 2021, a decrease of $1 million, or 1%. Excluding the unfavorable impact of foreign exchange of $11 million and the impact of divestitures and discontinuations of $3 million, the segment increased organically1,2 by approximately 7% compared to the second quarter of 2021, primarily due to increased sales of consumables and intraocular lenses.
Ophthalmic Pharmaceuticals segment revenues were $168 million for the second quarter of 2022, as compared to $193 million for the second quarter of 2021, a decrease of $25 million, or 13%. Excluding the unfavorable impact of foreign exchange of $6 million, the segment decreased organically1,2 by approximately 10% compared to the second quarter of 2021, mainly due to loss of exclusivity in the branded portfolio, primarily the LOTEMAX® franchise, and competitive market dynamics in the generics portfolio.
Operating income was $56 million for the second quarter of 2022, as compared to $58 million for the second quarter of 2021, a decrease of $2 million. The change was primarily driven by an increase in Selling, general and administrative (SG&A) expenses mainly due to inflationary impacts on transportation costs, R&D investment and Cost of goods sold, partially offset by a decrease in amortization of intangible assets and an increase in revenues. The Company is continuing to maintain a disciplined approach to cost management and leverage its infrastructure.
Net income for the second quarter of 2022 was $5 million, as compared to a net income of $44 million for the second quarter of 2021, a decrease of $39 million. The change was primarily due to an increase in interest expense and the decrease in operating results noted above, partially offset by a favorable change in the Provision for income taxes.
Adjusted net income (non-GAAP)1 for the second quarter of 2022 was $103 million, as compared to $116 million for the second quarter of 2021, a decrease of $13 million.
Cash flow from operations for the second quarter of 2022 was $156 million, as compared to $250 million for the second quarter of 2021, a decrease of $94 million. Cash flow from operations was negatively impacted by the change in our operating assets and liabilities driven by a strategic build in inventory, the timing of payments in the ordinary course of business and our operating results. Cash flow from operations in the second quarter of 2021 was prepared on a carve-out basis and does not include items we are now incurring as a publicly traded company, such as interest.
GAAP Earnings Per Share ("EPS") and Adjusted EPS (non-GAAP)1 for the second quarter of 2021 has been calculated on a pro forma basis after giving effect to our initial public offering ("IPO").
GAAP EPS Basic and Diluted for the second quarter of 2022 was $0.01, as compared to $0.13 for the second quarter of 2021. Adjusted EPS (non-GAAP)1 for the second quarter of 2022 was $0.29, as compared to $0.33 for the second quarter of 2021.
Adjusted EBITDA (non-GAAP)1 was $182 million for the second quarter of 2022, as compared to $200 million for the second quarter of 2021, a decrease of $18 million, primarily due to foreign exchange headwinds, the impact from the COVID-19 lockdown in China, higher SG&A expenses and R&D investment, partially offset by strong organic2 revenue growth.
Bausch + Lomb maintained guidance for the full year of 2022 as follows:
- Full-year revenue range of $3.75 – $3.80 billion, reflecting anticipated 4-5% organic1,2 growth
- Full-year Adjusted EBITDA (non-GAAP)1 range of $740 – $780 million
Other than with respect to GAAP Revenues, the Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking Adjusted EBITDA (non-GAAP)1 to GAAP net income (loss) or of forward-looking organic growth1,2 to reported revenue growth, due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. These amounts may be material and, therefore, could result in the projected GAAP measure or ratio being materially different or less than the projected non-GAAP measure or ratio. These statements represent forward-looking information and may not represent a financial outlook, and actual results may vary. Please see the risks and assumptions referred to in the Forward-looking Statements section of this news release.
- Bausch + Lomb's cash, cash equivalents and restricted cash were $446 million at June 30, 2022
- Basic and diluted weighted average shares outstanding for the second quarter of 2022 were 350 million shares
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
This news release contains forward-looking information and statements within the meaning of applicable securities laws (collectively, "forward-looking statements"), which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and positive and negative variations or similar expressions and phrases or statements that certain actions, events or results may, could, should or will be achieved, received or taken, or will occur or result, and similar such expressions also identify forward-looking information. Forward-looking statements include statements regarding Bausch + Lomb's future prospects and performance, including the Company's 2022 full-year guidance, the anticipated spinoff of Bausch + Lomb from Bausch Health Companies Inc. ("BHC") and the timing thereof, and details of the Company's product pipeline. These forward-looking statements, including the Company's full-year guidance, are based upon the current expectations and beliefs of management and are provided for the purpose of providing additional information about such expectations and beliefs, and readers are cautioned that these statements may not be appropriate for other purposes. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission ("SEC") and the Canadian Securities Administrators (the "CSA") (including the Company's final prospectus as filed with the SEC on May 5, 2022 pursuant to Rule 424(b)(4) under the Securities Act of 1933 relating to the Company's Registration Statement on Form S-1 and the Company's supplemented PREP prospectus as filed with the CSA on May 5, 2022), which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties relating to the proposed plan to spin off Bausch + Lomb from BHC, including the expected benefits and costs of the spinoff transaction, the expected timing of completion of the spinoff transaction and its terms (including the expectation that the spinoff transaction will be completed following the expiry of customary lock-ups related to the Bausch + Lomb IPO and achievement of targeted net leverage ratios, subject to market conditions and receipt of applicable shareholder and other necessary approvals), the ability to complete the spinoff transaction considering the various conditions to the completion of the spinoff transaction (some of which are outside the Company's and BHC's control, including conditions related to regulatory matters and receipt of applicable shareholder and other approvals), the impact of any potential sales of the Company's common shares by BHC subject to expiry of lock-ups, that market or other conditions are no longer favorable to completing the transaction, that applicable shareholder, stock exchange, regulatory or other approval is not obtained on the terms or timelines anticipated or at all, business disruption during the pendency of or following the spinoff transaction, diversion of management time on spinoff transaction-related issues, retention of existing management team members, the reaction of customers and other parties to the spinoff transaction, the qualification of the spinoff transaction as a tax-free transaction for Canadian and/or U.S. federal income tax purposes (including whether or not an advance ruling from the Canada Revenue Agency and/or the Internal Revenue Service will be sought or obtained), the ability of the Company and BHC to satisfy the conditions required to maintain the tax-free status of the spinoff transaction (some of which are beyond their control), other potential tax or other liabilities that may arise as a result of the spinoff transaction, the potential dis-synergy costs resulting from the spinoff transaction, the impact of the spinoff transaction on relationships with customers, suppliers, employees and other business counterparties, general economic conditions, conditions in the markets the Company is engaged in, behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting the Company's business. In particular, the Company can offer no assurance that any spinoff transaction will occur at all, or that any spinoff transaction will occur on the terms and timelines anticipated by the Company and BHC. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, the fear of that pandemic, the emergence of variant and subvariant strains of COVID-19 (including the Delta and Omicron variants and subvariants thereof) and any resulting reinstitution of lockdowns or other restrictions, the availability and effectiveness of vaccines for COVID-19 (including with respect to current or future variants and subvariants), COVID-19 vaccine immunization rates, the evolving reaction of governments, private sector participants and the public to that pandemic and the potential effects and economic impact of that pandemic, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). Finally, they also include, but are not limited to, risks and uncertainties caused by or relating to a potential recession and its impact on revenues, expenses and resulting margins. In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including, without limitation, assumptions regarding our 2022 full-year guidance with respect to expectations regarding base performance growth and organic growth, currency impact, run-rate dis-synergies and inflation, expectations regarding adjusted gross margin (non-GAAP), adjusted SG&A expense (non-GAAP) and the Company's ability to continue to manage such expense in the manner anticipated and the anticipated timing and extent of the Company's R&D expense; and the assumption that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. Management has also made certain assumptions in assessing the anticipated impacts of the COVID-19 pandemic on the Company and its results of operations and financial conditions, including: that there will be no material restrictions on access to health care products and services resulting from a possible resurgence of the virus and variant and subvariant strains thereof on a global basis in 2022; there will be increased availability and use of effective vaccines; that the strict social restrictions in the first half of 2020 will not be materially re-enacted in the event of a material resurgence of the virus and variant and subvariant strains thereof; that there will be an ongoing, gradual global recovery as the macroeconomic and health care impacts of the COVID-19 pandemic diminish over time; that the largest impact to the Company's businesses were seen in the second quarter of 2020; that, to the extent not already achieved, our revenues will likely return to pre-pandemic levels during 2022, but that rates of recovery will vary by geography and business unit, with some regions and business units expected to lag in recovery possibly beyond 2022; and no major interruptions in the Company's supply chain and distribution channels. If any of these assumptions regarding the impacts of the COVID-19 pandemic are incorrect, our actual results could differ materially from those described in these forward-looking statements.
Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses certain non-GAAP financial measures and ratios. Management uses these non-GAAP measures and ratios as key metrics in the evaluation of the Company's performance and the consolidated financial results and, in part, in the determination of cash bonuses for its executive officers. The Company believes these non-GAAP measures and ratios are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP measures and ratios address questions the Company routinely receives from analysts and investors, and in order to assure that all investors have access to similar data, the Company has determined that it is appropriate to make this data available to all investors.
These measures and ratios do not have any standardized meaning under GAAP and other companies may use similarly titled non-GAAP financial measures and ratios that are calculated differently from the way we calculate such measures and ratios. Accordingly, our non-GAAP financial measures and ratios may not be comparable to similar non-GAAP measures and ratios of other companies. We caution investors not to place undue reliance on such non-GAAP measures and ratios, but instead to consider them with the most directly comparable GAAP measures and ratios. Non-GAAP financial measures and ratios have limitations as analytical tools and should not be considered in isolation. They should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.
The reconciliations of these historic non-GAAP financial measures and ratios to the most directly comparable financial measures and ratios calculated and presented in accordance with GAAP are shown in the tables below.
EBITDA and Adjusted EBITDA (non-GAAP)
EBITDA (non-GAAP) is Net income attributable to Bausch + Lomb Corporation (its most directly comparable U.S. GAAP financial measure) adjusted for interest, income taxes, depreciation and amortization. Adjusted EBITDA (non-GAAP) is EBITDA (non-GAAP) further adjusted for the items described below. Management believes that Adjusted EBITDA (non-GAAP), along with the GAAP measures used by management, most appropriately reflect how the Company measures the business internally and sets operational goals and incentives. In particular, the Company believes that Adjusted EBITDA (non-GAAP) focuses management on the Company's underlying operational results and business performance. As a result, the Company uses Adjusted EBITDA (non-GAAP) both to assess the actual financial performance of the Company and to forecast future results as part of its guidance. Management believes Adjusted EBITDA (non-GAAP) is a useful measure to evaluate current performance. Adjusted EBITDA (non-GAAP) is intended to show our unleveraged, pre-tax operating results and therefore reflects our financial performance based on operational factors. In addition, cash bonuses for the Company's executive officers and other key employees are based, in part, on the achievement of certain Adjusted EBITDA (non-GAAP) targets.
EBITDA (non-GAAP) is Net income attributable to Bausch + Lomb (its most directly comparable U.S. GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization. Adjusted EBITDA (non-GAAP) is EBITDA (non-GAAP) further adjusted for the following items:
- Asset impairments: The Company has excluded the impact of impairments of finite-lived and indefinite-lived intangible assets as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions and divestitures. The Company believes that the adjustments of these items correlate with the sustainability of the Company's operating performance. Although the Company excludes impairments of intangible assets from measuring the performance of the Company and its business, the Company believes that it is important for investors to understand that intangible assets contribute to revenue generation.
- Restructuring and integration costs: The Company has incurred restructuring costs as it implemented certain strategies, which involved, among other things, improvements to its infrastructure and operations, internal reorganizations and impacts from the divestiture of assets and businesses. With regard to infrastructure and operational improvements which the Company has taken to improve efficiencies in the businesses and facilities, these tend to be costs intended to right size the business or organization that fluctuate significantly between periods in amount, size and timing, depending on the improvement project, reorganization or transaction. The Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the Company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors.
- Acquisition-related costs and adjustments excluding amortization of intangible assets: The Company excludes the impact of acquisition-related contingent consideration non-cash adjustments due to the inherent uncertainty and volatility associated with such amounts based on changes in assumptions with respect to fair value estimates, and the amount and frequency of such adjustments are not consistent and are significantly impacted by the timing and size of the Company's acquisitions, as well as the nature of the agreed-upon consideration.
- Share-based compensation: The Company excludes costs relating to share-based compensation. The Company believes that the exclusion of share-based compensation expense assists investors in the comparisons of operating results to peer companies. Share-based compensation expense can vary significantly based on the timing, size and nature of awards granted.
- Separation costs and separation-related costs: The Company has excluded certain costs incurred in connection with activities taken to: (i) separate the Bausch + Lomb business from the remainder of BHC and (ii) register the Bausch + Lomb business as an independent publicly traded entity. Separation costs are incremental costs directly related to effectuating the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, legal, audit and advisory fees, talent acquisition costs and costs associated with establishing a new board of directors and audit committee. Separation-related costs are incremental costs indirectly related to the separation of the Bausch + Lomb business from the remainder of BHC and include, but are not limited to, IT infrastructure and software licensing costs, rebranding costs and costs associated with facility relocation and/or modification. As these costs arise from events outside of the ordinary course of continuing operations, the Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the Company's operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors.
- Other Non-GAAP adjustments: The Company also excludes certain other amounts, including IT infrastructure investment, litigation and other matters, gain/(loss) on sales of assets and certain other amounts that are the result of other, non-comparable events to measure operating performance if and when present in the periods presented. These events arise outside of the ordinary course of continuing operations. Given the unique nature of the matters relating to these costs, the Company believes these items are not routine operating expenses. For example, legal settlements and judgments vary significantly, in their nature, size and frequency, and, due to this volatility, the Company believes the costs associated with legal settlements and judgments are not routine operating expenses. The Company has also excluded certain other costs, including settlement costs associated with the conversion of a portion of the Company's defined benefit plan in Ireland to a defined contribution plan. The Company excluded these costs as this event is outside of the ordinary course of continuing operations and is infrequent in nature. The Company believes that the exclusion of such out-of-the-ordinary-course amounts provides supplemental information to assist in the comparison of the financial results of the Company from period to period and, therefore, provides useful supplemental information to investors. However, investors should understand that many of these costs could recur and that companies in our industry often face litigation.
Adjusted Net Income (non-GAAP)
Adjusted net income (non-GAAP) is net income (loss) attributable to Bausch + Lomb Corporation (its most directly comparable GAAP financial measure) adjusted for asset impairments, restructuring and integration costs, acquisition-related contingent consideration, acquired in-process research and development costs, separation costs and separation-related costs and other non-GAAP adjustments, as these adjustments are described above, and further adjusted for amortization of intangible assets, as described below:
- Amortization of intangible assets: The Company has excluded the impact of amortization of intangible assets, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. The Company believes that the adjustments of these items correlate with the sustainability of the Company's operating performance. Although the Company excludes the amortization of intangible assets from its non-GAAP expenses, the Company believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.
Adjusted net income (non-GAAP) excludes the impact of these certain items that may obscure trends in the Company's underlying performance. Management uses Adjusted net income (non-GAAP) for strategic decision making, forecasting future results and evaluating current performance. By disclosing this non-GAAP measure, it is management's intention to provide investors with a meaningful, supplemental comparison of the Company's operating results and trends for the periods presented. Management believes that this measure is also useful to investors as such measure allows investors to evaluate the Company's performance using the same tools that management uses to evaluate past performance and prospects for future performance. Accordingly, the Company believes that Adjusted net income (non-GAAP) is useful to investors in their assessment of the Company's operating performance and the valuation of the Company. It is also noted that, in recent periods, our GAAP net income (loss) was significantly lower than our Adjusted net income (non-GAAP).
Organic Growth/Change and Organic Revenue
Organic growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of recent acquisitions, divestitures and discontinuations (if applicable). Organic growth/change is a change in GAAP Revenue (its most directly comparable GAAP financial measure) adjusted for certain items, as further described below, of businesses that have been owned for one or more years. Similarly, organic revenue, a non-GAAP measure, is GAAP revenue (its most directly comparable GAAP financial measure) adjusted for these same items. Organic revenue growth/change is impacted by changes in product volumes and price. The price component is made up of two key drivers: (i) changes in product gross selling price and (ii) changes in sales deductions. The Company uses organic growth/change and organic revenue to assess the performance of its reportable segments, and the Company in total, without the impact of foreign currency exchange fluctuations and recent acquisitions, divestitures and product discontinuations. The Company believes that such measures are useful to investors as they provide a supplemental period-to-period comparison.
Organic growth/change and organic revenue reflect adjustments for: (i) the impact of period-over-period changes in foreign currency exchange rates on revenues and (ii) the revenues associated with acquisitions, divestitures and discontinuations of businesses divested and/or discontinued. These adjustments are determined as follows:
- Foreign currency exchange rates: Although changes in foreign currency exchange rates are part of our business, they are not within management's control. Changes in foreign currency exchange rates, however, can mask positive or negative trends in the business. The impact of changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period.
- Acquisitions, divestitures and discontinuations: In order to present period-over-period organic revenue (non-GAAP) growth/change on a comparable basis, revenues associated with acquisitions, divestitures and discontinuations are adjusted to include only revenues from those businesses and assets owned during both periods. Accordingly, organic revenue and organic growth/change exclude from the current period, revenues attributable to each acquisition for twelve months subsequent to the day of acquisition, as there are no revenues from those businesses and assets included in the comparable prior period. Organic revenue and organic growth/change exclude from the prior period, all revenues attributable to each divestiture and discontinuance during the twelve months prior to the day of divestiture or discontinuance, as there are no revenues from those businesses and assets included in the comparable current period.
Constant Currency
Changes in the relative values of non-U.S. currencies to the U.S. dollar may affect the Company's financial results and financial position. To assist investors in evaluating the Company's performance, we have adjusted for foreign currency effects. Constant currency impact is determined by comparing 2022 reported amounts adjusted to exclude currency impact, calculated using 2021 monthly average exchange rates, to the actual 2021 reported amounts.
Adjusted EPS (non-GAAP)
Adjusted earnings per share or Adjusted EPS (non-GAAP) is calculated as Diluted income per share attributable to Bausch + Lomb Corporation ("GAAP EPS") (its most directly comparable GAAP financial measure), adjusted for the per diluted share impact of each adjustment made to reconcile Net income to Adjusted net income (non-GAAP) as discussed above. Like Adjusted net income (non-GAAP), Adjusted EPS (non-GAAP) excludes the impact of certain items that may obscure trends in the Company's underlying performance on a per share basis. By disclosing this non-GAAP measure, it is management's intention to provide investors with a meaningful, supplemental comparison of the Company's results and trends for the periods presented on a diluted share basis. Accordingly, the Company believes that Adjusted EPS (non-GAAP) is useful to investors in their assessment of the Company's operating performance, the valuation of the Company and an investor's return on investment. It is also noted that, for the periods presented, our GAAP EPS was significantly lower than our Adjusted EPS (non-GAAP).
© 2022 Bausch & Lomb Incorporated or its affiliates.
FINANCIAL TABLES FOLLOW
View original content to download multimedia:
SOURCE Bausch + Lomb Corporation
|
https://www.wibw.com/prnewswire/2022/08/04/bausch-lomb-announces-second-quarter-2022-results/
| 2022-08-04T11:44:14Z
|
U.S. Open qualifier Maxwell Moldovan races to third Stark Amateur Golf Championship win
Mike Popovich
The Repository
UNIONTOWN — Maxwell Moldovan took control right away and never let go.
The Green High School graduate and Ohio State junior won the Stark County Amateur Golf Tournament for the third time Sunday at Prestwick Country Club. Moldovan fired a blistering 66 on Saturday and shot 68 on Sunday, finishing at 10-under overall.
Moldovan, who played in last month's U.S. Open, also won the Stark Amateur in 2019 and 2020.
Green junior Kyle Smith finished second at 1-over. His 67 on Sunday was the lowest round of the
This story will be updated.
Reach Mike at mike.popovich@cantonrep.com
On Twitter: @mpopovichREP
|
https://www.cantonrep.com/story/sports/2022/07/24/maxwell-moldovan-stark-amateir-golf-championship-prestwick-country-club-green-ohio-state-u-s-open/10113617002/
| 2022-07-25T00:11:47Z
|
Premium Brand and Global Supporter of the Arts, LG SIGNATURE Unites with Famed Pianist to Share the Gift of Music and Raise Proceeds to Nurture the Talent of Deserving, Young Artists
SEOUL, South Korea, Sept. 6, 2022 /PRNewswire/ -- LG Electronics (LG) has announced the successful culmination of its main sponsorship for the Rheingau Music Festival 2022, spearheaded by the company's premium brand LG SIGNATURE.
Returning to Rheingau for the second consecutive year, LG SIGNATURE was supported by diverse music-lovers worldwide who resonate with the brand's long-standing commitment for the arts and culture. The brand's charity concert featuring world-renowned classical pianist Jan Lisiecki, was an especially popular audience attraction and the grand finale to the brand's hosted concert series.
This year's Rheingau Music Festival, which took place from June 25 to September 3, encompassed more than 100 jazz and classical music concerts, held at a variety of idyllic venues throughout the picturesque Rheingau region.
LG SIGNATURE was proud to host a trio of featured concerts at the popular music festival, treating audiences to the immense talents of pianist Jan Lisiecki, violinist Julia Fischer, and bassoonist Sophie Dervaux. Each a master of their chosen musical instrument, the three critically acclaimed artists embodied LG SIGNATURE's dedication to achieving perfection.
In addition to the three, headline classical performances, the brand played host to an exclusive charity concert featuring Jan Lisiecki. All proceeds from the event went toward helping artists – especially young classical musicians – throughout Europe.
Lisiecki, accompanied by the Norwegian Chamber Orchestra, delivered a memorable performance at the Kurhaus Wiesbaden convention center, including a beautiful rendition of Chopin's Concerto No. 1 in E minor, Op. 11. Along with getting to enjoy a sublime musical experience, concert attendees were given the opportunity to participate in a raffle with prizes including LG products. The special evening was rounded off with a meet and greet with Lisiecki himself.
"As a brand steadfastly committed to bringing art and technology together, we will continue to support major cultural events such as the Rheingau Music Festival," said Lee Jeong-seok, head of LG Electronics Global Marketing Center. "It was a joy for us to sponsor the festival again and collaborate with Jan Lisiecki, empowering and providing much-needed resources to deserving, young artists."
Throughout the Rheingau Music Festival 2022, LG SIGNATURE displayed a number of its innovative and aesthetically appealing products, for concert-goers to experience and admire, including the stunning LG SIGNATURE Wine Cellar. With a sleek design and precise temperature and humidity control, the Wine Cellar is the perfect solution for storing the delectable wines the Rheingau region is known for.
Staying true to its philosophy of "Art Inspires Technology, Technology Completes Art," LG SIGNATURE will continue to support the best of arts and culture, worldwide. LG SIGNATURE is a partner to multiple globally-renowned institutions, including UK's Royal Philharmonic Orchestra.
About LG SIGNATURE
LG SIGNATURE is the first ultra-premium brand across multiple product categories from global innovator LG Electronics. Designed for the most discerning consumers, LG SIGNATURE products deliver a state-of-the-art living experience that feels pure, sophisticated and luxurious. Combining the very best of everything LG has to offer, LG SIGNATURE products are designed with a focus on their "true essence" aligned with the brand's modern, distinctive design. For more information, visit www.LGSIGNATURE.com.
View original content to download multimedia:
SOURCE LG SIGNATURE
|
https://www.mysuncoast.com/prnewswire/2022/09/07/lgs-charity-concert-brings-magic-classical-mastery-rheingau-music-festival/
| 2022-09-07T02:38:35Z
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.